Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005229	s-alfa-2	g/l (g/l)	10200	22682	0.00%
3005229	s-alfa-2	— (—)	1806	2372	100.00%	Distribution not available
3005229	s-alfa2	g/l (—)	890	1427	100.00%	Distribution not available
3005229	alfa2-glob	g/l (—)	682	2715	100.00%	Distribution not available
3005229	s-a2glob	g/l (—)	410	876	100.00%	Distribution not available
3005229	s-alfa-2-fraktio	g/l (g/l)	307	369	0.00%
3005229	alfa-2	g/l (—)	113	347	100.00%	Distribution not available
3005229	alfa-2-glo	g/l (—)	85	96	100.00%	Distribution not available
3005229	s-alfa2-globuliini(valetietues-prot-fr)	g/l (—)	60	82	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Finngen Rheumatological endpoints

2889

7307

2.31

322.61

2.0

2.3

7.47

7.18

g/l

11.49

2204

5468

Glomerular diseases

924

2396

4.24

320.00

2.6

2.2

7.92

7.34

g/l

13.35

739

1777

Dialysis, with operation codes

701

1478

5.34

318.30

3.9

2.1

7.51

7.30

g/l

1.75

571

1098

Other and unspecified anaemias

2417

5774

4.48

307.65

2.5

2.1

7.36

7.48

g/l

2.04

1737

4210

Autoimmune diseases excluding thyroid diseases

3417

8345

2.34

307.65

1.9

2.4

7.41

7.31

g/l

2.25

2582

6187

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1357

1066

22.13

307.65

10.6

1.3

6.96

7.45

g/l

10.80

960

775

General symptoms and signs

3449

7252

2.45

307.65

2.4

2.0

7.38

7.28

g/l

1.70

2598

5371

Aplastic and other anaemias

2561

6178

4.33

307.65

2.5

2.1

7.36

7.48

g/l

2.05

1833

4502

All pneumoniae

3193

9917

2.29

307.65

3.0

1.9

7.63

7.25

g/l

20.24

2403

7430

Polyarthropathies

2681

6060

3.08

307.65

2.4

2.3

7.68

7.26

g/l

19.49

2058

4517

Influenza and pneumonia

3274

9810

2.26

307.65

3.0

1.9

7.60

7.25

g/l

17.36

2454

7365

Polyneuropathies and other disorders of the peripheral nervous system

1394

3102

5.13

307.65

2.3

2.2

7.11

7.45

g/l

8.25

1017

2283

Metabolic disorders

3146

8502

2.37

307.65

2.5

2.1

7.54

7.27

g/l

9.76

2336

6371

2958

8049

2.37

307.65

3.0

1.8

7.61

7.27

g/l

15.17

2223

6024

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4690

8826

4.06

307.65

2.5

2.1

7.33

7.39

g/l

1.14

3485

6585

Implicit Sepsis

2679

8493

2.56

307.65

2.4

2.1

7.56

7.36

g/l

5.54

1974

6275

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2958

8049

2.37

307.65

3.0

1.8

7.61

7.27

g/l

15.17

2223

6024

Condition for Implicit Sepsis (Organ dysfunction codes)

2846

9046

2.36

307.65

2.4

2.1

7.48

7.34

g/l

3.15

2127

6715

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

833

579

27.44

307.65

7.3

1.3

6.91

7.56

g/l

10.15

591

422

Multiple myeloma and malignant plasma cell neoplasms

672

619

17.66

307.65

16.5

1.5

7.02

7.49

g/l

5.26

482

461

Malaise and fatigue

1818

5252

3.02

307.65

2.1

7.50

7.34

g/l

2.74

1346

3808

Pneumonia, organism unspecified

2922

9396

2.32

307.65

3.0

1.9

7.66

7.26

g/l

20.17

2206

7018

Second line medication for Crohn's disease

2112

7515

2.95

307.65

5.0

1.7

7.46

7.33

g/l

2.09

1606

5645

Bacterial infection, other or unspecified

2321

6838

3.26

307.65

3.3

2.0

7.87

7.32

g/l

24.82

1680

4994

Multiple myeloma

398

328

21.81

307.65

20.5

1.6

7.05

7.61

g/l

3.77

292

236

Primary_lymphoid and hematopoietic malignant neoplasms

1647

3358

5.65

307.65

8.3

1.4

7.10

7.48

g/l

10.42

1225

2465

Systemic connective tissue disorders

1641

4882

3.62

307.65

1.8

2.3

7.76

7.42

g/l

8.19

1240

3567

Other anaemias

2433

5822

4.45

307.65

2.5

2.1

7.36

7.48

g/l

1.98

1746

4244

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3105

9969

2.25

307.65

3.0

2.0

7.64

7.26

g/l

19.98

2331

7456

First line medication for Crohn's disease

3855

7894

2.75

307.65

3.0

1.6

7.45

7.23

g/l

8.11

2945

5808

Multiple myeloma and malignant plasma cell neoplasms

672

586

18.69

307.65

16.5

1.4

7.02

7.52

g/l

5.75

482

425

ILD medications: immunosuppressive drugs

2593

6767

3.89

307.65

4.4

1.7

7.43

7.24

g/l

4.60

1992

4999

Heart failure, not strict

2894

7840

2.67

307.65

2.4

2.3

7.67

7.32

g/l

15.28

2184

5796

Inflammatory bowel disease treatment related agents

3963

9068

2.57

307.65

2.0

2.3

7.56

7.24

g/l

17.51

2998

6715

ILD medications: prednisolone, methylprednisolone, prednisone

3996

7988

2.93

307.65

2.1

1.7

7.51

7.24

g/l

11.47

3064

5860

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

398

328

21.81

307.65

20.5

1.6

7.05

7.61

g/l

3.77

292

236

ILD medications

4194

8020

2.98

307.65

2.9

1.7

7.46

7.24

g/l

8.21

3202

5884

Other systemic involvement of connective tissue (FG)

1209

2984

4.35

307.65

1.7

2.4

7.72

7.28

g/l

9.59

900

2166

Tramadol

2604

6942

2.49

307.65

2.3

1.9

7.54

7.21

g/l

12.35

2052

5034

Renal tubulo-interstitial diseases

3531

9195

3.09

307.65

2.4

2.2

7.64

7.29

g/l

19.84

2673

6801

Other soft tissue disorders, not elsewhere classified

2910

7931

2.33

307.65

2.3

2.2

7.38

7.33

g/l

0.57

2225

5911

Acute renal failure

1023

2745

4.09

307.65

2.9

2.1

7.74

7.37

g/l

6.57

787

1971

Renal failure

2594

5939

4.42

307.65

2.5

2.2

7.70

7.39

g/l

10.83

1984

4268

Primary_lymphoid and hematopoietic malignant neoplasms

1647

3318

5.71

307.65

8.3

1.4

7.10

7.45

g/l

8.70

1225

2422

Chronic kidney disease

1909

4142

5.19

307.65

2.3

2.1

7.71

7.39

g/l

8.94

1453

2933

Other and unspecified polyneuropathies, also in other diseases

1288

2717

5.49

307.65

2.0

2.2

7.10

7.46

g/l

8.54

939

1996

Oral corticosteroids

3859

9003

2.69

307.65

2.0

2.3

7.60

7.24

g/l

21.36

2910

6664

Other bacterial diseases

3584

9321

2.77

307.65

2.9

2.0

7.68

7.25

g/l

27.12

2674

6944

L04AX Other immunosuppressants

2087

7373

2.97

307.65

5.0

1.7

7.46

7.34

g/l

2.00

1583

5537

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

599

1078

6.65

307.65

3.4

2.2

8.25

7.46

g/l

12.29

398

795

Fever of other and unknown origin

1996

6104

3.17

307.65

3.7

2.1

7.60

7.30

g/l

7.65

1549

4473

Bacterial Sepsis

1844

6005

2.89

307.65

2.9

2.1

7.69

7.38

g/l

8.35

1337

4361

Examination and observation for other reasons

2014

4504

2.81

307.65

2.3

2.1

7.25

7.39

g/l

2.50

1663

3506

Anaemias

1038

711

10.38

307.65

2.5

1.2

7.32

6.91

g/l

5.11

792

551

Persons encountering health services for specific procedures and health care

3308

9614

2.19

307.65

2.6

2.0

7.44

7.31

g/l

3.08

2413

7257

Pain in limb

2570

7783

2.47

307.65

2.1

2.3

7.40

7.34

g/l

0.75

1995

5798

Multiple myeloma, excluding all cancers (controls excluding all cancers)

684

587

19.11

307.65

16.3

1.4

7.03

7.52

g/l

5.69

492

426

Autoimmune diseases excluding thyroid diseases, strict definition

3307

8089

2.34

307.65

1.9

2.4

7.42

7.30

g/l

2.36

2503

5996

Other systemic involvement of connective tissue

1236

3766

3.53

307.65

1.8

2.3

7.71

7.44

g/l

4.24

923

2749

Pneumonias (Asthma/COPD co-morbidities)

3182

9897

2.29

307.65

3.1

1.9

7.63

7.26

g/l

19.22

2393

7406

Implicit bacterial Sepsis

1620

5463

2.88

307.40

2.8

2.1

7.71

7.40

g/l

7.24

1170

3967

Infections, IBD-co-morbidities

604

730

6.38

307.22

4.1

2.1

7.41

7.07

g/l

2.85

423

572

Heart failure and antihypertensive medication

1036

1809

4.02

302.64

2.0

2.5

7.66

7.07

g/l

13.08

789

1326

Disorders of lipoprotein metabolism and other lipidaemias

2693

7935

2.20

272.62

2.2

2.1

7.63

7.30

g/l

12.97

1981

5916

Gout

1188

3591

3.22

272.41

3.2

2.3

7.67

7.32

g/l

7.14

917

2606

Hypertension, essential

2273

5586

2.39

271.93

2.1

2.2

7.58

7.06

g/l

25.44

1704

4246

Osteopathies and chondropathies

1902

7619

2.47

271.09

3.0

2.1

7.53

7.40

g/l

1.87

1344

5652

Heart failure,strict

1955

5948

2.49

264.64

2.1

2.3

7.65

7.36

g/l

7.53

1474

4320

Abnormal findings on examination of blood, without diagnosis

1743

6754

2.54

260.18

2.7

2.3

7.65

7.35

g/l

7.48

1253

5023

Other heart diseases

1286

2870

3.05

256.15

2.3

2.0

7.37

7.00

g/l

7.34

994

2210

Codeine

2723

7123

2.15

254.08

2.1

1.9

7.48

7.20

g/l

9.52

2115

5188

Autoimmune diseases related-to ILD

2542

10973

2.09

244.72

2.0

2.2

7.52

7.31

g/l

5.42

1913

8160

Glomerular disorders in diseases classified elsewhere

617

1464

4.71

242.00

2.6

2.2

7.99

7.37

g/l

10.06

492

1105

Unspecified kidney failure

552

1210

5.15

239.76

2.7

2.1

7.68

7.38

g/l

2.62

425

865

Nephropathy related operations

635

1551

4.56

239.62

3.9

2.3

7.52

7.38

g/l

0.90

509

1162

Certain infectious and parasitic diseases

2841

6977

2.08

239.07

2.5

1.8

7.48

7.20

g/l

9.98

2141

5181

Reimbursement for rheumatic diseases

1890

8432

2.32

237.75

1.7

2.3

7.68

7.34

g/l

10.72

1449

6227

Nutritional anaemias

1703

7147

2.42

232.96

2.0

2.2

7.54

7.42

g/l

1.58

1237

5215

Hypertensive diseases (excluding secondary)

1371

2899

2.82

230.40

2.2

2.0

7.46

6.99

g/l

13.08

1056

2223

Oedema, not elsewhere classified

1085

3772

3.00

229.42

2.2

2.1

7.56

7.38

g/l

2.10

826

2733

Pure hypercholesterolaemia

2347

7547

2.15

228.46

2.3

2.2

7.67

7.32

g/l

12.81

1721

5606

Hypertensive diseases

2181

5636

2.24

227.43

2.1

2.2

7.57

7.06

g/l

23.87

1660

4283

Hypertension

2177

5634

2.24

226.08

2.1

2.2

7.57

7.06

g/l

24.24

1656

4281

Gout, FINNGEN

1188

4420

2.86

225.76

3.2

2.2

7.67

7.31

g/l

7.86

917

3187

Iron deficiency anaemia

1463

5946

2.55

224.75

1.9

2.3

7.59

7.42

g/l

2.47

1059

4305

Other and unspecified iron deficiency

1198

4480

2.82

223.78

1.9

2.3

7.65

7.43

g/l

3.27

876

3259

Asthma, unspecified (mode), excluding more controls

1488

4713

2.55

223.00

2.1

1.9

7.54

7.22

g/l

7.83

1131

3532

Opioids

2735

7164

2.05

222.77

2.5

1.9

7.43

7.20

g/l

7.24

2113

5218

Diseases of oesophagus, stomach and duodenum

3089

9933

1.93

221.50

2.1

2.2

7.37

7.35

g/l

0.32

2227

7490

Medical observation and evaluation for suspected diseases and conditions

2019

4562

2.32

221.41

2.3

2.1

7.36

7.39

g/l

0.25

1523

3541

Septicaemia

1418

5590

2.55

216.88

3.0

2.0

7.62

7.31

g/l

6.72

1027

4078

Diverticular disease of intestine

2338

7598

2.11

215.21

2.5

2.2

7.44

7.40

g/l

0.50

1724

5661

Abnormalities of breathing

2480

7272

2.07

215.08

2.3

2.1

7.40

7.32

g/l

1.16

1865

5442

Codeine or tramadol medication

3300

9920

1.88

214.30

2.1

2.2

7.51

7.29

g/l

7.54

2567

7273

Cardiovascular diseases (excluding rheumatic etc)

1440

3223

2.63

213.77

2.2

2.0

7.34

6.98

g/l

8.25

1128

2492

Pain in joint

1711

4890

2.38

212.09

2.0

2.2

7.42

7.34

g/l

1.04

1332

3651

Heart failure, strict

2078

7145

2.18

209.21

2.1

2.3

7.65

7.42

g/l

5.24

1561

5184

Explicit Sepsis

1451

5867

2.47

208.21

3.0

2.1

7.62

7.37

g/l

4.54

1055

4255

Autoimmune diseases

3078

8370

1.91

206.98

2.0

2.4

7.37

7.31

g/l

1.00

2327

6206

Other arthritis (FG)

995

3517

2.96

205.84

2.2

2.5

7.82

7.18

g/l

18.46

753

2605

Care involving dialysis

441

913

5.47

205.27

2.5

2.0

7.58

7.30

g/l

1.92

353

713

Diseases of arteries, arterioles and capillaries (FINNGEN)

838

1771

3.47

205.08

2.2

7.82

7.06

g/l

19.37

666

1354

Used for control exclusion in common control thyroid runs

2910

7735

1.94

204.32

2.0

2.4

7.34

7.30

g/l

0.36

2196

5745

Benign neoplasm of colon, rectum, anus and anal canal

1771

5708

2.30

203.76

2.2

1.4

7.45

g/l

0.03

1256

4227

Asthma, excluding more controls

2035

5014

2.21

202.32

2.0

1.8

7.48

7.21

g/l

7.02

1539

3773

All-cause Heart Failure

2024

7046

2.15

197.95

2.1

2.3

7.66

7.43

g/l

4.98

1514

5102

Dyspnoea

2623

10643

1.94

197.84

2.4

2.2

7.52

7.34

g/l

4.47

1982

7869

Dental caries

889

2989

3.09

197.83

3.7

2.1

7.40

7.34

g/l

0.36

668

2230

Osteoporosis

1032

3639

2.88

196.76

2.2

2.1

7.56

7.57

g/l

0.05

698

2646

Asthma, unspecified (mode)

1525

5236

2.38

196.17

2.1

1.8

7.55

7.24

g/l

7.23

1152

3912

Other diseases of blood and blood-forming organs, wide

877

2995

3.13

195.47

3.1

2.2

7.10

7.45

g/l

5.25

677

2219

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3140

9918

1.84

192.46

2.1

2.3

7.34

7.37

g/l

0.34

2406

7316

Other diseases of intestines

2833

8866

1.89

190.47

2.3

2.1

7.35

7.33

g/l

0.24

2082

6691

Asthma

2140

5581

2.10

187.96

2.0

1.8

7.48

7.23

g/l

6.72

1614

4190

Polymyalgia rheumatica

652

1922

3.74

187.96

1.7

2.3

8.21

7.48

g/l

12.62

457

1382

Other specific joint derangements/joint disorders

1910

6110

2.14

186.55

1.9

2.3

7.37

7.24

g/l

2.18

1464

4615

Any gastric operation

2072

4975

2.13

185.38

2.2

1.8

7.38

7.28

g/l

1.43

1581

3621

GASTRO-related operations

2072

4975

2.13

185.38

2.2

1.8

7.38

7.28

g/l

1.43

1581

3621

Other heart diseases, wide

2411

7741

1.97

185.24

2.4

2.2

7.38

7.30

g/l

1.07

1830

5825

Dentinal caries

802

2678

3.13

182.62

3.8

2.1

7.39

7.34

g/l

0.29

593

1999

Transplanted organ and tissue status

463

1092

4.68

182.38

5.5

2.1

7.06

7.38

g/l

2.87

373

844

Benign neoplasm: Colon

1574

5482

2.28

181.18

2.2

1.4

7.44

7.47

g/l

0.21

1110

4057

Pain in throat and chest

2292

7174

1.99

180.92

2.2

2.1

7.35

7.33

g/l

0.19

1731

5363

Other septicaemia

1231

5073

2.48

179.42

2.7

2.0

7.63

7.33

g/l

5.75

891

3698

Persons encountering health services in other circumstances, wide

3353

9988

1.77

178.36

2.1

2.2

7.34

7.37

g/l

0.37

2560

7356

Asthma (mode)

2078

5622

2.07

177.50

2.0

1.8

7.46

7.23

g/l

5.75

1565

4223

Type 2 diabetes, wide definition

2461

8573

1.92

175.30

2.0

2.4

7.94

7.19

g/l

57.53

1762

6403

Spondylopathies

2370

7567

1.95

174.02

2.5

2.1

7.42

7.36

g/l

0.79

1731

5669

Erysipelas

1678

7362

2.15

172.85

2.2

2.0

7.65

7.29

g/l

10.55

1273

5440

Other specified/unspecified arthritis

882

3213

2.87

172.72

2.1

2.4

7.84

7.27

g/l

13.01

663

2373

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

392

558

5.49

172.70

2.4

2.1

7.78

7.13

g/l

6.51

311

429

Acute tubulo-interstitial nephritis

1740

7524

2.11

171.26

2.2

2.1

7.67

7.32

g/l

10.55

1284

5505

Cardiovascular diseases

1224

2641

2.57

170.84

2.2

1.9

7.30

7.00

g/l

5.19

964

2048

Asthma (only as main-diagnosis), excluding more controls

1775

5014

2.15

170.83

2.0

1.8

7.48

7.21

g/l

7.02

1336

3773

Codes for special purposes

1285

5613

2.37

170.69

2.7

2.1

7.51

7.30

g/l

3.09

906

4225

Provisional assignment of new diseases of uncertain etiology

1283

5603

2.37

170.51

2.6

2.1

7.51

7.30

g/l

3.07

905

4218

Pain, not elsewhere classified

806

2819

2.98

169.78

2.4

2.1

7.46

7.31

g/l

1.35

626

2095

Exposure to unspecified factor

2623

11331

1.83

169.03

2.1

2.2

7.34

7.36

g/l

0.20

2056

8353

Enlarged lymph nodes

562

1596

3.73

168.41

2.1

7.40

7.35

g/l

0.17

416

1189

Low back pain

1992

7842

2.00

166.70

2.6

2.1

7.44

7.34

g/l

1.47

1493

5909

Ulcer of lower limb, not elsewhere classified

635

1991

3.48

165.34

2.3

2.2

7.98

7.46

g/l

8.20

530

1435

Diabetic nephropathy, excluding more controls

590

1430

3.73

164.49

1.7

2.0

8.17

7.66

g/l

6.85

458

1041

Cerebrovascular diseases (FINNGEN)

887

2278

2.88

163.44

2.3

2.1

7.44

7.05

g/l

6.66

679

1732

Neurological diseases, wide definition

648

877

3.78

162.89

2.2

2.0

7.28

7.05

g/l

1.67

493

692

Rheumatoid arthritis

1065

3968

2.54

160.86

1.8

2.4

7.74

7.30

g/l

9.47

795

2901

Complications of surgical and medical care, not elsewhere classified

2707

11045

1.79

160.04

2.2

7.50

7.33

g/l

4.11

2011

8217

Care involving use of rehabilitation procedures

1801

8696

2.02

159.56

2.3

2.1

7.43

7.34

g/l

1.03

1231

6520

Headache

1568

6270

2.13

159.42

2.0

7.32

7.28

g/l

0.38

1152

4653

Symptoms and signs involving cognition, perception, emotional state and behaviour

2663

10580

1.80

158.62

2.0

2.3

7.31

7.37

g/l

1.01

1943

7911

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

589

1809

3.53

158.27

2.9

1.4

7.24

7.47

g/l

1.77

455

1311

Diseases of the skin and subcutaneous tissue

2744

7707

1.82

156.91

2.3

2.1

7.36

7.32

g/l

0.39

2082

5679

Continuous positive airway pressure

675

1900

3.22

155.79

2.2

2.3

7.71

7.10

g/l

10.54

498

1474

L04AA Selective immunosuppressants

739

2639

2.95

151.07

1.8

2.3

7.37

7.40

g/l

0.18

598

1978

Fall on same level

3001

9832

1.73

150.70

2.2

7.41

7.32

g/l

1.66

2232

7414

Asthma (only as main-diagnosis)

1833

5581

2.02

150.25

2.0

1.8

7.49

7.23

g/l

6.73

1374

4190

Dorsalgia

2619

7987

1.81

150.13

2.4

2.1

7.39

7.34

g/l

0.72

1967

6003

Symptoms and signs involving the skin and subcutaneous tissue

1922

10181

1.93

149.99

2.2

7.16

7.40

g/l

7.32

1474

7522

Disorders resulting from impaired renal tubular function

239

378

7.59

149.89

2.3

2.5

7.60

7.33

g/l

1.08

193

296

Other disorders of skin and subcutaneous tissue

2010

9937

1.90

148.64

2.3

2.2

7.58

7.38

g/l

4.34

1532

7279

Gout, idiopatic and unspecified

946

3880

2.59

147.72

2.1

2.4

7.76

7.35

g/l

8.61

745

2818

Covid-19 confirmed case

918

3692

2.60

147.68

2.7

2.2

7.59

7.37

g/l

2.60

678

2750

Other disorders of fluid, electrolyte and acid-base balance

1001

4042

2.50

146.71

2.6

2.1

7.60

7.41

g/l

2.10

714

2946

COPD/asthma related infections

2796

8052

1.77

146.48

2.9

1.8

7.48

7.27

g/l

6.29

2106

6026

COPD/asthma/ILD related infections

2796

8052

1.77

146.48

2.9

1.8

7.48

7.27

g/l

6.29

2106

6026

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

119

28.56

146.26

10.8

1.1

6.93

7.67

g/l

2.33

Malignant immunoproliferative diseases

130

101

21.04

144.85

10.1

1.2

7.01

7.67

g/l

2.35

Coagulation defects, purpura and other haemorrhagic conditions

683

2404

3.00

143.73

2.4

2.2

7.02

7.46

g/l

7.40

523

1780

Glomerulonephritis

443

1206

4.00

143.15

2.8

2.3

7.79

7.38

g/l

3.60

350

918

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2524

9846

1.78

143.02

2.8

2.1

7.35

7.36

g/l

0.03

1800

7507

Speech therapy

943

3907

2.53

142.99

2.2

7.49

7.43

g/l

0.32

645

2898

Disorders of thyroid, IBD co-morbidities

425

750

4.26

142.58

2.0

2.1

7.48

7.07

g/l

3.04

323

589

Parasetamol

1980

5281

1.95

140.50

2.3

2.0

7.45

7.13

g/l

9.22

1469

4034

Benign neoplasm of colon, rectum, anus and anal canal

1918

9383

1.90

140.23

2.2

2.3

7.44

g/l

0.02

1367

6919

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

851

1532

2.84

139.00

2.2

1.9

7.34

7.23

g/l

0.75

663

1160

Atrial fibrillation and flutter

871

2176

2.69

138.69

2.6

2.1

7.37

7.06

g/l

4.09

678

1650

Small fibre neuropathy

206

309

8.29

136.80

2.4

2.5

7.15

7.41

g/l

0.91

143

232

Disturbances of skin sensation

799

3118

2.66

136.49

1.9

2.2

6.91

7.39

g/l

12.27

648

2358

Diseases of arteries, arterioles and capillaries

2055

8474

1.86

136.22

2.0

2.4

7.70

7.39

g/l

9.32

1550

6177

Other pulmonary diagnosis

2092

5636

1.89

135.88

2.5

1.8

7.43

7.23

g/l

4.47

1594

4231

Heart failure and bmi 25plus

1135

3473

2.35

135.56

2.0

2.4

7.77

7.54

g/l

2.95

850

2440

Syncope and collapse

1244

5175

2.19

135.33

2.2

2.1

7.34

7.36

g/l

0.11

916

3742

Other necrotizing vasculopathies (FG)

300

637

5.26

135.23

1.4

2.8

8.40

7.13

g/l

15.33

225

468

L04AD Calcineurin inhibitors

415

1122

3.99

134.92

2.6

2.5

7.20

7.35

g/l

0.79

354

855

Viral Sepsis

676

2460

2.90

133.62

3.2

2.1

7.48

7.41

g/l

0.36

479

1804

Hypertensive heart and/or renal disease

884

2767

2.59

133.60

1.9

2.4

7.64

7.20

g/l

7.66

663

2037

Oxycodone

1106

4875

2.28

132.66

5.0

2.0

7.90

7.30

g/l

14.76

802

3470

Implicit viral Sepsis

673

2454

2.89

132.52

3.2

2.1

7.48

7.41

g/l

0.37

477

1799

Other dorsopathies, not elsewhere classified

2602

7994

1.75

132.16

2.2

2.1

7.33

7.34

g/l

0.02

1911

6009

Seropositive rheumatoid arthritis

796

3160

2.62

130.74

1.8

2.5

7.70

7.26

g/l

7.46

593

2299

Excluding asthma or asthma-COPD overlap

2072

5636

1.87

130.69

2.5

1.8

7.43

7.23

g/l

4.42

1574

4231

Gout, unspecified

775

3068

2.69

130.65

2.1

2.3

7.73

7.34

g/l

6.54

617

2221

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1025

2783

2.39

127.77

2.3

2.1

7.26

7.00

g/l

3.78

777

2141

Symptoms and signs involving the urinary system

2171

9617

1.78

127.58

2.0

2.3

7.40

g/l

0.08

1585

7134

COPD differential diagnosis

2053

5622

1.86

126.81

2.5

1.8

7.43

7.23

g/l

3.96

1560

4223

ILD differential diagnosis

2053

5622

1.86

126.79

2.5

1.8

7.43

7.23

g/l

3.96

1560

4223

Symptoms and signs involving the circulatory and respiratory systems

2503

7286

1.75

126.63

2.3

2.1

7.32

g/l

0.00

1896

5454

Pain (limb, back, neck, head abdominally)

1946

5246

1.89

126.26

2.2

2.1

7.38

7.32

g/l

0.60

1433

3875

Gout, strict definition

701

2690

2.79

126.23

2.0

2.3

7.82

7.35

g/l

8.08

557

1949

Lower back pain or/and sciatica

2677

11227

1.68

126.10

2.5

2.1

7.43

7.35

g/l

1.43

2014

8354

Endocrine, nutritional and metabolic diseases

1882

5111

1.90

125.34

2.1

2.2

7.47

7.07

g/l

13.78

1420

3906

Asthma (diagnoses ohter than nonallergic)

2251

11247

1.74

125.11

2.0

2.2

7.53

7.33

g/l

5.20

1688

8340

Malignant immunoproliferative diseases

130

128

16.45

125.09

10.1

1.8

7.01

7.54

g/l

1.71

Chronic periodontitis

564

1934

3.10

124.94

3.3

2.1

7.54

7.40

g/l

0.90

430

1444

Symptoms and signs involving the nervous and musculoskeletal systems

1619

8662

1.92

124.66

2.0

2.3

7.24

7.42

g/l

3.67

1236

6371

Any reimbursement code in KELA

1182

2650

2.27

124.16

2.4

1.5

7.41

6.88

g/l

14.88

920

2035

Other special examinations and investigations of persons without complaint or reported diagnosis

1726

4562

1.95

122.67

2.3

2.1

7.33

7.39

g/l

0.60

1191

3541

Non-follicular lymphoma, hilmo, excluding all cancers

423

1242

3.73

122.57

2.6

1.4

7.26

7.44

g/l

0.91

330

909

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1875

9761

1.83

122.19

2.4

2.3

7.55

7.40

g/l

2.73

1394

7143

Symptoms and signs concerning food and fluid intake

376

1015

3.95

121.84

2.0

2.2

7.25

7.46

g/l

1.12

283

753

Other necrotizing vasculopathies

346

896

4.29

120.98

1.6

2.6

8.41

7.36

g/l

12.08

259

673

Disorders of mineral metabolism

351

915

4.19

120.77

3.7

2.2

7.46

7.31

g/l

0.65

245

694

Cardiac arrhythmias

1430

4760

2.02

120.56

2.3

7.29

7.08

g/l

3.57

1101

3652

Preparatory care for dialysis

254

523

5.65

120.17

2.0

2.8

7.59

7.32

g/l

1.20

225

397

Diseases of pulp and periapical tissues

996

4535

2.27

120.08

3.6

2.0

7.31

7.35

g/l

0.23

715

3376

Antihypertensive medication - note that there are other indications

1176

2950

2.21

119.72

2.0

2.2

7.32

6.96

g/l

7.36

913

2221

Non-ischemic cardiomyopathy

1040

3919

2.28

119.64

2.2

2.3

7.46

7.40

g/l

0.48

779

2848

Constipation

2388

10200

1.71

119.64

2.7

2.2

7.39

g/l

0.02

1682

7631

Nephrotic syndrome

191

301

7.40

119.51

2.7

2.6

8.14

7.24

g/l

5.31

157

233

Soft tissue disorders

2575

7994

1.70

118.61

2.2

7.32

7.33

g/l

0.13

1941

5955

Disorders of calcium metabolism

299

705

4.71

118.36

4.1

2.2

7.46

7.36

g/l

0.34

207

544

Lymphoid leukaemia

283

642

4.96

118.06

2.7

1.4

6.84

7.41

g/l

4.98

223

474

Hyperlipidaemia, other/unspecified

1207

5648

2.09

117.01

2.3

2.1

7.64

7.37

g/l

4.37

833

4169

Other and unspecified dermatitis

1391

7233

1.97

116.97

2.1

2.2

7.38

7.39

g/l

0.05

1055

5312

Diseases of the musculoskeletal system and connective tissue

1206

2803

2.19

116.92

2.3

2.1

7.35

7.15

g/l

2.50

928

2127

Atrial fibrillation and flutter with reimbursement

749

1861

2.67

116.21

2.6

2.2

7.51

7.07

g/l

6.75

567

1423

Abnormalities of gait and mobility

495

1656

3.23

115.49

1.8

2.4

7.38

7.44

g/l

0.30

406

1209

Osteoporosis with pathological fracture (FG)

305

747

4.51

114.76

1.9

2.4

7.71

7.34

g/l

2.29

211

522

Depression medications

517

774

3.41

113.74

1.8

1.2

7.16

6.89

g/l

2.13

416

601

Neoplasms

1660

4729

1.91

113.48

2.8

1.2

7.21

7.32

g/l

1.31

1263

3595

Other CVD (FINNGEN)

407

917

3.71

113.21

2.8

2.3

7.49

7.10

g/l

3.26

291

687

Dermatitis and eczema

2748

11250

1.63

112.58

2.1

2.2

7.32

7.37

g/l

0.69

2091

8342

Purpura and other haemorrhagic conditions

492

1661

3.15

112.12

2.4

2.3

6.93

7.44

g/l

6.73

369

1247

Bleeding

2284

9982

1.70

111.84

2.2

2.3

7.48

7.40

g/l

1.11

1695

7365

Neurological diseases

2124

6143

1.77

111.71

2.1

2.3

7.25

7.42

g/l

3.44

1547

4697

Dermatitis

1617

8950

1.85

111.63

2.1

2.2

7.38

7.39

g/l

0.03

1206

6617

Valvular heart disease excluding rheumatic fever

1372

5176

1.99

111.44

2.3

7.25

7.41

g/l

2.23

992

3807

Benign neoplasm: Colon

1607

8717

1.86

111.43

2.3

7.43

7.46

g/l

0.16

1134

6437

Asthma, hospital admission 2, infections

1525

8169

1.88

110.57

2.2

7.60

7.36

g/l

5.18

1153

6028

Asthma-related infections

1525

8169

1.88

110.57

2.2

7.60

7.36

g/l

5.18

1153

6028

Extracorporeal dialysis

290

707

4.57

110.16

2.6

2.5

7.60

7.25

g/l

1.78

212

546

Rheumatoid arthritis, including avohilmo

1163

5822

2.07

109.88

1.8

2.3

7.73

7.42

g/l

5.85

871

4280

Non-rheumatic valve diseases

1365

5162

1.99

109.77

2.3

7.25

7.41

g/l

2.23

985

3799

Diabetic nephropathy

593

2214

2.83

109.75

1.7

2.0

8.18

7.76

g/l

5.26

460

1571

Non-follicular lymphoma

423

1342

3.44

108.43

2.6

2.5

7.26

7.42

g/l

0.76

330

1009

Chronic periapical parodontitis

660

2641

2.61

107.60

4.5

2.1

7.30

7.39

g/l

0.52

480

1962

Persons encountering health services for examination and investigation

1682

4562

1.88

107.42

2.1

7.33

7.39

g/l

0.58

1232

3541

Genitourinary diseases

1443

3743

1.96

105.10

2.1

7.35

7.23

g/l

1.35

1111

2805

Chronic lymphocytic leukaemia, helper endpoint

191

346

6.63

104.87

2.1

1.4

6.68

7.45

g/l

6.27

158

250

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

191

346

6.63

104.87

2.1

1.4

6.68

7.45

g/l

6.27

158

250

Spinal stenosis

1511

6480

1.88

104.43

2.2

7.47

7.43

g/l

0.35

1085

4793

Lymphoid leukaemia

283

709

4.47

103.90

2.7

2.5

6.84

7.40

g/l

4.84

223

533

Follow-up examination after treatment for conditions other than malignant neoplasms

1139

3660

2.08

103.26

2.2

2.1

7.41

7.39

g/l

0.10

906

2858

Hypothyroidism (congenital or acquired)

439

746

3.44

102.62

2.3

1.2

7.20

6.90

g/l

1.95

338

579

Chronic gastritis

918

4325

2.21

102.53

2.1

2.3

7.40

7.48

g/l

0.51

687

3196

Diaphragmatic hernia

1122

5692

2.04

102.38

2.3

2.2

7.46

7.48

g/l

0.10

822

4184

Complications of medical and surgical care

1925

10888

1.71

101.75

2.4

2.2

7.49

7.36

g/l

2.04

1406

8094

Arthropathies

2120

6371

1.72

101.51

2.1

2.2

7.36

7.24

g/l

1.85

1620

4780

Hypothyroidism, levothyroxine purchases

436

745

3.42

101.32

2.3

1.2

7.22

6.90

g/l

2.15

337

579

Hypothyroidism and >3 levothyroxin purchases

436

745

3.42

101.32

2.3

1.2

7.22

6.90

g/l

2.15

337

579

Adjustment and management of implanted device

661

2741

2.54

100.58

2.5

2.0

7.35

7.45

g/l

0.64

536

1995

Amyloidosis, other/unspecified

141

197

9.12

100.31

8.5

2.1

7.25

7.34

g/l

0.20

110

149

Complications of procedures, not elsewhere classified

2056

10764

1.68

100.18

2.1

2.2

7.49

7.34

g/l

2.85

1537

8007

Intestinal infectious diseases

2314

11183

1.64

100.18

2.8

2.1

7.48

7.34

g/l

3.05

1718

8322

Asthma-related pneumonia or sepsis

1058

5300

2.06

99.24

2.3

2.2

7.73

7.40

g/l

5.93

802

3815

Asthma, hospital admissions 3, pneumonia

1058

5300

2.06

99.24

2.3

2.2

7.73

7.40

g/l

5.93

802

3815

Glucagon-like peptide-1 (GLP-1) analogues

1662

7848

1.79

99.12

2.1

2.4

7.99

7.24

g/l

41.98

1193

5812

Asthma-related pneumonia

1055

5291

2.05

98.66

2.3

2.2

7.73

7.40

g/l

5.97

799

3806

Diarrhoea and gastroenteritis of presumed infectious origin

1723

9129

1.75

97.50

2.6

2.0

7.47

7.34

g/l

2.11

1298

6777

Bacterial pneumoniae

1164

5342

1.98

97.01

3.7

1.9

7.66

7.31

g/l

7.11

839

3919

ILD medications: azathioprine

393

1260

3.25

96.73

1.8

1.5

7.31

7.20

g/l

0.52

297

942

Other disorders of white blood cells

256

629

4.50

96.08

2.0

2.5

7.14

7.41

g/l

1.18

202

482

Bacterial pneumonia, not elsewhere classified

1120

5090

2.00

96.02

3.6

1.9

7.66

7.31

g/l

7.03

813

3729

Dizziness and giddiness

1955

9589

1.69

95.42

2.0

2.3

7.37

7.40

g/l

0.24

1429

7119

Diabetes mellitus

2529

9575

1.60

95.24

1.9

2.3

7.84

7.15

g/l

50.32

1829

7226

Amyloidosis

151

239

7.71

95.16

8.1

2.2

7.26

7.34

g/l

0.20

117

186

Hypothyroidism, drug reimbursement

301

546

4.04

94.48

2.2

1.3

7.36

6.92

g/l

2.71

231

427

Chronic lower respiratory diseases

2945

10434

1.55

94.29

2.0

2.3

7.53

7.29

g/l

8.17

2224

7757

Gastrointestinal diseases

1326

3465

1.94

94.25

2.5

1.8

7.31

7.36

g/l

0.36

1002

2692

Diabetes, varying definitions

2518

9560

1.60

94.25

1.9

2.3

7.84

7.16

g/l

49.02

1825

7210

Benign neoplasms

1673

5375

1.79

94.22

2.2

1.4

7.21

7.30

g/l

1.15

1236

4081

Other disorders of urethra and urinary system

1767

7794

1.73

93.68

2.1

2.2

7.54

7.34

g/l

4.30

1310

5723

Spondylosis

1455

7007

1.82

93.66

2.0

2.2

7.41

7.39

g/l

0.14

1084

5257

Haemorrhage from respiratory passages

1009

4694

2.05

93.52

2.2

7.35

7.43

g/l

0.60

763

3407

Chronic lymphocytic leukaemia

191

386

5.92

93.16

2.1

2.5

6.68

7.49

g/l

6.85

158

281

Disorders of other endocrine glands

1120

5767

1.96

92.18

2.4

2.2

7.36

7.43

g/l

0.56

838

4253

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2416

9364

1.60

91.44

1.9

2.4

7.93

7.16

g/l

57.72

1745

7056

Dorsopathies

2478

8002

1.60

90.98

2.3

2.1

7.29

7.33

g/l

0.48

1844

6014

Other disorders of kidney and ureter

473

1755

2.87

90.96

2.3

2.4

7.54

7.41

g/l

0.74

360

1301

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2169

7925

1.64

90.89

3.8

1.4

7.34

7.35

g/l

0.06

1655

5917

Malignant neoplasm, wide definition for exclusion

2169

7925

1.64

90.87

3.8

1.4

7.35

g/l

0.05

1655

5917

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2169

7925

1.64

90.86

3.8

1.4

7.35

g/l

0.05

1655

5917

Certain disorders involving the immune mechanism

599

2483

2.52

90.80

2.7

2.2

7.24

7.40

g/l

1.34

457

1866

Other intervertebral disc disorders

2074

7786

1.66

90.31

2.2

2.1

7.39

7.34

g/l

0.43

1500

5845

Secondary hypertension

260

662

4.12

90.06

2.2

2.1

7.31

7.06

g/l

1.12

197

491

Cardiomyopathy

572

2345

2.55

88.85

2.6

2.2

7.33

7.39

g/l

0.29

469

1714

Hypertensive Heart Disease

717

2607

2.33

88.70

2.0

2.4

7.69

7.20

g/l

7.50

528

1921

Nerve, nerve root and plexus disorders

2667

11007

1.54

87.20

2.2

7.43

7.35

g/l

1.20

1940

8231

Benign neoplasms

2348

8316

1.60

87.09

2.2

2.1

7.27

7.34

g/l

0.84

1722

6304

Other joint disorders

1973

6368

1.67

86.86

2.0

2.2

7.35

7.24

g/l

1.50

1502

4778

Insulin medication

1580

7933

1.74

86.81

2.0

2.4

8.03

7.19

g/l

43.98

1116

5928

Diseases of the eye and adnexa

1837

5451

1.71

86.60

2.1

7.24

7.30

g/l

0.60

1375

4180

Type 2 diabetes

2452

9384

1.57

86.34

1.9

2.4

7.88

7.16

g/l

52.39

1777

7068

Disorders of choroid and retina

2158

9943

1.61

86.08

2.2

2.3

7.56

7.39

g/l

3.23

1542

7369

Sicca syndrome [Sjögren]

330

1033

3.43

85.96

1.8

2.5

7.28

7.47

g/l

0.99

257

771

Disorders of parathyroid gland

683

3032

2.33

85.92

2.3

2.2

7.38

7.60

g/l

2.12

509

2203

Malignant neoplasm

2210

8263

1.61

85.68

4.0

1.4

7.35

7.36

g/l

0.12

1670

6181

Other antidepressants

2615

8901

1.55

84.75

2.1

2.3

7.36

g/l

0.01

1963

6581

Gastro-oesophageal reflux disease

1711

9170

1.68

84.35

2.0

2.3

7.38

7.37

g/l

0.09

1201

6911

STROKE

1509

6056

1.77

84.28

2.4

7.43

7.23

g/l

3.47

1126

4538

1055

5545

1.93

83.59

2.3

2.2

7.52

7.32

g/l

2.93

803

4098

2836

9982

1.52

83.47

2.9

2.0

7.43

7.34

g/l

1.66

2117

7417

Asthma, including avohilmo

2838

11051

1.51

82.99

1.9

2.3

7.49

7.32

g/l

4.41

2140

8205

Gonarthrosis [arthrosis of knee](FG)

1852

6625

1.67

82.97

2.0

2.4

7.52

7.21

g/l

9.08

1367

4916

388

1353

3.00

82.83

2.2

2.3

7.36

7.32

g/l

0.12

318

1013

Sulfasalazine

725

3374

2.21

82.81

1.7

2.3

7.61

7.25

g/l

5.25

551

2506

Other diseases of urinary system

2514

9231

1.55

82.76

2.3

2.2

7.48

7.31

g/l

3.78

1910

6838

Infections of the skin and subcutaneous tissue

1361

7787

1.77

82.60

2.5

2.2

7.52

7.29

g/l

3.94

1034

5829

Diabetes, insulin treatment (Kela reimbursement)

2523

10128

1.55

82.50

1.9

2.3

7.92

7.20

g/l

55.16

1824

7618

Venous thromboembolism

1509

8673

1.73

82.49

2.6

2.2

7.52

7.43

g/l

1.13

1123

6336

Diseases of liver

946

4881

2.00

82.06

1.8

2.4

7.40

7.38

g/l

0.15

694

3657

Use of hypnotics and sedatives

2641

10112

1.53

81.87

2.5

2.2

7.31

7.36

g/l

0.62

1967

7548

Hypertensive Renal Disease

181

386

5.23

81.36

1.8

2.7

7.56

7.23

g/l

1.33

141

290

Diabetes medication

2495

9958

1.54

81.15

1.9

2.3

7.90

7.17

g/l

54.54

1792

7501

Fracture of lumbar spine and pelvis

688

3179

2.25

80.77

2.3

2.1

7.46

7.53

g/l

0.40

469

2282

Need for other prophylactic measures

232

602

4.21

80.61

2.4

2.5

7.51

7.39

g/l

0.46

184

462

Disorders of lens

1833

7100

1.66

80.53

2.6

2.3

7.56

7.37

g/l

3.57

1303

5422

Acquired haemolytic anaemia

148

270

6.44

80.33

3.6

2.2

6.08

7.46

g/l

10.79

110

201

Coxarthrosis [arthrosis of hip](FG)

1395

5814

1.77

79.63

2.1

2.5

7.53

7.24

g/l

6.02

1002

4268

Other/unspecified dorsalgia

946

4897

1.97

79.40

2.7

2.1

7.50

7.39

g/l

0.92

710

3651

Azathioprine

393

1410

2.89

79.35

1.8

2.4

7.31

7.18

g/l

0.67

297

1062

Bacterial pneumonia (organism specified)

1241

6386

1.81

79.27

3.9

2.0

7.68

7.36

g/l

6.47

898

4665

Symptoms and signs involving the digestive system and abdomen

2523

8301

1.54

78.65

2.2

7.31

7.37

g/l

0.72

1864

6191

Myalgia

580

2519

2.37

78.51

2.0

2.1

7.28

7.40

g/l

0.86

428

1888

Other and unspecified disorders of white blood cells

196

461

4.74

78.18

1.9

2.6

7.04

7.35

g/l

1.26

161

352

Other external causes of accidental injury

2035

6381

1.62

77.86

2.2

7.37

7.35

g/l

0.16

1513

4784

Injuries to the abdomen, lower back, lumbar spine and pelvis

1032

5541

1.90

77.28

2.3

2.2

7.44

7.41

g/l

0.16

733

4066

Thrombocytopenia, unspecified

280

848

3.57

77.23

2.0

2.5

6.55

7.42

g/l

10.73

205

644

Falls/tendency to fall

2592

8620

1.52

76.56

2.2

7.34

7.32

g/l

0.22

1919

6525

SLE (Finngen)

159

319

5.51

76.53

1.8

2.3

7.26

7.41

g/l

0.42

130

246

Accidents

2028

6381

1.61

76.52

2.2

7.38

7.35

g/l

0.24

1514

4784

Parodontitis or operation codes

2257

10918

1.55

76.36

2.3

2.2

7.46

7.36

g/l

1.61

1733

8097

Parodontitis

2255

10918

1.55

76.27

2.3

2.2

7.46

7.36

g/l

1.61

1731

8098

Diseases of oral cavity, salivary glands and jaws

2294

7634

1.56

76.04

2.4

2.0

7.32

7.39

g/l

1.00

1712

5589

Other arrhythmias

1497

6840

1.70

75.79

2.0

2.2

7.24

7.33

g/l

1.05

1078

5108

Intracranial trauma

1221

5128

1.81

75.74

2.1

2.3

7.29

7.42

g/l

1.45

889

3915

Injuries to the head

2588

11350

1.50

75.70

2.1

2.2

7.35

7.36

g/l

0.09

1911

8479

Streptococcal septicaemia

298

947

3.36

75.56

4.0

2.1

7.56

7.22

g/l

2.30

217

706

Chronic periodontitis, including avohilmo

2243

10919

1.54

75.34

2.3

2.2

7.46

7.35

g/l

1.72

1722

8097

Benign neoplasm: Colon, unspecified

721

3473

2.15

75.20

2.3

1.4

7.41

7.47

g/l

0.30

478

2547

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

165

351

5.42

75.18

2.3

1.4

6.46

7.51

g/l

8.89

110

252

Haemolytic anaemias

169

365

5.19

75.00

3.4

2.1

6.08

7.41

g/l

12.18

126

272

Abnormal findings on diagnostic imaging of lung

1356

7804

1.74

74.94

2.3

7.67

7.41

g/l

5.16

1020

5700

Seronegative rheumatoid arthritis

357

1269

2.95

73.82

2.1

2.8

7.60

7.22

g/l

2.71

281

931

Presence of cardiac and vascular implants and grafts

1359

6046

1.75

73.61

1.8

2.2

7.39

7.46

g/l

0.59

917

4540

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

184

433

4.78

73.57

2.2

1.4

6.60

7.51

g/l

7.62

127

312

Diseases of the respiratory system

1590

4750

1.70

73.56

2.6

1.9

7.52

7.26

g/l

4.92

1212

3543

Statin medication

1581

5318

1.69

73.50

2.0

2.4

7.43

7.08

g/l

10.54

1241

3894

Explicit bacterial Sepsis

342

1193

3.03

73.46

4.0

2.1

7.59

7.33

g/l

1.56

252

888

Other and unspecified diseases of blood and blood-forming organs

146

285

5.93

73.44

5.4

2.6

7.03

7.43

g/l

1.45

124

223

Weight loss

345

1215

3.03

73.28

2.2

2.3

7.25

7.40

g/l

0.69

260

917

Cough

1003

5230

1.88

73.18

2.4

2.1

7.40

g/l

0.01

758

3860

Disorders of eyelid, lacrimal system and orbit

2103

10799

1.55

72.99

2.3

2.2

7.31

7.40

g/l

1.22

1560

8001

Kidney transplant status

201

506

4.32

72.70

1.7

2.5

7.30

7.17

g/l

0.37

171

398

Factors influencing health status and contact with health services

794

1895

2.14

72.65

2.3

1.8

7.35

7.43

g/l

0.47

599

1508

Other functional intestinal disorders

1101

5894

1.82

71.82

2.5

2.2

7.37

7.41

g/l

0.28

770

4350

Insulin, intermediate and long-acting

1438

8562

1.68

71.47

1.9

2.3

8.01

7.31

g/l

30.16

1021

6346

Other cataract

1225

5464

1.78

71.40

2.5

2.3

7.47

7.38

g/l

0.85

897

4156

Cerebrovascular diseases

1991

9257

1.57

71.26

2.3

7.51

7.41

g/l

1.32

1461

6840

Pruritus

350

1259

2.93

71.02

2.0

2.4

7.25

7.49

g/l

1.65

277

944

Hypo-osmolality and hyponatraemia

524

2278

2.39

70.99

2.8

2.0

7.49

7.46

g/l

0.11

383

1642

Other nutritional deficiencies

1433

8496

1.68

70.92

1.9

2.2

7.80

7.26

g/l

19.14

1043

6462

Seropositive rheumatoid arthritis, wide

796

4076

2.02

70.92

1.8

2.3

7.70

7.47

g/l

2.40

593

2976

Gingivitis and periodontal diseases

2239

7585

1.54

70.67

2.4

2.0

7.37

7.39

g/l

0.17

1738

5559

Abdominal and pelvic pain

2468

8301

1.51

70.59

2.3

2.2

7.34

7.37

g/l

0.27

1834

6191

Abnormal weight loss

325

1135

3.06

70.27

2.0

2.4

7.23

7.40

g/l

0.77

243

862

Other disorders involving the immune mechanism, not elsewhere classified

147

298

5.52

70.20

2.1

2.5

7.40

7.18

g/l

0.69

115

235

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

777

3966

2.03

69.91

1.9

2.3

7.68

7.47

g/l

2.22

580

2900

Viral pneumonia

376

1415

2.78

69.75

3.2

1.9

7.54

7.28

g/l

1.56

285

1033

Other/unspecified seropositive rheumatoid arthritis

787

4040

2.01

69.63

1.8

2.3

7.70

7.47

g/l

2.43

587

2950

DVT of lower extremities and pulmonary embolism

1170

6763

1.77

69.56

2.7

2.2

7.49

7.44

g/l

0.36

873

4922

Peripheral artery disease

1306

6241

1.73

69.06

1.9

2.3

7.97

7.41

g/l

18.46

971

4507

Paroxysmal tachycardia

496

1773

2.42

68.72

1.8

2.1

7.21

7.08

g/l

0.79

376

1359

Episodal and paroxysmal disorders

2621

9155

1.48

68.70

1.9

2.3

7.29

7.36

g/l

1.09

1919

6871

Giant cell arteritis

200

529

4.24

68.45

1.5

2.7

8.79

7.41

g/l

11.27

151

385

Arthrosis

1735

5968

1.62

68.27

2.0

2.3

7.44

7.26

g/l

3.02

1284

4448

Mixed connective tissue disease

245

737

3.58

68.21

1.7

2.5

7.26

7.43

g/l

0.64

199

566

Isolated proteinuria

141

283

5.60

68.20

3.2

2.6

7.73

7.26

g/l

1.60

119

215

Unspecified haematuria

1157

5725

1.77

68.07

2.2

2.3

7.37

7.39

g/l

0.15

855

4210

Other specified/unspecified systemic involvement of connective tissue

222

631

3.79

67.43

1.7

2.6

7.34

7.36

g/l

0.06

184

480

Insulin, combination of fast acting with intermediate-acting or long-acting

1580

9159

1.62

67.37

2.0

2.3

8.03

7.31

g/l

33.10

1116

6789

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2372

10479

1.49

67.11

2.4

2.2

7.34

7.37

g/l

0.24

1771

7802

Hernia

2256

10294

1.51

67.03

2.4

2.2

7.32

7.39

g/l

1.08

1670

7629

All influenza

643

3106

2.13

66.95

4.3

1.9

7.47

7.28

g/l

1.66

459

2310

Viral hepatitis, IBD co-morbidity

124

221

5.84

66.75

2.0

1.6

7.38

6.97

g/l

1.08

177

Senile cataract

1695

6632

1.62

66.72

2.6

2.3

7.57

7.38

g/l

3.20

1193

5069

Systemic lupus erythematosus

159

359

4.88

66.56

1.8

2.1

7.26

7.45

g/l

0.58

130

273

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

20.82

66.42

13.5

1.4

6.98

7.94

g/l

2.73

Other diseases of pleura

1280

6804

1.71

66.06

2.4

2.3

7.70

7.40

g/l

5.84

965

4929

Other bacterial intestinal infections

533

2412

2.30

66.04

3.5

2.1

7.51

7.47

g/l

0.18

356

1762

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1529

9576

1.62

66.04

2.3

2.2

7.48

7.38

g/l

1.12

1133

7098

Vasculitis limited to skin, not elsewhere classified

139

285

5.57

65.97

2.3

2.4

7.38

7.42

g/l

0.09

112

216

Asthma, hospital admissions , main diagnosis only

1908

11250

1.54

65.65

2.0

2.2

7.50

7.34

g/l

3.27

1424

8368

Sleep disorders (combined)

2363

10551

1.49

65.54

1.9

2.3

7.39

7.35

g/l

0.57

1745

7919

Pulmonary heart disease, diseases of pulmonary circulation

912

5021

1.87

64.97

2.4

2.2

7.44

7.46

g/l

0.11

685

3665

Parodontitis and operation codes

2083

10861

1.51

64.47

2.3

7.45

7.36

g/l

1.17

1600

8072

Bronchitis

2495

11321

1.46

63.76

3.1

2.0

7.42

7.35

g/l

1.01

1859

8425

Chronic periodontitis, complicated

330

1227

2.86

63.39

3.8

2.4

7.63

7.37

g/l

1.56

260

933

Hyperparathyroidism

573

2685

2.20

63.25

2.4

2.2

7.37

7.60

g/l

2.00

426

1939

Cystitis

1995

8069

1.53

62.93

2.2

7.47

7.32

g/l

2.56

1532

5938

Obesity related asthma

832

4494

1.90

62.75

1.9

2.3

7.54

7.30

g/l

3.27

608

3379

Other acute lower respiratory infections

1281

7445

1.67

62.45

3.2

2.1

7.57

7.38

g/l

3.15

965

5445

Sciatica+with lumbago

1170

6605

1.71

62.43

2.1

7.43

7.36

g/l

0.64

898

5000

Coxarthrosis

1288

5256

1.69

62.23

2.1

2.4

7.50

7.31

g/l

2.77

927

3881

Direct fill therapy

374

1487

2.62

62.02

4.9

2.2

7.43

7.38

g/l

0.17

278

1142

Injuries to the hip and thigh

1230

6801

1.69

61.82

2.1

2.2

7.43

7.45

g/l

0.16

830

4983

Obesity and other hyperalimentation

1343

8238

1.64

61.24

1.8

2.3

7.84

7.26

g/l

21.75

981

6250

Other diseases of blood and blood-forming organs

251

821

3.28

60.98

4.3

2.5

7.01

7.33

g/l

1.89

202

625

Obesity

1334

8191

1.64

60.77

1.8

2.3

7.83

7.26

g/l

21.54

978

6216

Fibromyalgia

238

751

3.32

60.61

2.2

2.1

7.50

7.31

g/l

0.75

184

577

Other arthrosis

1270

5499

1.68

60.50

2.0

2.4

7.44

7.27

g/l

2.27

967

4093

Any event in cancer register

2123

8499

1.50

60.49

3.6

1.6

7.32

7.36

g/l

0.31

1604

6367

Shoulder lesions

1853

7457

1.54

60.44

2.2

2.3

7.46

7.35

g/l

1.48

1378

5551

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

131

275

5.30

60.06

1.9

2.6

7.33

7.19

g/l

0.34

102

215

Other retinal disorders

1648

8606

1.57

59.78

2.1

2.3

7.66

7.42

g/l

4.91

1158

6332

SLE, strict definition

153

366

4.61

59.61

1.8

1.9

7.20

7.48

g/l

1.02

124

280

SLE, ICD10

153

366

4.61

59.61

1.8

1.9

7.20

7.48

g/l

1.02

124

280

Other (not insulin) diabetes medications

2321

9666

1.47

59.09

1.9

2.4

7.94

7.18

g/l

54.77

1677

7263

Bacterial intestinal infections, IBD co-morbidities

533

2525

2.19

58.96

3.6

2.1

7.50

7.49

g/l

0.05

361

1853

Chronic rhinitis, nasopharyngitis and pharyngitis

758

4052

1.91

58.91

2.0

2.2

7.23

7.36

g/l

1.26

602

3058

Immunodeficiencies

183

501

3.95

58.88

4.5

2.3

7.18

7.34

g/l

0.51

135

395

Anaemia in chronic diseases classified elsewhere

125

258

5.52

58.88

1.8

2.5

7.29

7.33

g/l

0.07

196

Other autoimmune haemolytic anaemias

138

8.10

58.76

2.9

2.1

5.65

7.48

g/l

13.66

106

Dialysis

156

382

4.45

58.69

2.2

2.0

7.36

7.23

g/l

0.36

132

291

Other and unspecified vasculitis limited to skin

126

263

5.47

58.63

2.4

2.5

7.39

7.44

g/l

0.11

100

199

Type 2 diabetes, definitions combined

2249

9227

1.47

58.56

1.9

2.4

7.82

7.17

g/l

41.52

1616

6949

Idiopathic gout

327

1263

2.76

58.50

2.1

2.3

7.92

7.38

g/l

4.92

255

923

Visual disturbances and blindness

1230

7561

1.66

58.45

2.3

2.2

7.38

7.42

g/l

0.33

897

5598

Disorders of gallbladder, biliary tract and pancreas

2380

10705

1.45

58.10

2.2

2.3

7.45

7.36

g/l

1.43

1743

7999

Diseases of the digestive system

1183

7199

1.67

58.07

2.2

7.48

7.42

g/l

0.47

861

5266

Acute bronchitis

1024

5889

1.74

57.89

3.1

2.1

7.60

7.39

g/l

3.02

794

4280

Polyuria

644

3292

2.02

57.88

2.0

2.3

7.32

7.41

g/l

0.54

510

2434

Other gastritis (incl. Duodenitis)

642

3282

2.02

57.53

2.3

7.50

7.43

g/l

0.46

461

2454

Visual disturbances

1138

6891

1.69

57.44

2.3

2.2

7.35

7.41

g/l

0.40

837

5115

COPD (mode)

817

3538

1.88

57.43

1.8

1.9

8.03

7.29

g/l

19.84

627

2578

Type 2 diabetes, strict (exclude DM1)

2254

9291

1.47

57.43

1.9

2.4

7.83

7.17

g/l

42.41

1621

6997

Pulmonary embolism

821

4549

1.86

57.36

2.5

2.3

7.51

7.46

g/l

0.28

618

3319

Benzodiazepine use

2324

11572

1.45

56.85

2.1

2.2

7.43

7.34

g/l

1.26

1725

8624

Pulmonary heart disease

821

4562

1.85

56.83

2.5

2.2

7.51

7.46

g/l

0.31

618

3325

Fracture of rib(s), sternum and thoracic spine

803

4440

1.86

56.48

2.6

2.3

7.35

7.40

g/l

0.28

592

3258

Other disorders of teeth and supporting structures

559

2739

2.10

56.28

3.2

2.1

7.30

7.40

g/l

0.54

375

2026

Hyperkalaemia

206

629

3.53

56.16

2.5

2.1

7.84

7.37

g/l

1.97

145

470

Dysphagia

662

3447

1.98

56.14

2.3

7.28

7.45

g/l

1.52

477

2548

External causes of morbidity and mortality

1568

5002

1.59

56.11

2.2

7.41

7.34

g/l

0.71

1164

3792

Temporal arteritis

172

471

4.07

56.08

1.5

2.8

8.76

7.48

g/l

9.32

132

343

Immunodeficiency with predominantly antibody defects

122

257

5.29

55.79

5.1

2.0

7.21

7.40

g/l

0.50

210

Gonarthrosis

1565

5769

1.58

55.78

2.0

2.3

7.50

7.28

g/l

4.33

1159

4286

Injuries to the thorax

1126

6860

1.68

55.53

2.3

2.2

7.36

7.39

g/l

0.22

832

5061

Abnormal findings on examination of urine, without diagnosis

176

490

3.90

55.42

3.4

2.6

7.74

7.30

g/l

1.86

139

372

Osteonecrosis

213

670

3.42

55.37

7.2

2.1

7.67

7.39

g/l

1.08

155

519

Unspecified privation

325

1283

2.65

55.02

2.0

2.3

7.59

7.39

g/l

0.97

274

978

Atherosclerosis, excluding cerebral and coronary sclerosis

1198

5907

1.66

54.72

1.9

2.3

7.99

7.42

g/l

17.61

899

4254

Benign neoplasm: Colon, unspecified

721

3907

1.91

54.51

2.3

7.41

7.45

g/l

0.19

478

2887

Diabetic retinopathy, excluding more controls

656

1861

2.05

54.49

1.7

2.0

8.07

7.70

g/l

3.80

470

1354

Abnormalities of heart beat

815

4526

1.82

54.25

2.1

7.22

7.39

g/l

1.75

584

3328

General examination and investigation of persons without complaint and reported diagnosis

1371

4552

1.62

54.16

2.3

2.1

7.28

7.39

g/l

1.22

931

3535

ILD, hospital admission 2, with pulmonary infections

312

1220

2.70

54.12

2.3

1.8

7.96

7.31

g/l

5.92

241

890

Type 1 diabetes

590

2980

2.02

54.04

1.7

2.3

7.91

7.14

g/l

14.24

430

2275

Irritable bowel syndrome

615

3165

1.99

53.60

2.1

2.2

7.12

7.38

g/l

2.80

442

2399

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

172

6.59

53.28

2.6

1.4

7.00

7.80

g/l

2.79

123

Systemic lupus erythematosus, unspecified

133

312

4.71

53.21

1.8

1.9

7.22

7.52

g/l

0.95

107

243

Hard cardiovascular diseases

1976

8705

1.48

52.99

2.3

7.62

7.35

g/l

7.17

1453

6476

Asthma/COPD (KELA code 203)

2121

10416

1.45

52.95

2.0

2.3

7.53

7.30

g/l

6.77

1565

7745

Nausea and vomiting

647

3348

1.95

52.72

2.7

2.2

7.52

7.46

g/l

0.36

476

2453

Type 2 diabetes, definitions combined, including avohilmo

2217

9184

1.45

52.53

1.9

2.4

7.82

7.16

g/l

42.08

1601

6934

Deposits [accretions] on teeth

205

622

3.35

52.35

6.1

1.9

7.12

7.31

g/l

0.76

161

486

Insulin, fast-acting

883

5124

1.76

52.21

1.8

2.2

8.02

7.28

g/l

20.85

634

3823

Mood disorders, excluding more controls

2170

9230

1.45

51.94

2.0

2.3

7.29

7.38

g/l

1.30

1642

6942

Hernia of abdominal wall, postoperative

428

1950

2.26

51.93

2.0

7.52

7.34

g/l

1.08

330

1415

Exposure to other specified factors

1580

9875

1.52

51.82

2.1

2.2

7.41

7.34

g/l

0.78

1242

7389

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1388

9031

1.56

51.66

2.1

2.3

7.49

7.39

g/l

1.02

1027

6672

IgA nephropathy (IgA glomerulonephritis)

111

232

5.34

51.28

1.7

2.5

7.29

7.22

g/l

0.14

177

Giant cell arteritis with polymyalgia rheumatica

172

501

3.82

51.23

1.5

2.7

8.76

7.54

g/l

8.68

132

369

Chronic nephritic syndrome

159

436

3.96

51.23

2.5

2.7

7.55

7.28

g/l

0.92

130

341

Vocal cord dysfunction

290

1028

2.69

51.07

2.5

2.4

7.42

7.01

g/l

2.31

213

827

Soft tissue disorders related to use, overuse and pressure

655

3506

1.92

50.95

2.1

2.3

7.33

7.40

g/l

0.35

482

2628

Obesity, other/unspecified

718

3951

1.85

50.87

1.6

2.2

7.80

7.24

g/l

11.52

539

3011

Non-allergic asthma (mode), excluding more controls

449

2084

2.19

50.54

1.9

1.8

7.51

7.29

g/l

1.76

338

1519

Depression or dysthymia

1713

6420

1.51

50.27

2.1

2.3

7.30

7.39

g/l

1.15

1282

4795

Lumbar disc prolapse

1412

7324

1.55

49.93

2.3

2.1

7.38

7.35

g/l

0.23

1037

5544

Biguanides

2255

9877

1.42

49.49

1.9

2.3

7.97

7.19

g/l

56.52

1643

7404

Endocarditis

139

355

4.25

49.49

1.9

2.3

7.49

7.42

g/l

0.13

107

262

Other (seronegative) rheumatoid arthritis, wide

536

2720

2.04

49.28

2.0

2.2

7.74

7.50

g/l

1.77

404

2002

Enterocolitis due to Clostridium difficile

340

1446

2.46

49.19

4.1

2.2

7.46

g/l

0.01

228

1062

Other symptoms and signs involving cognitive functions and awareness

1130

6649

1.63

49.19

2.0

2.3

7.31

7.46

g/l

1.72

807

4872

Concussion

968

5026

1.69

49.09

2.0

2.3

7.30

7.42

g/l

0.98

699

3834

Conduction disorders

759

3549

1.82

48.81

2.2

2.1

7.43

g/l

0.02

553

2555

Seropositive rheumatoid arthritis, strict definition

436

2061

2.20

48.71

1.7

2.3

7.81

7.44

g/l

3.29

329

1552

Cardiomyopathy, other and unspecified

254

950

2.82

48.15

2.3

2.1

7.43

7.39

g/l

0.09

213

697

Any mental disorder

2632

9590

1.39

48.14

2.1

2.3

7.34

7.38

g/l

0.38

1935

7191

Prurigo nodularis

117

270

4.85

48.06

1.6

3.0

7.39

7.45

g/l

0.12

201

Undetermined asthma, excluding more controls

304

1235

2.54

47.96

2.0

1.7

7.51

7.33

g/l

0.93

221

914

Postmenopausal osteoporosis with pathological fracture

232

837

3.00

47.81

2.0

2.3

7.72

g/l

0.01

158

613

Other disorders of veins

939

5675

1.69

47.80

2.1

2.2

7.28

7.43

g/l

1.83

750

4204

Viral infections characterized by skin and mucous membrane lesions

929

5596

1.69

47.73

3.3

2.1

7.28

7.36

g/l

0.72

691

4185

Other disorders of lacrimal gland

813

4740

1.75

47.55

2.6

2.3

7.23

7.46

g/l

3.00

606

3527

Fibrosis and cirrhosis of liver

251

943

2.83

47.44

1.6

2.6

7.16

7.36

g/l

0.87

175

721

Methotrexate

367

1634

2.32

47.25

1.8

2.5

7.61

7.28

g/l

2.43

289

1212

Biological medication for rheuma

353

1545

2.35

47.23

1.5

2.3

7.68

7.29

g/l

3.08

267

1187

Agranulocytosis

322

1365

2.47

46.88

3.3

2.3

7.17

7.44

g/l

1.31

248

1037

Sleep apnoea

2137

10342

1.42

46.75

2.0

2.3

7.44

7.34

g/l

1.58

1581

7779

Other diseases of pericardium

158

459

3.70

46.58

1.7

2.3

7.91

7.40

g/l

1.98

112

339

Polyarthrosis

524

2571

2.01

46.56

2.2

2.4

7.72

7.40

g/l

2.75

354

1868

Secondary and unspecified malignant neoplasm of lymph nodes

276

1098

2.66

46.39

1.7

2.4

7.45

7.38

g/l

0.22

213

835

Cutaneous abscess, furuncle and carbuncle

586

3133

1.91

45.75

2.1

2.2

7.58

7.31

g/l

2.25

458

2366

Psychiatric diseases

2548

9314

1.38

45.74

2.1

2.3

7.33

7.38

g/l

0.47

1875

7008

Other diseases of anus and rectum

722

4112

1.79

45.69

2.3

7.47

7.44

g/l

0.18

499

3050

Other diseases of intestine

351

1561

2.34

45.67

2.5

2.2

7.45

7.43

g/l

0.07

270

1165

Insulin, fast-acting or short human

886

5340

1.69

45.58

1.8

2.2

8.02

7.32

g/l

18.72

636

3962

Anxiety disorders, excluding more controls

1773

8144

1.46

45.30

2.1

2.3

7.14

7.37

g/l

5.96

1366

6152

Diseases of pulp and periapical tissues, including avohilmo

2513

9536

1.38

45.26

2.2

7.39

7.36

g/l

0.35

1932

7009

Retention of urine

896

4574

1.69

44.93

1.9

2.3

7.48

7.40

g/l

0.66

655

3358

Urticaria and erythema

764

4441

1.75

44.92

2.3

2.1

7.28

7.37

g/l

0.72

588

3327

Persons with potential health hazards related to communicable diseases

656

3612

1.83

44.88

2.2

2.0

7.27

7.23

g/l

0.23

440

2838

Secondary right heart disease

169

528

3.48

44.75

2.0

2.4

6.98

7.54

g/l

3.65

137

399

Persons encountering health services for specific procedures, not carried out

208

726

3.00

44.69

2.2

2.0

7.46

7.25

g/l

0.95

189

572

Any operation in hilmo

11.52

44.42

1.8

1.3

7.19

7.20

g/l

0.00

Obesity due to excess calories

947

5846

1.65

44.25

1.8

2.3

7.85

7.24

g/l

16.72

679

4465

Coxibs

703

2054

1.85

44.23

2.1

2.2

7.41

7.29

g/l

0.91

540

1455

Noninfective enteritis and colitis

1016

6374

1.62

44.19

2.3

2.2

7.31

7.35

g/l

0.30

740

4770

Dental pulpitis 4

2508

9552

1.38

44.15

2.2

7.39

7.36

g/l

0.41

1928

7027

Sleep apnoea, including avohilmo

2222

10450

1.40

43.99

1.9

2.3

7.42

7.34

g/l

1.21

1645

7840

Dental pulpitis 1

2507

9557

1.38

43.94

2.2

7.40

7.36

g/l

0.43

1928

7030

Subjective visual disturbances

589

3203

1.89

43.77

2.3

2.2

7.32

7.44

g/l

0.84

458

2396

Convulsions, not elsewhere classified

453

2218

2.06

43.74

1.7

2.0

7.45

7.27

g/l

1.09

346

1666

Mood disorders

2245

10715

1.39

43.69

2.0

2.3

7.28

7.38

g/l

1.70

1703

8003

Special screening examination for other diseases and disorders

218

788

2.87

43.67

2.8

2.2

7.54

7.47

g/l

0.21

171

605

Isolated proteinuria with specified morphological lesion

115

7.31

43.63

4.2

2.6

7.74

7.49

g/l

0.38

Mood [affective] disorders

2237

10692

1.39

43.54

2.0

2.3

7.27

7.38

g/l

1.84

1697

7986

Other diseases of the digestive system

840

5064

1.70

43.54

2.1

2.2

7.54

7.42

g/l

0.90

607

3687

Cardiomyopathies, Primary/intrinsic

350

1587

2.29

43.43

1.9

2.2

7.32

7.33

g/l

0.04

286

1156

GI-bleeding

842

5084

1.69

43.36

2.1

2.2

7.54

7.43

g/l

0.89

612

3691

Other headache syndromes

896

5486

1.66

43.25

1.8

2.4

7.17

7.38

g/l

2.78

670

4135

Non-allergic asthma (mode)

449

2214

2.06

43.14

1.9

1.8

7.51

7.29

g/l

1.72

338

1628

Injury, poisoning and certain other consequences of external causes

1237

3975

1.58

43.13

2.2

2.3

7.39

7.32

g/l

0.57

921

3009

Benign neoplasm of other and ill-defined parts of digestive system

460

2321

2.05

43.07

2.1

1.4

7.32

7.47

g/l

0.95

331

1686

Anxiety (asthma-related co-morbidities)

1107

5573

1.58

43.01

1.8

2.2

7.13

7.27

g/l

1.66

870

4243

Other anxiety disorders

803

4218

1.71

43.00

1.8

2.1

7.17

7.28

g/l

0.94

639

3224

Dental pulpitis 2

1775

6310

1.46

42.80

2.2

7.43

7.38

g/l

0.47

1337

4538

Hepatomegaly and splenomegaly, not elsewhere classified

8.51

42.50

1.8

6.94

7.43

g/l

0.85

Other CVD

549

2959

1.92

42.33

2.5

2.2

7.50

g/l

0.01

388

2105

Type 1 diabetes, wide definition, subgroup 1

454

2283

2.03

42.29

1.7

2.2

7.96

7.13

g/l

12.47

324

1745

Early onset COPD, excluding more controls

484

2493

1.99

42.28

2.0

1.8

7.93

7.19

g/l

12.46

370

1864

Iron deficiency anaemia secondary to blood loss (chronic)

436

2173

2.07

42.26

2.0

2.3

7.32

7.44

g/l

0.56

289

1590

Injuries to the shoulder and upper arm

1885

11306

1.41

42.02

2.4

2.2

7.38

g/l

0.00

1387

8414

Symptoms and signs involving speech and voice

797

4784

1.70

41.97

2.4

2.2

7.12

7.45

g/l

6.30

611

3517

ILD, hospital admissions 3, with pneumonia sepsis

266

1091

2.57

41.96

2.2

1.9

7.99

7.32

g/l

5.55

208

790

Undetermined asthma

304

1316

2.38

41.74

2.0

1.7

7.51

7.33

g/l

0.90

221

968

Cardiomyopathy (excluding other)

357

1661

2.23

41.57

1.8

2.1

7.32

7.33

g/l

0.03

292

1205

All anxiety disorders

1118

5814

1.57

41.42

1.8

2.2

7.13

7.30

g/l

2.46

878

4424

In situ neoplasms

811

4672

1.69

41.29

2.2

1.4

7.43

7.47

g/l

0.22

621

3382

Dental caries 1

1943

7062

1.42

41.10

2.2

7.38

g/l

0.04

1474

5099

Dental caries, including avohilmo

1941

7058

1.42

41.00

2.2

7.38

g/l

0.02

1472

5095

Other diseases of liver

444

2251

2.03

40.94

2.1

2.3

7.42

7.38

g/l

0.15

337

1694

Diffuse large B-cell lymphoma, helper endpoint

166

542

3.31

40.85

1.9

1.4

7.69

7.50

g/l

0.48

127

406

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

166

542

3.31

40.85

1.9

1.4

7.69

7.50

g/l

0.48

127

406

Depression

2017

10044

1.40

40.74

2.0

2.3

7.27

7.37

g/l

1.73

1528

7533

Volume depletion

262

1081

2.53

40.49

1.8

2.1

7.68

7.41

g/l

1.30

183

787

Other medical care

948

5851

1.61

40.27

3.7

2.1

7.72

7.43

g/l

4.03

696

4319

Calcific aortic valvular stenosis

834

5016

1.67

40.27

2.2

7.57

7.48

g/l

0.60

586

3588

Calcific aortic valvular stenosis, operated

834

5016

1.67

40.27

2.2

7.57

7.48

g/l

0.60

586

3588

Other neurological diseases

1738

9934

1.43

40.18

2.2

2.3

7.32

7.44

g/l

1.75

1234

7334

Adverse effects, not elsewhere classified

427

2145

2.04

40.17

2.1

2.2

7.22

7.38

g/l

1.04

357

1631

AV-block

480

2272

1.98

40.16

2.2

2.1

7.43

7.47

g/l

0.15

337

1597

Sequelae of external causes of morbidity and mortality

633

3615

1.80

40.12

2.4

2.3

7.57

7.45

g/l

0.88

485

2675

Other dialysis

120

322

4.08

40.11

2.4

2.6

7.50

7.28

g/l

0.56

104

246

Calcific aortic valvular stenosis, diagnosis (helper)

833

5015

1.67

40.06

2.2

7.57

7.48

g/l

0.59

585

3587

Operations 2 for CAVS

833

5015

1.67

40.06

2.2

7.57

7.48

g/l

0.59

585

3587

Other respiratory diseases principally affecting the interstitium

512

2750

1.93

40.02

2.3

2.2

7.85

7.43

g/l

4.93

394

1997

Fracture of femur

713

3833

1.74

39.95

2.3

2.1

7.51

7.55

g/l

0.22

445

2738

Benign neoplasm: Sigmoid colon

472

2471

1.97

39.78

2.3

1.4

7.51

7.47

g/l

0.16

348

1801

Disorder of lipoprotein metabolism, unspecified

382

1857

2.13

39.78

1.7

2.2

7.81

7.39

g/l

4.23

290

1360

Calcific aortic valvular stenosis, including rheumatic fever

835

5036

1.66

39.74

2.2

7.56

7.49

g/l

0.51

587

3602

Non-Hodgkin lymphoma, all

163

536

3.30

39.74

3.8

2.5

7.08

7.47

g/l

1.52

120

402

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

155

495

3.38

39.53

2.8

1.4

7.13

7.52

g/l

1.52

120

370

Conjunctivitis

1482

8955

1.46

39.47

2.2

7.18

7.38

g/l

4.31

1178

6672

Spondylopathies in diseases classified elsewhere

131

6.45

39.36

18.4

1.3

7.51

7.32

g/l

0.30

Other and unspecified immunodeficiencies with predominantly antibody defects

120

6.63

39.32

5.4

2.2

7.33

7.40

g/l

0.09

Hypotension

477

2522

1.96

39.15

2.6

2.2

7.46

7.49

g/l

0.14

332

1794

Acetic acid derivatives and related substances

693

2049

1.79

38.96

2.1

2.2

7.37

7.28

g/l

0.62

541

1453

Arthropathies in other diseases classified elsewhere

126

355

3.81

38.95

2.5

2.4

7.71

7.13

g/l

2.35

260

Artrosis, including avohilmo

1948

7694

1.40

38.94

2.0

2.3

7.38

7.29

g/l

1.25

1455

5751

Amputation

309

1397

2.31

38.89

1.7

2.3

8.10

7.41

g/l

7.19

248

1004

Fracture of shoulder and upper arm

833

5150

1.65

38.87

2.5

2.2

7.43

7.44

g/l

0.02

605

3807

Dental caries 1 and operation codes

2098

7830

1.39

38.85

2.2

7.40

7.38

g/l

0.09

1591

5699

Cardiomyopathy in other diseases

10.56

38.76

9.1

2.1

7.24

7.74

g/l

0.88

Idiopathic thrombocytopenic purpura

117

316

4.02

38.66

2.4

2.5

6.81

7.43

g/l

3.10

238

Dental pulpitis 2, only avohilmo

1791

6501

1.43

38.51

2.2

7.41

7.38

g/l

0.26

1346

4664

Disorders of lacrimal system

955

6118

1.59

38.46

2.6

2.2

7.24

7.47

g/l

3.27

699

4521

Rotator cuff syndrome

1403

7165

1.47

38.36

2.2

2.3

7.47

7.36

g/l

1.22

1051

5338

Abnormal involuntary movements

347

1650

2.18

38.24

2.1

2.3

7.11

7.43

g/l

3.10

267

1230

Disorders of conjunctiva

1672

9974

1.42

38.13

2.2

7.18

7.38

g/l

4.70

1307

7411

Fungal Sepsis

134

400

3.61

38.06

2.8

2.4

7.80

7.35

g/l

1.47

304

Other pulmonary heart/vessel disease

172

598

3.09

37.88

2.0

2.4

6.98

7.55

g/l

3.90

137

457

Neurotic, stress-related and somatoform disorders

1801

9210

1.40

37.82

2.1

2.2

7.14

7.37

g/l

5.87

1393

6917

Zoster [herpes zoster]

475

2537

1.93

37.69

3.9

2.2

7.34

7.49

g/l

0.94

335

1864

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1310

6082

1.49

37.62

2.6

1.4

7.27

7.47

g/l

3.31

969

4472

Covid-19 suspected case

410

2077

2.02

37.57

2.4

2.2

7.36

7.27

g/l

0.38

250

1598

Dental operations

1669

6029

1.44

37.51

2.3

2.0

7.39

7.40

g/l

0.12

1227

4459

Asthma and allergy, excluding more controls

219

844

2.61

37.40

1.9

1.5

7.21

7.14

g/l

0.21

165

641

Other diseases of upper respiratory tract

2561

10091

1.33

37.14

2.2

7.33

7.40

g/l

1.09

1923

7460

Anxiety disorders

1819

9329

1.39

36.87

2.1

2.2

7.15

7.37

g/l

5.78

1405

7003

Ischaemic heart disease, wide definition

1876

8523

1.40

36.87

2.3

2.4

7.60

7.35

g/l

5.89

1386

6347

Other and unspecified coagulation defects

147

472

3.30

36.84

2.6

2.4

7.16

7.34

g/l

0.63

122

364

Non-invasive ventilation

439

2145

1.96

36.82

3.1

2.3

7.88

7.12

g/l

6.52

156

1675

Functional dyspepsia

598

3440

1.78

36.79

2.4

2.3

7.32

7.43

g/l

0.66

421

2590

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

400

2036

2.04

36.78

1.5

2.3

7.06

7.38

g/l

2.70

295

1520

Hypokalaemia

302

1385

2.26

36.52

2.7

2.1

7.53

7.43

g/l

0.38

208

1023

Allergic asthma (mode), excluding more controls

405

2020

2.00

36.45

1.9

1.7

7.42

7.17

g/l

1.67

299

1535

Ischemic heart diseases

1886

8606

1.39

36.23

2.3

2.4

7.59

7.36

g/l

5.48

1397

6401

Rash and other nonspecific skin eruption

270

1187

2.37

36.22

2.0

2.3

7.11

7.46

g/l

2.58

214

891

Cirrhosis of liver, NAS

172

613

3.00

36.19

1.6

2.7

6.96

7.38

g/l

1.90

119

469

Lichen simplex chronicus and prurigo

197

751

2.76

36.16

1.9

2.7

7.46

7.37

g/l

0.24

152

568

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

7.42

36.07

3.7

1.4

7.50

7.80

g/l

0.42

ILD, hospital admissions

433

2283

1.97

36.00

2.3

7.85

7.43

g/l

4.12

335

1662

Other coagulation defects

197

751

2.74

35.98

2.5

7.21

7.42

g/l

0.89

163

575

Type 1 diabetes, wide definition

469

2520

1.90

35.94

1.7

2.2

7.96

7.15

g/l

12.30

335

1920

Other abnormalities of plasma proteins

161

5.46

35.92

4.7

2.9

7.64

7.40

g/l

0.34

120

Amputation of toe

231

957

2.55

35.83

1.8

2.5

8.09

7.40

g/l

5.55

186

713

Parodontitis or/and operation codes

1384

5676

1.47

35.80

2.3

2.4

7.41

7.30

g/l

1.20

1074

4187

Pacemaker

892

5569

1.59

35.75

2.1

2.3

7.32

7.51

g/l

2.06

624

3980

Other symptoms and signs involving the nervous and musculoskeletal systems

895

5742

1.58

35.72

2.0

2.3

7.17

7.38

g/l

2.81

650

4258

Diseases of the myoneural junction and muscle

332

1596

2.16

35.72

1.6

2.3

7.27

7.41

g/l

0.77

241

1181

Other and unspecified types of non-Hodgkin lymphoma, hilmo

155

527

3.17

35.59

2.8

2.6

7.13

7.44

g/l

1.09

120

394

Pleural effusion

446

2382

1.94

35.58

2.6

2.2

7.70

7.37

g/l

2.80

349

1713

Need for immunization against other single viral diseases

185

4.95

35.51

2.9

2.1

7.35

7.36

g/l

0.02

143

Other interstitial pulmonary diseases

436

2321

1.95

35.21

2.3

7.86

7.43

g/l

4.43

338

1684

Chronic sinusitis

913

5899

1.57

35.20

2.4

2.3

7.32

7.35

g/l

0.15

722

4417

Drug-induced osteoporosis with pathological fracture

202

4.92

35.05

1.6

2.3

7.69

7.78

g/l

0.12

149

Interstitial lung disease

436

2326

1.94

34.98

2.3

7.86

7.43

g/l

4.37

338

1690

Interstitial lung disease endpoints

436

2326

1.94

34.98

2.3

7.86

7.43

g/l

4.37

338

1690

Other abnormal findings of blood chemistry

140

452

3.30

34.91

3.4

2.3

7.46

7.38

g/l

0.20

122

355

Cellulitis

506

2818

1.84

34.91

2.7

2.2

7.62

7.36

g/l

2.15

393

2103

Chronic ulcer of skin, not elsewhere classified

215

872

2.60

34.82

2.2

2.3

7.72

7.40

g/l

1.39

156

652

Other noninfective gastroenteritis and colitis

549

3129

1.79

34.82

2.7

2.2

7.42

7.45

g/l

0.16

413

2309

Asthma and allergy

219

875

2.52

34.73

1.9

1.6

7.21

7.16

g/l

0.13

165

661

Reactive arthropathies, FINNGEN

172

622

2.87

34.64

2.3

2.7

7.44

7.06

g/l

1.93

131

467

Other reaction to severe stress, and adjustment disorders

638

3794

1.70

34.50

2.5

2.1

7.11

7.28

g/l

1.70

510

2895

Stroke, excluding SAH

1517

8032

1.42

34.44

2.3

7.50

7.46

g/l

0.34

1108

5889

Diffuse large B-cell lymphoma

166

599

2.99

34.31

1.9

2.7

7.69

7.38

g/l

0.92

127

450

Pericarditis

118

346

3.63

34.31

1.9

2.2

8.20

7.34

g/l

3.84

256

COPD

1139

6372

1.50

34.30

1.9

2.4

7.90

7.36

g/l

15.85

865

4634

Tumor necrosis factor alpha inhibitors

290

1338

2.22

34.29

1.5

2.4

7.66

7.27

g/l

2.64

218

1031

Trochanteric bursitis

338

1658

2.10

34.28

2.3

7.43

7.51

g/l

0.31

248

1236

Dental caries 3

1982

7456

1.37

34.24

2.2

7.39

7.38

g/l

0.06

1508

5419

Other and unspecified effects of external causes

533

3030

1.79

34.08

2.0

2.2

7.21

7.35

g/l

1.10

439

2287

Diabetic neuropathy

333

1628

2.13

33.99

2.0

7.94

7.79

g/l

0.72

240

1152

Peripheral artery operations in Hilmo

373

1906

2.03

33.87

1.9

2.3

8.06

7.38

g/l

8.66

297

1356

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1025

6725

1.52

33.86

1.9

2.1

7.20

7.39

g/l

3.16

829

5038

Benign neoplasm: Ascending colon

348

1738

2.08

33.85

2.1

1.4

7.49

g/l

0.02

248

1262

Abnormal findings on diagnostic imaging of other body structures

338

1670

2.10

33.77

3.0

2.4

7.31

7.50

g/l

1.06

231

1253

Stroke, including SAH

1569

8360

1.41

33.50

2.3

7.49

7.45

g/l

0.33

1148

6145

Nonalcoholic fatty liver disease

235

1007

2.43

33.46

2.0

2.5

7.50

7.29

g/l

0.93

180

775

Diseases of spleen

170

5.04

33.46

2.1

6.66

7.47

g/l

2.35

126

Voice disturbances

617

3680

1.71

33.45

2.6

2.3

7.06

7.45

g/l

7.40

482

2727

Implicit fungal Sepsis

122

373

3.52

33.44

2.9

2.4

7.82

7.37

g/l

1.38

285

Dental caries 1, only avohilmo

1954

7379

1.37

33.10

2.2

2.3

7.39

g/l

0.03

1491

5322

Psoriatic and enteropathic arthropathies

252

1115

2.32

33.06

1.7

2.6

7.59

7.11

g/l

3.15

179

836

Deforming dorsopathies

583

3431

1.73

33.01

2.3

2.2

7.40

7.42

g/l

0.09

419

2581

Injuries to the knee and lower leg

2560

11289

1.31

32.94

2.0

2.3

7.41

7.35

g/l

0.78

1893

8429

Ischaemic Stroke, excluding all haemorrhages

1436

7730

1.43

32.89

2.2

2.3

7.50

7.46

g/l

0.27

1050

5656

Urticaria

573

3358

1.74

32.89

2.3

2.1

7.22

7.39

g/l

1.43

440

2529

Acute upper respiratory infections of multiple and unspecified sites

1497

8023

1.41

32.88

3.1

2.0

7.30

7.35

g/l

0.45

1123

6011

Benign neoplasm: Transverse colon

283

1324

2.23

32.87

2.4

1.4

7.49

7.48

g/l

0.02

203

959

Unspecified fall

1071

7213

1.49

32.78

2.2

7.41

7.42

g/l

0.00

783

5312

Phlebitis and thrombophlebitis (not including DVT)

542

3142

1.77

32.67

2.7

2.2

7.39

7.45

g/l

0.30

400

2330

Allergic conjunctivitis

1060

7065

1.49

32.62

1.9

2.1

7.21

7.37

g/l

2.41

858

5286

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

109

315

3.73

32.59

4.3

1.4

7.07

7.40

g/l

0.97

229

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

233

1008

2.40

32.49

3.5

2.3

7.66

7.35

g/l

1.71

169

758

Dental caries 3 and operation codes

2119

8159

1.34

32.26

2.2

7.38

g/l

0.01

1615

5963

Allergic asthma (mode)

405

2108

1.91

32.22

1.9

1.7

7.42

7.19

g/l

1.52

299

1597

Acute sinusitis

993

6197

1.51

32.11

3.2

2.0

7.35

7.30

g/l

0.39

756

4711

Eosinophilic disease (BM)

117

5.83

32.09

2.4

1.5

7.43

7.41

g/l

0.02

Osteopathy in diseases classified elsewhere

8.00

32.03

15.1

2.3

7.31

7.50

g/l

0.29

Papulosquamous disorders

879

5774

1.55

31.74

2.1

2.3

7.46

7.38

g/l

0.63

638

4341

Viral pneumonia (unknown virus, not influenza)

173

659

2.74

31.67

2.1

2.4

7.56

7.32

g/l

0.80

139

505

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1190

5637

1.47

31.66

2.7

1.4

7.32

7.49

g/l

2.12

889

4125

Selective serotonin reuptake inhibitors

2229

8901

1.33

31.61

2.1

2.3

7.39

7.36

g/l

0.29

1725

6581

Rheumatism, unspecified

332

1666

2.05

31.60

2.1

2.3

7.53

7.51

g/l

0.06

252

1247

Myeloproliferative diseases

253

1152

2.30

31.51

2.8

2.4

6.95

7.42

g/l

3.81

180

869

Spondyloarthritis

406

2180

1.90

31.47

2.2

7.61

7.35

g/l

1.75

301

1617

Spondylopathies (FG)

272

1267

2.20

31.38

1.8

2.6

7.32

7.12

g/l

0.98

199

946

ILD, hospital admissions 1, main diag only

386

2053

1.95

31.38

2.4

2.3

7.83

7.42

g/l

3.56

295

1496

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

107

6.42

31.38

3.7

2.0

7.50

7.44

g/l

0.07

Open wound of head

1138

7765

1.46

31.31

2.1

2.2

7.41

7.39

g/l

0.14

845

5724

Cytomegalovirus infection, IBD co-morbidity

213

4.36

31.28

7.5

2.3

6.95

7.36

g/l

1.05

166

Somatoform disorder

359

1859

1.98

31.13

2.3

7.21

7.42

g/l

1.48

271

1410

Heart failure and coronary heart disease

922

4549

1.55

31.12

1.9

2.3

7.85

7.41

g/l

8.65

662

3256

Osteomyelitis

187

751

2.61

30.92

1.9

2.2

7.96

7.35

g/l

3.24

143

577

Migraine

820

4504

1.56

30.90

1.9

2.2

7.15

7.33

g/l

2.24

645

3480

Overexertion and strenuous or repetitive movements

243

1093

2.30

30.85

2.5

2.4

7.61

7.30

g/l

1.44

200

847

Gastroduodenal ulcer

658

4064

1.65

30.85

2.0

2.3

7.48

7.45

g/l

0.16

469

3004

Cholelithiasis, broad definition with cholecystitis

1955

10093

1.34

30.67

2.3

7.50

7.37

g/l

2.21

1404

7507

Open wound of lower leg

347

1790

1.99

30.56

2.0

2.1

7.55

7.47

g/l

0.35

259

1337

Other/unspecified cytomegaloviral diseases

179

4.68

30.41

8.1

2.4

7.00

7.31

g/l

0.65

138

Other symptoms and signs involving the urinary system

281

1350

2.16

30.37

2.1

2.5

7.57

7.34

g/l

1.02

157

991

Atopic dermatitis

943

5375

1.51

30.36

1.8

2.1

7.25

7.27

g/l

0.14

757

4074

Injuries to the elbow and forearm

1423

9307

1.40

30.12

2.0

2.2

7.38

g/l

0.02

1037

6942

Cytomegaloviral disease

224

4.17

30.01

7.5

2.3

6.93

7.35

g/l

1.15

176

Later onset COPD, excluding more controls

544

2500

1.74

29.83

1.6

1.9

7.99

7.33

g/l

11.09

416

1763

Superficial injury of head

497

2883

1.76

29.79

1.9

2.2

7.52

7.44

g/l

0.46

388

2111

Migraine with aura

400

2172

1.87

29.74

1.5

2.3

7.00

7.30

g/l

3.14

328

1691

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1143

5476

1.46

29.65

2.6

1.4

7.37

7.50

g/l

1.36

844

4002

Benign neoplasm of other and unspecified endocrine glands

303

1509

2.07

29.60

2.4

1.4

7.40

7.44

g/l

0.11

216

1115

DVT of lower extremities

481

2776

1.78

29.60

2.9

2.2

7.41

7.45

g/l

0.19

356

2038

Benign neoplasm of other and ill-defined parts of digestive system

460

2625

1.80

29.57

2.1

2.3

7.32

7.48

g/l

1.05

331

1939

Motor neuron disease

162

4.78

29.48

1.3

1.9

6.54

7.52

g/l

4.43

124

Disorders of continuity of bone

219

964

2.35

29.28

3.9

2.1

7.36

g/l

0.01

165

756

Special screening examination for infectious and parasitic diseases

369

1441

1.94

29.20

2.4

2.1

6.91

7.15

g/l

1.72

308

1175

Disorders of skin appendages

908

6105

1.50

29.09

2.2

7.38

7.31

g/l

0.49

687

4617

Coronary atherosclerosis

1654

7899

1.37

29.04

2.2

2.4

7.68

7.37

g/l

7.80

1245

5877

Other disorders of bone

406

2240

1.85

28.89

3.5

1.9

7.40

7.31

g/l

0.41

289

1715

Dental operations, only avohilmo

1728

6558

1.36

28.80

2.2

7.37

7.40

g/l

0.25

1297

4789

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1153

5550

1.45

28.75

2.6

1.4

7.37

7.50

g/l

1.31

850

4056

Psoriasis

626

3896

1.64

28.72

1.8

2.3

7.56

7.34

g/l

2.05

460

2933

Motor neuron disease (with DMD)

167

4.62

28.34

1.3

1.8

6.54

7.51

g/l

4.42

129

Reactive arthropathies

207

902

2.37

28.32

2.1

2.4

7.40

7.25

g/l

0.54

155

669

Rare circulating lymphoid malignancy

109

345

3.40

28.31

4.3

2.8

7.07

7.39

g/l

0.91

261

Myeloproliferative diseases (CML excluded)

228

1041

2.29

28.28

3.0

2.5

6.93

7.40

g/l

3.62

165

788

Other inflammation of eyelid

319

1648

1.99

28.11

2.7

2.4

7.14

7.48

g/l

2.87

234

1231

Other diseases of hard tissues of teeth

1267

6760

1.41

27.89

3.0

2.0

7.18

7.37

g/l

3.08

951

5042

Personality disorders, excluding more controls

422

2376

1.80

27.88

1.7

2.2

7.14

7.25

g/l

0.64

340

1838

Marginal zone B-cell lymphoma

105

6.11

27.68

2.0

1.9

6.84

7.49

g/l

1.54

Failure and rejection of transplanted organs and tissues

119

5.43

27.51

7.2

2.4

6.89

7.26

g/l

0.76

Abnormal serum enzyme levels

734

4730

1.56

27.50

2.1

2.3

7.33

7.32

g/l

0.05

541

3525

Osteonecrosis due to drugs

144

5.09

27.50

14.8

1.8

7.63

7.51

g/l

0.15

108

Phobic anxiety disorders

201

873

2.34

27.40

1.9

2.1

7.20

7.26

g/l

0.17

163

688

Hypothyroidism, strict autoimmune

1448

7013

1.38

27.35

1.9

2.4

7.43

7.32

g/l

1.28

1086

5176

Complications of internal orthopaedic prosthetic devices, implants and grafts

570

3518

1.66

27.32

2.0

2.3

7.64

7.49

g/l

0.92

406

2543

Pain in thoracic spine

313

1618

1.98

27.32

2.9

2.1

7.18

7.41

g/l

1.28

236

1233

Other chronic obstructive pulmonary disease

1069

6233

1.45

27.20

1.8

2.4

7.94

7.36

g/l

17.32

815

4529

Cholelithiasis

1868

9987

1.32

27.14

2.3

7.49

7.38

g/l

1.75

1348

7422

L01XX Other antineoplastic agents

185

789

2.48

27.14

3.8

2.6

6.60

7.48

g/l

10.34

135

591

Gastric ulcer

455

2651

1.76

27.11

2.0

2.3

7.46

7.47

g/l

0.03

325

1954

Other disorders of skin and subcutaneous tissue, not elsewhere classified

354

1916

1.90

27.08

2.2

2.1

7.68

7.49

g/l

0.93

245

1407

Recurrent or chronic depression

743

3475

1.56

27.07

1.8

2.2

7.13

7.33

g/l

2.33

587

2674

Gonarthrosis,primary

2110

10274

1.30

26.95

2.0

2.3

7.53

7.37

g/l

3.57

1559

7615

Sub-endpoint used in defining T1D endpoints

625

3881

1.61

26.84

1.7

2.1

7.90

7.32

g/l

9.33

451

2865

Meniscus derangement

1170

5682

1.42

26.73

2.1

2.3

7.38

7.27

g/l

1.21

863

4239

Adalimumab

182

770

2.43

26.61

1.4

2.2

7.60

7.25

g/l

1.59

135

605

Other diseases of arteries and capillaries

240

1144

2.17

26.54

2.0

2.3

7.63

7.41

g/l

0.84

177

848

Substance abuse, excluding more controls

1137

7081

1.42

26.54

1.6

2.3

7.48

7.32

g/l

1.91

858

5347

Injuries to the ankle and foot

1249

8232

1.39

26.50

2.1

2.2

7.34

7.30

g/l

0.37

969

6244

L04AC Interleukin inhibitors

123

431

2.98

26.48

1.4

2.0

7.70

7.27

g/l

1.36

338

Fitting and adjustment of other devices

828

5193

1.51

26.30

2.3

2.1

7.37

7.44

g/l

0.53

489

3813

Sequelae with surgical and medical care as external cause

486

2909

1.71

26.28

2.1

2.2

7.62

7.49

g/l

0.70

357

2142

Cervical disc disorders

790

5284

1.52

26.25

2.2

7.29

7.39

g/l

0.77

557

3992

Temporomandibular joint disorders

280

1410

2.02

26.23

2.4

2.1

7.27

7.33

g/l

0.20

203

1068

Acute upper respiratory infections

2248

11024

1.29

26.15

2.9

2.1

7.35

7.38

g/l

0.29

1690

8191

Secondary uncertain malignant neoplasm

338

1828

1.91

26.07

1.9

2.3

7.54

7.44

g/l

0.35

252

1333

Disorders of sclera, cornea, iris and ciliary body

1114

7955

1.42

26.06

2.1

2.2

7.42

7.36

g/l

0.45

824

5950

Hypoparathyroidism

124

444

2.99

26.03

1.6

2.3

7.52

7.58

g/l

0.11

345

Dental pulpitis 4, only avohilmo

2427

9979

1.28

26.02

2.0

2.3

7.39

7.36

g/l

0.41

1908

7305

Mycoses

571

3563

1.63

26.01

2.7

2.2

7.49

7.41

g/l

0.45

417

2658

Other and unspecified drugs and medicaments

212

971

2.27

25.95

3.3

2.3

7.66

7.38

g/l

1.30

149

734

All influenza (not pneumonia)

314

1654

1.94

25.93

4.3

1.8

7.35

7.24

g/l

0.44

226

1237

Dental caries 3, only avohilmo

1977

7758

1.31

25.90

2.2

2.3

7.37

7.39

g/l

0.11

1510

5633

Other infectious diseases

218

1012

2.24

25.87

2.5

2.3

7.93

7.40

g/l

3.07

154

768

Cardiodefibrillation

925

6404

1.47

25.86

2.1

2.3

7.30

7.47

g/l

1.86

727

4666

Systemic sclerosis (FG)

211

3.96

25.72

1.9

2.7

7.15

7.06

g/l

0.18

158

Carcinoma in situ of skin of other and unspecified parts of face

227

1077

2.21

25.65

2.0

1.5

7.53

7.54

g/l

0.03

182

755

Myositis

254

3.66

25.64

1.5

2.1

7.25

7.35

g/l

0.16

188

Superficial injury of lower leg

489

2943

1.69

25.62

1.9

2.2

7.39

7.40

g/l

0.07

356

2195

Other disorders of eye and adnexa

299

1558

1.97

25.62

1.9

2.3

7.25

7.40

g/l

0.74

247

1170

Disorders of muscles

231

1098

2.17

25.58

1.6

2.1

7.36

7.39

g/l

0.07

177

823

Diseases of external ear

719

4747

1.54

25.50

2.1

2.3

7.43

7.38

g/l

0.28

491

3552

Cerebral palsy and other paralytic syndromes

269

1357

2.04

25.39

1.9

2.3

7.29

7.37

g/l

0.32

207

1029

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

355

1966

1.86

25.28

2.0

1.4

7.41

7.45

g/l

0.13

257

1449

Paralytic ileus and intestinal obstruction

565

3541

1.62

25.22

2.6

2.2

7.53

7.44

g/l

0.48

398

2617

Dermatopolymyositis (FG)

132

4.92

25.21

3.0

2.7

7.22

6.95

g/l

0.62

102

Stomatitis and related lesions

186

815

2.35

25.17

3.2

1.9

7.47

7.34

g/l

0.32

127

623

In situ neoplasms

811

5506

1.50

25.17

2.2

7.43

7.49

g/l

0.39

621

3979

Infection of intervertebral disc (pyogenic)

150

4.74

25.15

2.2

2.1

8.28

7.26

g/l

2.88

114

Charcot foot

175

4.32

25.09

2.4

2.8

8.01

7.07

g/l

2.68

135

Other peripheral vascular diseases

208

959

2.25

25.06

1.7

2.4

7.16

7.36

g/l

0.80

160

730

Polyarthritis, unspecified

110

375

3.09

25.03

2.6

2.2

7.91

7.17

g/l

2.65

274

Other and unspecified acquired haemolytic anaemias

103

5.70

24.90

2.9

1.6

5.88

7.45

g/l

5.34

Other pleural conditions

286

1490

1.99

24.82

2.8

2.2

7.61

7.35

g/l

1.55

220

1075

Other chronic obstructive pulmonary disease, including avohilmo

1287

7870

1.38

24.82

1.8

2.4

7.87

7.37

g/l

15.77

971

5749

Peripheral arterial reconstruction

457

2737

1.72

24.81

1.8

2.3

8.08

7.41

g/l

9.21

347

1952

Pyoderma gangrenosum

6.63

24.79

2.1

1.8

7.72

7.56

g/l

0.17

Benign neoplasm: Sigmoid colon

472

2851

1.70

24.79

2.3

7.51

7.46

g/l

0.22

348

2105

Dermatopolymyositis

134

4.82

24.73

3.0

2.0

7.22

7.34

g/l

0.19

101

Hypertrophic cardiomyopathy

130

491

2.81

24.62

2.7

2.8

7.31

7.37

g/l

0.11

114

373

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

679

4463

1.55

24.58

2.4

2.2

7.36

7.42

g/l

0.32

503

3321

Carcinoma in situ of skin of scalp and neck

299

3.46

24.57

1.8

1.4

7.16

7.63

g/l

1.64

214

Pneumonia due to other infectious organisms, not elsewhere classified

306

3.32

24.56

6.1

1.9

7.68

7.30

g/l

0.93

228

Essential (haemorrhagic) thrombocythaemia

121

441

2.92

24.54

2.4

1.4

6.84

7.49

g/l

3.36

329

Sequelae of cerebrovascular disease

870

5271

1.47

24.43

2.0

2.3

7.53

7.45

g/l

0.50

601

3824

Pyogenic arthritis

170

728

2.42

24.38

3.0

2.4

7.66

7.17

g/l

2.10

128

525

Other overlap syndromes

179

4.18

24.27

1.8

2.5

7.03

7.51

g/l

1.43

139

Benign neoplasm: Transverse colon

283

1483

1.98

24.25

2.4

7.49

7.43

g/l

0.19

203

1103

Other enthesopathies

592

3787

1.59

24.17

1.9

2.3

7.34

g/l

0.03

443

2837

Diseases of salivary glands

406

2364

1.75

24.16

2.4

2.1

7.43

7.45

g/l

0.05

291

1739

Dental pulpitis 1, only avohilmo

2418

10033

1.27

24.11

2.0

2.3

7.38

7.36

g/l

0.26

1897

7342

Psoriatic arthropathies

218

1038

2.16

24.03

1.7

2.4

7.72

7.20

g/l

3.12

153

777

Benign neoplasm: Rectum, anus and anal canal

461

2789

1.69

23.96

2.2

1.4

7.48

7.47

g/l

0.03

348

2029

Degeneration of macula and posterior pole

1157

6939

1.40

23.95

2.1

2.3

7.59

7.46

g/l

1.24

804

5027

Behavioural syndromes associated with physiological disturbances and physical factors

534

3339

1.62

23.87

1.9

2.0

7.24

7.31

g/l

0.40

395

2529

Myeloid leukaemia

277

3.45

23.83

1.8

1.4

7.04

7.51

g/l

1.39

206

Other general symptoms and signs

107

364

3.01

23.69

1.4

2.5

7.40

g/l

0.00

279

Heart failure and hypertrophic cardiomyopathy

207

3.95

23.60

2.9

2.3

7.56

7.35

g/l

0.34

151

Valvular operations

344

1927

1.83

23.58

1.6

2.1

7.00

7.43

g/l

3.73

259

1387

Erosion of teeth

5.52

23.53

4.0

2.3

7.29

7.15

g/l

0.15

Injuries to unspecified part of trunk, limb or body region

233

1150

2.09

23.47

1.8

2.4

7.64

7.35

g/l

1.38

176

874

Encephalitis

279

3.39

23.43

2.0

2.5

7.21

7.41

g/l

0.41

218

Migraine without aura

292

1551

1.91

23.38

2.1

2.2

7.16

7.28

g/l

0.59

228

1223

Oter anti-inflammatory and antirheumatic agents, non-steroids

557

1917

1.64

23.37

2.4

2.3

7.45

7.32

g/l

0.80

418

1341

Other encephalitis

265

3.46

23.31

2.0

2.6

7.18

7.45

g/l

0.60

206

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

317

3.18

23.06

1.5

2.1

7.18

7.38

g/l

0.48

252

Nonorganic sleeping disorders, excluding more controls

322

1775

1.85

23.04

1.6

2.3

7.07

7.37

g/l

2.13

242

1355

Donors of organs and tissues

5.36

23.02

8.6

1.9

6.97

7.27

g/l

0.56

Benign neoplasm: Ascending colon

348

1977

1.82

23.00

2.1

2.4

7.49

7.47

g/l

0.08

248

1450

Bipolar affective disorders

321

1770

1.84

22.92

1.8

2.2

7.30

7.25

g/l

0.19

249

1353

Other and unspecified aplastic anaemias

114

5.10

22.92

1.5

2.0

6.96

7.25

g/l

0.44

Diabetic retinopathy

799

3438

1.50

22.87

1.8

2.0

8.03

7.81

g/l

2.08

571

2483

Benign neoplasm: Stomach

242

1226

2.04

22.78

2.4

1.4

7.44

7.50

g/l

0.17

173

895

Oxicams

556

1976

1.62

22.74

2.2

2.3

7.26

7.29

g/l

0.14

409

1391

1196

8104

1.37

22.68

1.6

2.3

7.39

7.31

g/l

0.69

925

6057

Other symptoms and signs involving the circulatory and respiratory systems

155

658

2.44

22.67

2.0

2.3

7.22

7.43

g/l

0.54

491

Hypersplenism

9.10

22.57

1.6

1.3

5.92

7.53

g/l

3.14

Pneumonia derived septicemia

101

349

3.06

22.52

5.7

2.6

7.50

7.38

g/l

0.25

265

Metatarsalgia

211

1019

2.13

22.50

2.2

7.26

7.40

g/l

0.48

170

767

Myelodysplastic syndrome

105

5.39

22.41

2.1

1.8

6.07

7.52

g/l

5.89

Dentofacial anomalies [including malocclusion]

457

2767

1.65

22.33

2.3

2.0

7.30

g/l

0.02

350

2080

Sequelae of other external causes

143

592

2.52

22.25

2.9

2.5

7.37

7.39

g/l

0.05

124

454

Missing teeth due to accident, extraction or parodontitis

277

1479

1.93

22.24

3.8

2.0

7.41

7.47

g/l

0.20

195

1099

Discitis, unspecified

173

4.11

22.18

3.6

2.0

8.42

7.22

g/l

3.32

127

Benign neoplasm: Caecum

261

1372

1.97

22.14

2.8

1.4

7.40

7.50

g/l

0.34

195

997

Benign neoplasm of other and unspecified endocrine glands

303

1668

1.87

22.11

2.4

2.3

7.40

7.42

g/l

0.04

216

1269

Other/unspecified reactive arthropathies

161

704

2.37

22.08

2.3

2.4

7.45

7.31

g/l

0.45

124

541

Renal tubulo-interstitial disorders in diseases classified elsewhere

106

5.23

22.03

5.3

2.0

7.02

7.04

g/l

0.03

Intracranial injury

1161

8288

1.37

21.99

2.1

2.2

7.28

7.39

g/l

1.18

831

6130

Presence of other functional implants

1335

7094

1.35

21.99

2.3

2.2

7.58

7.46

g/l

1.19

875

5337

Alcohol use disorder, Swedish definition

1145

7842

1.37

21.82

1.7

2.3

7.35

7.32

g/l

0.25

889

5854

Acute myeloid leukaemia and myelodysplastic syndromes

208

3.77

21.81

1.9

2.3

6.62

7.51

g/l

3.25

156

Pneumocystosis

190

3.96

21.77

6.9

2.5

7.80

7.42

g/l

0.75

142

Filling of root of tooth

303

3.18

21.69

5.4

2.6

7.57

7.27

g/l

0.59

243

Elevated blood glucose level

193

916

2.18

21.64

2.0

2.2

7.76

7.35

g/l

1.79

142

701

Other viral diseases

490

3073

1.61

21.51

3.5

2.1

7.27

7.28

g/l

0.05

383

2336

Paracetamol of NSAID medication

335

919

1.86

21.51

2.4

1.9

7.26

7.12

g/l

0.55

254

668

Superficial injury of hip and thigh

332

1891

1.80

21.49

1.9

2.3

7.35

7.49

g/l

0.57

231

1391

Other enthesopathy of foot (+metatarsalgia)

218

1084

2.06

21.47

2.2

7.25

7.40

g/l

0.52

176

819

Fracture of foot, except ankle

448

2763

1.65

21.42

2.3

2.1

7.31

7.35

g/l

0.14

340

2103

Disorders of synovium and tendon

998

6501

1.40

21.39

1.9

2.3

7.42

7.34

g/l

0.57

723

4876

1238

8296

1.35

21.39

1.6

2.3

7.36

7.31

g/l

0.45

958

6206

Myocardial infarction

1227

6561

1.36

21.38

2.2

2.3

7.78

7.39

g/l

9.54

900

4837

Benign neoplasm: Rectum

403

2432

1.70

21.25

2.1

1.4

7.48

7.46

g/l

0.07

306

1766

Mixed and other personality disorders

152

658

2.37

21.18

1.6

2.0

7.11

7.26

g/l

0.51

134

518

Pneumococcal septicemia

335

3.03

21.06

5.6

2.7

7.47

7.36

g/l

0.22

253

Kela reimbursement Agammaglobulinemia (D80-84)

6.00

21.06

3.4

2.4

7.13

7.42

g/l

0.36

Budesonide

251

1318

1.94

21.04

2.0

2.5

7.26

7.21

g/l

0.15

196

984

Carcinoma in situ of skin of scalp and neck

329

3.13

20.94

1.8

2.5

7.16

7.44

g/l

0.78

238

Migraine with aura and triptan purchases

230

1173

1.99

20.91

1.4

1.9

6.96

7.34

g/l

2.92

188

886

Other complications of surgical and medical care, not elsewhere classified

221

1117

2.04

20.88

2.5

2.3

7.58

7.39

g/l

0.77

158

843

Disorders of the thyroid gland

1994

10358

1.27

20.78

2.0

2.3

7.38

7.36

g/l

0.22

1491

7689

Noninfectious colitis NAS

292

1618

1.85

20.77

2.4

2.2

7.42

g/l

0.01

220

1211

Other metabolic disorders

254

1347

1.93

20.71

3.5

2.1

7.37

7.29

g/l

0.23

206

1031

Cervicalgia

420

2573

1.66

20.70

2.1

2.2

7.31

7.47

g/l

0.85

308

1917

Decubitus ulcer and pressure area

160

721

2.32

20.61

1.8

2.3

8.15

7.48

g/l

3.16

109

519

Protozoal diseases

308

3.12

20.59

6.0

2.6

7.66

7.27

g/l

1.07

238

Other embolism and thrombosis

303

1705

1.82

20.56

2.8

2.2

7.48

7.44

g/l

0.14

234

1258

Etanercept

139

588

2.44

20.55

1.6

2.3

7.75

7.32

g/l

1.58

106

456

Amiodarone users

271

1480

1.90

20.50

2.0

2.3

7.32

7.43

g/l

0.40

207

1096

Non-selective monoamine reuptake inhibitors

836

5757

1.43

20.36

2.1

2.3

7.49

7.41

g/l

0.61

629

4204

Radiculopathy

379

2279

1.70

20.20

2.5

2.2

7.35

7.49

g/l

0.81

290

1693

Haemorrhage, not elsewhere classified

103

382

2.83

20.16

2.4

2.7

7.16

7.59

g/l

1.41

282

Eosinophilia

171

3.95

20.11

2.4

1.8

7.43

7.39

g/l

0.05

132

Myeloid leukaemia

307

3.10

20.11

1.8

2.6

7.04

7.37

g/l

0.81

227

Inflammatory bowel disease

600

4011

1.52

20.10

2.1

2.2

7.21

7.32

g/l

0.69

426

3048

Wegener granulomatosis

139

4.28

20.08

1.2

2.4

7.64

7.36

g/l

0.50

103

Basal cell carcinoma, including avohilmo

1370

8259

1.32

20.04

2.5

2.2

7.40

7.48

g/l

0.76

997

5991

Other specified/unspecified necrotizing vasculopathies

145

4.23

19.89

1.4

3.0

7.75

7.27

g/l

0.87

110

Basal cell carcinoma

1340

8163

1.32

19.83

2.5

2.2

7.40

7.49

g/l

0.94

975

5922

Generalized anxiety disorder

227

1176

1.96

19.73

1.7

2.3

6.87

7.31

g/l

3.03

175

908

Other skin changes

387

2360

1.68

19.63

3.0

2.3

7.43

7.52

g/l

0.39

249

1742

Recurring oral aphthae, including avohilmo

293

1655

1.81

19.61

2.6

2.3

7.23

7.47

g/l

1.18

206

1258

Major coronary heart disease event excluding revascularizations

1552

8341

1.30

19.57

2.2

2.4

7.76

7.39

g/l

10.91

1124

6159

Cramp and spasm

118

475

2.59

19.56

2.5

2.4

7.18

7.27

g/l

0.23

371

Other specified and unspecified disorders of eye and adnexa

111

436

2.67

19.43

2.2

2.3

7.09

7.34

g/l

0.73

333

Opening and dilatation of root channel of tooth

139

603

2.38

19.42

4.2

2.2

7.53

7.28

g/l

0.65

100

473

5-aminosalicylic acid

358

2138

1.70

19.41

1.8

2.3

7.22

7.17

g/l

0.17

268

1611

Progressive vascular leukoencephalopathy

113

451

2.67

19.36

2.3

2.4

7.46

7.65

g/l

0.46

317

Neuromuscular dysfunction of bladder

218

1128

1.99

19.34

2.0

2.5

7.20

7.32

g/l

0.39

150

843

Retinal detachments and breaks

805

5744

1.42

19.29

2.4

2.3

7.36

7.42

g/l

0.32

593

4243

Other or unspecified ileus, impaction or obstruction

402

2483

1.65

19.25

2.4

2.2

7.50

7.44

g/l

0.26

285

1840

Disorders of adult personality and behaviour

449

2842

1.60

19.24

1.7

2.1

7.14

7.24

g/l

0.67

359

2193

Postprocedural endocrine and metabolic disorders, not elsewhere classified

235

1246

1.93

19.22

3.4

2.1

7.37

7.31

g/l

0.18

190

953

Vitreous haemorrhage

241

1294

1.92

19.15

2.0

2.4

7.82

7.44

g/l

2.04

184

974

Viral pneumonia (known virus, not influenza)

246

3.30

19.14

5.7

2.6

7.11

7.34

g/l

0.39

186

Panic disorder

221

1148

1.95

19.08

1.6

2.2

7.28

7.29

g/l

0.02

172

880

Benign neoplasm: Adrenal gland

183

897

2.12

19.02

2.1

1.4

7.47

7.35

g/l

0.32

125

674

Coxarthrosis, primary

1392

9353

1.31

19.01

2.1

2.3

7.53

7.45

g/l

0.91

995

6855

Carcinoma in situ of skin of other and unspecified parts of face

227

1205

1.96

18.91

2.0

2.3

7.53

7.56

g/l

0.09

182

857

Disorders of vitreous body and globe

1108

8133

1.35

18.85

2.3

7.31

7.46

g/l

1.68

826

6005

Major coronary heart disease event

1663

8749

1.28

18.83

2.1

2.4

7.70

7.39

g/l

8.55

1219

6469

Suppurative and necrotic conditions of lower respiratory tract

147

665

2.31

18.80

2.7

2.6

8.18

7.34

g/l

3.78

105

509

993

6924

1.37

18.75

2.7

2.2

7.38

7.52

g/l

1.32

716

4995

Other and unspecified myopathies

215

1122

1.98

18.69

1.6

2.3

7.39

7.40

g/l

0.02

148

840

Actinic keratosis

928

6470

1.38

18.67

2.8

2.2

7.38

7.53

g/l

1.54

667

4665

Angina pectoris

1411

7372

1.31

18.66

2.2

2.4

7.64

7.39

g/l

4.89

968

5461

Drug-induced polyneuropathy

5.37

18.63

13.7

1.3

6.91

7.54

g/l

1.31

Psoriasis vulgaris

394

2444

1.64

18.61

1.7

2.2

7.58

7.36

g/l

1.30

289

1857

Carpal tunnel syndrome

1242

8573

1.32

18.56

2.2

2.3

7.49

7.37

g/l

1.39

926

6421

Fissure and fistula of anal and rectal regions

480

3118

1.56

18.50

2.2

2.3

7.40

7.36

g/l

0.18

369

2381

Substance abuse

1137

8220

1.33

18.45

1.6

2.3

7.48

7.29

g/l

2.67

858

6176

Open wound of ankle and foot

213

1111

1.97

18.39

2.2

2.3

7.69

7.33

g/l

1.73

168

843

Spondylolisthesis/Spondylolysis

372

2281

1.66

18.38

2.6

2.2

7.48

7.46

g/l

0.07

267

1725

Acute pancreatitis

434

2767

1.60

18.30

1.7

2.3

7.45

7.38

g/l

0.27

328

2062

Thyroiditis, ILD-related definition

221

1169

1.93

18.24

2.4

2.3

7.44

7.40

g/l

0.11

169

884

Transient ischemic attack

1220

7729

1.32

18.23

2.1

2.3

7.37

7.46

g/l

0.85

874

5645

Disorders of vitreous body

1076

7936

1.34

18.20

2.3

7.30

7.45

g/l

1.76

803

5867

Other diseases of lip and oral mucosa

341

2052

1.70

18.18

2.5

2.1

7.33

7.48

g/l

0.74

248

1506

Other viral hepatitis

119

496

2.47

18.16

2.2

1.8

7.43

7.15

g/l

0.70

383

Systemic sclerosis

265

3.13

18.09

1.9

2.1

7.15

7.44

g/l

0.75

199

Gout due to impairment of renal function

129

4.37

18.07

2.7

1.8

7.72

7.27

g/l

0.91

Fracture of forearm

1077

7596

1.34

18.03

2.0

2.2

7.39

7.43

g/l

0.26

765

5627

Mental and behavioural disorders due to psychoactive substance use

1167

8389

1.32

18.00

1.6

2.3

7.47

7.29

g/l

2.74

880

6296

Myocardial infarction, without ST-elevation

967

6625

1.37

17.99

2.1

2.3

7.80

7.43

g/l

6.30

682

4809

Idiopathic urticaria

169

3.70

17.94

1.2

1.9

6.90

7.47

g/l

1.69

140

Skin changes due to chronic exposure to nonionizing radiation

944

6619

1.37

17.91

2.8

2.2

7.37

7.52

g/l

1.49

679

4769

Other diseases of the respiratory system

483

3172

1.55

17.90

2.1

2.2

7.77

7.42

g/l

3.05

343

2303

Other respiratory disorders and diseases

483

3172

1.55

17.90

2.1

2.2

7.77

7.42

g/l

3.05

343

2303

Extrapyramidal and movement disorders

817

5920

1.40

17.90

2.0

2.3

7.12

7.47

g/l

6.41

595

4335

Hallux valgus (acquired)

662

3315

1.46

17.84

2.1

2.4

7.57

7.32

g/l

2.53

479

2434

Enthesopathies of lower limb, excluding foot

408

2576

1.61

17.82

2.2

7.25

7.37

g/l

0.69

319

1966

Memory loss

248

1380

1.86

17.73

2.1

2.4

7.26

7.50

g/l

1.27

192

1037

Other extrapyramidal and movement disorders in other diseases

498

3298

1.54

17.73

2.1

2.3

7.14

7.49

g/l

3.96

380

2427

Diplopia

291

1692

1.76

17.71

2.1

2.2

7.31

7.46

g/l

0.63

203

1265

Persistent mood disorders

382

2382

1.63

17.61

2.0

2.2

7.41

7.42

g/l

0.06

309

1793

Malignant neoplasm of skin

1461

8634

1.29

17.58

2.5

2.3

7.33

7.48

g/l

2.12

1062

6306

Fenamates

331

1319

1.72

17.58

2.0

2.2

7.43

7.31

g/l

0.53

262

939

Amputation of foot

315

2.93

17.51

1.4

2.7

8.13

7.29

g/l

2.74

231

Lupus erythematosus

271

3.06

17.41

2.1

7.38

7.55

g/l

0.30

206

Injury of unspecified body region

176

878

2.07

17.40

1.6

2.5

7.67

7.37

g/l

1.16

132

673

Pyothorax

116

491

2.48

17.38

3.0

2.5

8.12

7.29

g/l

2.67

372

Hypertension, Pulmonary Arterial

5.01

17.36

2.6

1.8

6.84

7.19

g/l

0.53

Ankylosing spondylitis

183

925

2.03

17.31

1.7

2.0

7.34

7.33

g/l

0.02

136

722

Unspecified acute lower respiratory infection

302

1784

1.73

17.26

3.1

2.1

7.57

7.36

g/l

0.93

202

1333

Other hammer toe(s) (acquired)

379

2221

1.63

17.25

1.9

2.5

7.67

7.43

g/l

1.53

279

1601

Familial hypercholesterolemia

361

2238

1.65

17.21

2.3

2.2

7.71

7.39

g/l

2.37

244

1628

Exclusions for E4_PCOS_BROAD

315

1882

1.70

17.18

3.0

2.2

7.33

7.36

g/l

0.06

230

1434

Vitamin B12 deficiency anaemia

265

1515

1.80

17.17

1.9

2.4

7.39

7.43

g/l

0.12

192

1107

Bronchiectasis

215

1157

1.92

17.14

2.6

2.5

7.64

7.40

g/l

1.16

171

839

Scoliosis

162

786

2.11

17.13

2.4

2.2

7.15

7.41

g/l

0.98

121

592

Bullous disorders

154

738

2.17

17.09

2.0

2.5

7.09

7.47

g/l

2.13

121

555

COPD, early/later onset

1080

6922

1.33

17.06

1.8

2.3

7.94

7.37

g/l

16.79

824

5030

Invasive ventilation

181

920

2.03

17.04

2.6

2.4

7.90

7.37

g/l

2.53

147

695

Benign neoplasm: Caecum

261

1493

1.80

17.02

2.8

2.3

7.40

7.46

g/l

0.19

195

1110

Sleep disorders

377

2365

1.62

16.94

1.5

2.2

7.21

7.35

g/l

0.69

279

1795

KRA_PSY_EATING, excluding more controls

342

2.69

16.94

1.7

7.24

7.22

g/l

0.04

271

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1001

7379

1.34

16.91

2.2

2.3

7.16

7.36

g/l

2.79

742

5535

Insomnia

283

1651

1.74

16.89

1.6

2.3

7.12

7.33

g/l

1.15

214

1263

Use of pramipexole

498

3337

1.52

16.82

1.9

2.3

7.32

7.51

g/l

1.40

365

2447

Collagenous colitis

207

1105

1.93

16.82

3.1

2.4

7.50

7.39

g/l

0.32

155

832

Myocardial infarction, strict

1122

6245

1.33

16.78

2.1

2.3

7.78

7.39

g/l

9.10

822

4589

COPD, hospital admissions

1069

6879

1.33

16.73

1.8

2.3

7.93

7.37

g/l

15.97

812

4999

Nonischemic cardiomyopathy

143

671

2.21

16.72

1.7

2.3

7.25

7.34

g/l

0.20

116

512

Fall on and from stairs and steps

514

3469

1.50

16.65

2.2

7.56

7.44

g/l

0.66

372

2568

Atopic dermatitis, strict definition with reimbursement

414

2579

1.57

16.58

1.8

2.0

7.15

7.26

g/l

0.61

320

1987

Heartburn

217

1179

1.88

16.58

2.1

2.4

7.30

7.43

g/l

0.45

163

907

111

467

2.41

16.49

1.4

1.7

6.81

7.07

g/l

0.87

101

365

Conjunctivitis (acute, non atopic)

488

3251

1.51

16.47

2.7

2.1

7.14

7.42

g/l

2.75

375

2431

Substance use, excluding alcohol

340

2096

1.65

16.43

1.6

2.3

7.58

7.28

g/l

2.31

253

1610

Sarcoidosis

292

1737

1.72

16.38

1.9

2.2

7.24

7.38

g/l

0.73

220

1322

Primary biliary cholangitis (PBC)

221

3.22

16.37

1.4

1.9

7.80

7.33

g/l

1.40

171

Hyperplasia of prostate

854

3558

1.39

16.35

2.5

2.4

7.17

7.37

g/l

2.00

607

2703

Other disorders of eyelid

995

7277

1.34

16.34

2.1

2.3

7.43

7.49

g/l

0.42

737

5313

Viral hepatitis

139

649

2.20

16.29

2.2

2.0

7.40

7.22

g/l

0.45

108

504

Ulcerative colitis

463

3070

1.53

16.29

2.3

2.2

7.24

7.33

g/l

0.46

332

2321

Other interventions on the root canals of the tooth

156

3.68

16.28

5.4

1.7

7.44

7.27

g/l

0.24

122

Personality disorders

422

2741

1.56

16.26

1.7

2.1

7.14

7.24

g/l

0.64

340

2107

Other specified/unspecified inflammatory spondylopathies

400

2.55

16.23

1.7

1.9

7.23

7.22

g/l

0.01

308

Candidiasis

272

1591

1.75

16.19

3.1

2.3

7.49

7.42

g/l

0.25

193

1199

COPD related to multimorbidity

932

5884

1.35

16.12

1.7

2.3

7.95

7.37

g/l

14.78

700

4270

Other degenerative diseases of the nervous system

565

2941

1.48

16.09

1.9

2.3

7.36

7.55

g/l

1.30

375

2191

Sequelae of injuries of lower limb

196

1042

1.93

16.06

2.2

2.4

7.39

7.27

g/l

0.42

155

798

Nonorganic sleeping disorders

322

1970

1.66

16.06

1.6

2.2

7.07

7.31

g/l

1.55

242

1503

Vasomotor and allergic rhinitis

617

4271

1.44

16.00

2.1

2.2

7.08

7.32

g/l

2.68

465

3243

Other benign neoplasms of skin

716

5072

1.40

15.96

3.0

1.4

7.35

7.44

g/l

0.71

506

3710

Hypermobility syndrome

338

2.67

15.96

2.1

1.8

7.18

7.39

g/l

0.43

281

Iridocyclitis

457

3039

1.53

15.94

2.3

2.2

7.56

7.41

g/l

0.99

338

2267

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

406

2626

1.56

15.90

1.9

2.2

7.35

7.28

g/l

0.29

296

2024

Agoraphobia

167

3.46

15.87

1.8

1.7

7.30

7.20

g/l

0.12

133

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

275

1626

1.73

15.86

2.0

1.4

7.73

7.46

g/l

1.27

201

1172

Diseases of the ear and mastoid process

2389

10039

1.21

15.86

2.2

7.28

7.36

g/l

1.18

1710

7669

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

221

1228

1.85

15.83

2.9

2.4

7.36

g/l

0.01

163

936

Localized swelling, mass and lump of skin and subcutaneous tissue

611

4302

1.44

15.83

2.2

2.3

7.34

7.43

g/l

0.61

476

3176

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

9.25

15.82

2.5

1.1

6.65

7.63

g/l

1.34

Hydronephrosis

234

1322

1.81

15.77

1.8

2.1

7.81

7.34

g/l

2.93

170

983

Insulin, fast-acting (human)

259

1505

1.75

15.70

1.6

2.1

7.84

7.26

g/l

4.46

188

1162

Chronic pancreatitis

276

1638

1.73

15.68

1.9

2.4

7.37

7.35

g/l

0.06

216

1231

Melanocytic naevi

482

3248

1.50

15.67

2.2

1.4

7.12

7.38

g/l

2.44

369

2435

Fracture of lower leg, including ankle

1079

8271

1.31

15.65

2.0

2.3

7.53

7.38

g/l

1.77

797

6154

Allergic purpura

275

2.88

15.64

1.7

2.5

7.42

7.37

g/l

0.07

210

Benign neoplasm: Stomach

242

1389

1.79

15.60

2.4

7.44

7.46

g/l

0.05

173

1041

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1286

7974

1.29

15.60

2.6

2.2

7.38

7.49

g/l

1.29

933

5792

Other and unspecified injuries of head

137

650

2.17

15.53

1.6

2.4

7.09

7.39

g/l

0.90

103

492

Systemic atrophies primarily affecting the central nervous system

115

511

2.36

15.49

1.4

2.7

6.92

7.36

g/l

1.85

387

Restless leg syndrome

266

1571

1.73

15.40

2.0

2.3

7.14

7.44

g/l

1.83

202

1183

Persons encountering health services in other circumstances

656

4698

1.41

15.27

2.3

2.2

7.25

7.35

g/l

0.75

504

3458

Erosion of teeth, including avohilmo

311

1844

1.65

15.21

2.5

1.9

7.20

7.29

g/l

0.38

245

1356

Faecal incontinence

213

1186

1.85

15.18

1.6

2.3

7.54

7.58

g/l

0.10

163

891

Other local infections of skin and subcutaneous tissue

211

1170

1.85

15.18

3.0

2.3

7.51

7.36

g/l

0.52

150

894

Other disorders of glucose regulation and pancreatic internal secretion

177

928

1.96

15.17

2.0

2.3

7.53

7.40

g/l

0.40

129

699

Lesion of lateral popliteal nerve

116

521

2.31

15.13

2.4

2.3

7.12

7.25

g/l

0.31

397

Pain and other conditions associated with female genital organs and menstrual cycle

290

1679

1.68

15.09

2.0

7.19

7.36

g/l

0.85

222

1291

Inflammatory diseases of the central nervous system

175

916

1.96

15.08

2.7

2.3

7.26

7.34

g/l

0.24

122

693

Demyelinating diseases of the central nervous system

156

784

2.03

15.05

1.6

2.1

6.97

7.32

g/l

1.57

120

599

Migraine without aura and triptan purchases

215

1197

1.82

15.05

1.6

1.9

7.09

7.31

g/l

1.13

172

922

Guillain-Barre syndrome

160

3.55

15.03

2.4

2.5

7.44

7.36

g/l

0.10

123

Alcoholic liver disease

227

1293

1.80

14.99

1.3

2.4

7.09

7.32

g/l

1.04

171

964

Vascular disorders of the intestines

166

858

2.00

14.94

2.4

2.3

7.60

7.45

g/l

0.44

119

631

Intestinal stricture

659

4755

1.41

14.92

2.5

2.2

7.49

7.44

g/l

0.26

464

3497

Cyst of kidney

176

930

1.96

14.92

2.6

2.5

7.62

7.44

g/l

0.57

128

704

Alcohol induced polyneuropathy

105

4.30

14.88

1.3

2.0

7.36

7.37

g/l

0.01

Other and unspecified urticaria

345

2190

1.60

14.84

2.4

2.2

7.26

7.40

g/l

0.68

265

1654

Other and unspecified local infections of skin and subcutaneous tissue

199

1092

1.87

14.83

3.1

2.3

7.55

7.35

g/l

0.71

144

834

Acute pancreatitis (for exclusion)

434

2904

1.52

14.80

1.7

2.2

7.45

7.40

g/l

0.18

328

2147

Thyrotoxicosis

483

3301

1.48

14.74

1.9

2.2

7.56

7.44

g/l

0.60

365

2460

Special screening examination for neoplasms

107

470

2.36

14.70

3.3

2.3

7.51

7.39

g/l

0.21

362

Systemic sclerosis, icd10

292

2.80

14.67

1.9

7.18

7.49

g/l

0.87

221

Carcinoma in situ of skin

193

1056

1.89

14.67

1.9

1.4

7.51

7.53

g/l

0.05

154

755

Crystal arthropathies, rheuma endpoint

204

3.20

14.66

1.7

3.1

7.75

7.11

g/l

1.71

146

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

284

1730

1.68

14.64

2.4

1.4

7.42

7.50

g/l

0.32

204

1204

Benign neoplasm of mouth and pharynx

230

1323

1.78

14.64

3.1

1.4

7.62

7.48

g/l

0.37

164

972

Chronic tubulo-interstitial nephritis

100

428

2.43

14.62

2.1

7.31

7.39

g/l

0.15

324

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

183

3.31

14.61

6.9

1.3

7.53

7.50

g/l

0.04

138

Herpesviral [herpes simplex] infections

227

1301

1.78

14.58

3.2

2.3

7.26

7.39

g/l

0.47

179

981

Benign neoplasm: Adrenal gland

183

987

1.92

14.56

2.1

2.6

7.47

7.39

g/l

0.19

125

757

Cervicobrachial syndrome

398

2620

1.54

14.55

2.1

7.08

7.37

g/l

2.55

289

1974

Other disorders of peripheral nervous system

5.41

14.53

3.6

1.7

6.84

7.42

g/l

1.03

Recurring oral aphthae

110

492

2.32

14.52

3.5

2.6

7.21

7.37

g/l

0.33

381

Other specified/unspecified bacterial intestinal infections

156

803

2.01

14.25

2.9

2.4

7.58

7.36

g/l

0.69

105

612

Abnormality of white blood cells, not elsewhere classified

4.82

14.23

2.0

1.7

7.32

7.44

g/l

0.09

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

300

2.68

14.22

1.5

1.7

7.81

7.09

g/l

1.73

242

Diagnoses used for exclusion with ILD

553

3906

1.44

14.20

2.2

7.37

7.41

g/l

0.18

394

2869

Ascites

172

917

1.93

14.15

1.6

2.4

6.77

7.39

g/l

3.77

127

696

Other shoulder lesions

177

950

1.90

14.11

1.6

2.1

7.47

7.33

g/l

0.40

133

716

Chronic viral hepatitis

390

2.45

14.10

1.9

1.7

7.46

7.15

g/l

0.75

310

Abnormal results of function studies

178

959

1.90

14.09

2.4

2.6

7.24

7.35

g/l

0.32

129

740

Thoracic aortic aneurysm

318

2014

1.62

14.06

2.2

2.4

7.15

7.30

g/l

0.68

240

1482

Spirochaetal infections, other/unspecified

191

1057

1.86

13.96

2.3

2.5

7.08

7.38

g/l

1.42

140

806

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

239

1411

1.74

13.94

1.8

1.4

7.76

7.44

g/l

1.32

172

1036

Other/unspecified rheumatoid arthritis

293

1823

1.64

13.93

1.9

2.3

7.81

7.54

g/l

1.19

210

1332

Thyrotoxicosis, other and/or unspecified

370

2425

1.55

13.88

2.0

2.3

7.46

7.42

g/l

0.14

285

1833

COPD-related respiratory insufficiency

295

1843

1.64

13.85

1.9

2.3

8.16

7.35

g/l

7.87

202

1313

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

837

5553

1.34

13.85

2.6

1.4

7.81

7.47

g/l

4.50

601

4064

Other inflammatory liver diseases

148

755

2.02

13.85

1.7

2.7

7.77

7.34

g/l

1.54

103

578

Problems related to lifestyle

176

949

1.89

13.79

1.6

2.3

7.41

7.29

g/l

0.30

126

723

Other disorders of ear

1937

10706

1.21

13.78

2.3

2.2

7.28

7.41

g/l

2.04

1301

8123

Benign neoplasm: Rectum, anus and anal canal

461

3172

1.48

13.77

2.2

2.3

7.48

7.45

g/l

0.11

348

2329

Open wound of forearm

180

980

1.88

13.76

2.0

2.3

7.54

7.39

g/l

0.50

145

754

Other and unspecified visual disturbances

199

1120

1.82

13.70

2.7

2.3

7.39

g/l

0.00

156

846

Mucosal proctocolitis

223

1295

1.75

13.65

2.3

7.14

7.28

g/l

0.55

184

998

Juvenile arthritis (FINNGEN)

254

2.78

13.63

1.8

2.0

7.44

7.08

g/l

0.87

194

Dementia in Alzheimer disease

169

2599

0.55

13.59

1.5

2.2

7.31

7.57

g/l

0.79

1829

Internal derangement of knee

660

4824

1.38

13.49

2.0

2.3

7.39

7.25

g/l

1.21

498

3624

Diabetic retinopathy, strict definition

383

2232

1.54

13.49

1.7

1.9

8.15

7.76

g/l

2.88

259

1615

Keratitis

648

4739

1.38

13.48

2.0

2.2

7.37

7.34

g/l

0.17

477

3557

Fibroblastic disorders

484

3373

1.45

13.40

2.3

7.31

7.39

g/l

0.37

362

2489

Folate deficiency anaemia

100

4.22

13.37

2.2

1.8

7.22

7.33

g/l

0.11

Transport accidents

756

5008

1.35

13.36

1.8

2.2

7.18

7.35

g/l

1.74

546

3776

Nummular dermatitis

182

1006

1.86

13.35

2.3

2.5

7.21

7.38

g/l

0.63

128

762

Haemorrhoids and perianal venous thrombosis

588

4239

1.40

13.34

2.1

2.3

7.40

7.46

g/l

0.29

404

3136

Congenital malformations, deformations and chromosomal abnormalities

957

7093

1.30

13.30

1.9

2.2

7.16

7.30

g/l

1.36

734

5378

Respiratory insufficiency

177

971

1.86

13.18

1.6

7.67

7.30

g/l

1.57

121

695

Other lack of coordination

170

3.26

12.99

1.7

2.5

7.05

7.36

g/l

0.66

126

Excessive attrition of teeth

642

2519

1.39

12.96

2.3

2.0

7.20

7.35

g/l

1.13

487

1830

Early onset COPD

484

3401

1.45

12.89

2.0

2.4

7.93

7.28

g/l

10.06

370

2529

Other diseases of pancreas

176

975

1.86

12.88

2.2

2.4

7.36

7.37

g/l

0.03

130

741

Other crystal arthropathies

220

2.96

12.87

1.7

2.2

7.75

7.23

g/l

1.24

153

Acute posthaemorrhagic anaemia

372

2.43

12.82

3.3

2.5

7.52

g/l

0.01

279

Misadventures to patients during surgical and medical care

286

1805

1.61

12.80

1.8

2.2

7.59

7.44

g/l

0.49

189

1341

Unspecified nephritic syndrome

254

2.78

12.79

2.1

2.5

7.67

7.36

g/l

0.59

192

Aortic aneurysm

521

3649

1.42

12.79

2.1

2.3

7.29

g/l

0.00

391

2653

Organ-limited amyloidosis

6.71

12.72

3.7

1.4

7.07

7.53

g/l

0.67

Traumatic subdural haemorrhage

279

1724

1.62

12.68

2.3

7.12

7.58

g/l

4.14

191

1252

Sequelae of injuries, of poisoning and of other consequences of external causes

439

3038

1.46

12.63

2.4

2.2

7.41

7.33

g/l

0.35

320

2301

Anterior Iridocyclitis

396

2691

1.49

12.56

2.3

2.2

7.54

7.40

g/l

0.73

290

2017

Unknown and unspecified causes of morbidity

136

696

1.99

12.55

2.4

2.2

7.47

7.37

g/l

0.23

525

Temporomandibular joint disorders, including avohilmo

622

4562

1.37

12.55

2.1

7.09

7.31

g/l

2.38

475

3486

Other viral diseases, not elsewhere classified

303

1939

1.58

12.51

3.2

2.2

7.42

7.32

g/l

0.33

234

1474

Barrett oesophagus

119

585

2.11

12.48

2.2

2.7

7.44

7.36

g/l

0.18

459

Propionic acid derivatives

579

2076

1.41

12.44

2.4

2.2

7.39

7.29

g/l

0.63

436

1471

Otitis externa

405

2769

1.48

12.43

2.1

2.2

7.38

7.41

g/l

0.11

289

2091

Pemphigoid

342

2.50

12.43

1.6

2.5

7.04

7.59

g/l

2.46

245

Benign neoplasm: Rectosigmoid junction

104

487

2.23

12.42

2.0

1.4

7.34

7.51

g/l

0.44

358

Allergic rhinitis

434

2973

1.46

12.39

2.2

2.1

7.06

7.28

g/l

1.74

335

2279

Nonhereditary hypogammaglobulinemia

110

3.84

12.36

3.9

1.6

7.22

7.54

g/l

0.50

Personal history of other diseases and conditions

158

849

1.88

12.35

4.1

2.0

7.05

7.41

g/l

1.54

111

668

Ocular pain

152

813

1.91

12.35

1.6

2.3

7.39

7.36

g/l

0.06

125

622

Other and unspecified paralytic syndromes

134

3.50

12.34

3.0

2.4

6.95

7.53

g/l

1.04

Congenital malformations of the urinary system

111

532

2.14

12.32

2.0

2.4

7.46

7.32

g/l

0.32

416

Hypothyroidism, other/unspecified

1770

9719

1.21

12.26

2.0

2.3

7.41

7.35

g/l

0.54

1325

7213

Oesophageal varices

101

471

2.23

12.17

1.6

2.4

6.97

7.38

g/l

1.25

351

Anti-inflammatory and antirheumatic products, non-steroids

577

2076

1.41

12.16

2.6

2.2

7.34

7.29

g/l

0.29

439

1471

Artificial joint operation, meniscal resection

1949

10903

1.20

12.08

2.2

2.3

7.55

7.37

g/l

4.07

1441

8076

Fracture of skull and facial bones

383

2606

1.49

12.05

2.5

2.2

7.21

7.31

g/l

0.50

294

1965

COPD, hospital admissions 3, with asthma pneumonia sepsis

630

3968

1.37

12.04

1.9

2.3

8.04

7.38

g/l

12.91

473

2835

Allergic urticaria

147

784

1.91

12.03

2.1

2.3

7.35

7.36

g/l

0.03

113

606

Alcohol-induced chronic pancreatitis

143

758

1.94

12.03

1.8

2.4

7.37

7.22

g/l

0.39

108

592

Poisoning by drugs, medicaments and biological substances

365

2458

1.50

12.03

2.0

2.2

7.42

7.25

g/l

1.04

279

1899

Diseases of male genital organs

1041

4123

1.29

12.02

2.1

2.3

7.13

7.31

g/l

2.04

777

3140

Benign neoplasm: Rectum

403

2778

1.48

12.02

2.1

2.3

7.48

7.44

g/l

0.14

306

2039

Arthropathic psoriasis

226

1368

1.69

12.01

1.7

2.4

7.77

7.36

g/l

2.14

160

1055

Total colectomy operation

421

2.28

12.00

2.6

2.4

7.49

7.23

g/l

0.62

331

Total colectomy

421

2.28

12.00

2.6

2.4

7.49

7.23

g/l

0.62

331

Ptosis of eyelid

250

1556

1.65

11.99

2.6

2.5

7.31

7.49

g/l

1.05

207

1162

Other diseases of stomach and duodenum

149

802

1.91

11.98

2.1

2.7

7.74

7.46

g/l

1.01

115

621

Cholecystectomy

1440

10452

1.23

11.96

2.3

2.2

7.46

7.39

g/l

0.82

1034

7726

Ankylosing spondylitis, ICD10

171

959

1.82

11.94

1.7

2.4

7.33

7.29

g/l

0.10

127

743

Follicular lymphoma

110

535

2.14

11.93

1.4

7.64

7.44

g/l

0.41

395

Speech disturbances, not elsewhere classified

195

1141

1.75

11.84

1.9

2.3

7.27

7.46

g/l

0.61

139

860

Other forms of systemic lupus erythematosus

4.51

11.83

1.9

2.5

7.12

7.57

g/l

0.63

Delirium, not induced by alcohol and other psychoactive substances

256

1605

1.63

11.82

2.0

2.3

7.73

7.46

g/l

1.23

172

1179

Atopic dermatitis, strict definition

383

2559

1.48

11.80

1.8

2.0

7.14

7.24

g/l

0.49

303

1975

Dermatitis due to substances taken internally

113

555

2.09

11.80

4.1

2.6

7.46

7.47

g/l

0.02

427

Disorders of vestibular function (Vertigo)

960

7515

1.28

11.79

2.0

2.3

7.44

7.45

g/l

0.05

676

5520

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

154

3.27

11.77

2.5

1.4

6.91

7.39

g/l

1.05

113

Poisoning by medicine

330

2187

1.53

11.77

2.1

2.2

7.40

7.25

g/l

0.79

255

1688

Carcinoma in situ of skin of upper limb, including shoulder

278

2.64

11.77

2.5

1.4

7.35

7.72

g/l

0.96

196

Other immunodeficiencies

104

3.82

11.75

4.5

1.9

6.94

7.29

g/l

0.45

Microscopic polyangiitis

4.56

11.74

1.5

1.9

8.33

7.59

g/l

0.97

COPD, hospital admission 2, with asthma infections

729

4723

1.33

11.74

1.8

2.3

8.02

7.37

g/l

14.41

544

3413

Acute gastritis

171

966

1.81

11.72

1.6

2.5

7.44

7.45

g/l

0.02

117

743

Mental and behavioural disorders due to sedatives or hypnotics

122

617

2.02

11.70

1.4

2.1

7.40

7.21

g/l

0.59

480

Cystic kidney disease

313

2.49

11.69

1.8

2.4

7.58

7.34

g/l

0.43

246

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

119

3.61

11.69

7.1

1.3

7.49

7.44

g/l

0.05

Epilepsy

570

4172

1.38

11.66

2.0

2.3

7.28

7.38

g/l

0.58

395

3111

Psoriatic arthropathies, ICD10

212

1273

1.70

11.64

1.7

2.4

7.72

7.35

g/l

1.79

148

976

Other specified/unspecified soft tissue disorders

111

545

2.10

11.63

2.4

2.1

7.67

7.46

g/l

0.56

400

Paraplegia, diplegia of upper limbs

226

2.79

11.61

1.8

2.5

7.87

7.24

g/l

1.46

173

Mental and behavioural disorders due to alcohol

971

7466

1.28

11.60

1.6

2.3

7.43

7.29

g/l

1.54

741

5613

Other bursopathies

266

1691

1.60

11.58

2.3

2.2

7.41

7.45

g/l

0.11

198

1260

Neuralgia and neuritis, unspecified

106

513

2.12

11.53

2.8

2.2

7.42

7.40

g/l

0.02

390

Hypothyreosis and Thyroxine purchase for inclusion criteria

1834

10162

1.20

11.53

2.1

2.2

7.42

7.36

g/l

0.67

1374

7544

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

100

472

2.16

11.49

1.5

1.8

7.40

7.21

g/l

0.43

374

Macular pucker

348

2355

1.51

11.49

1.9

2.4

7.61

7.48

g/l

0.57

247

1740

Ovarian cyst

626

2667

1.37

11.48

1.9

2.1

7.32

7.52

g/l

1.66

457

2009

Other disorders of the musculoskeletal system and connective tissue

306

2013

1.55

11.48

2.2

2.3

7.49

7.45

g/l

0.12

228

1517

Exclusions for E4_PCOS_CONSORTIUM

1237

6258

1.25

11.47

2.1

7.52

7.37

g/l

1.79

916

4702

Acute and subacute iridocyclitis

366

2495

1.49

11.47

2.4

2.2

7.51

7.40

g/l

0.55

268

1872

Mental disorders, not otherwise specified

137

726

1.92

11.44

1.6

2.1

7.18

7.32

g/l

0.45

104

568

Other disorders of gingiva or/and edentulous alveolar ridge

103

495

2.14

11.42

2.3

2.0

7.61

7.30

g/l

0.81

388

Biomechanical lesions, not elsewhere classified

113

564

2.07

11.39

2.3

2.5

7.29

7.41

g/l

0.39

430

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

265

1635

1.59

11.27

1.8

2.3

7.14

7.38

g/l

1.13

212

1255

Diseases of inner ear

1113

8782

1.25

11.26

2.0

2.3

7.42

7.43

g/l

0.06

781

6479

Polymyositis

4.15

11.26

1.9

2.2

7.34

7.39

g/l

0.06

Emotionally unstable personality disorder

157

872

1.82

11.23

1.6

1.8

7.15

7.24

g/l

0.29

126

689

Benign neoplasm: Descending colon

153

850

1.86

11.19

2.2

1.4

7.90

7.41

g/l

1.63

102

630

Autoimmune hepatitis

4.45

11.18

1.4

2.3

7.72

7.65

g/l

0.07

Intestinal adhesions without obstruction

180

1047

1.76

11.17

3.0

2.2

7.43

7.41

g/l

0.06

134

784

Primary gonarthrosis, bilateral

1114

7855

1.25

11.16

1.9

2.4

7.63

7.41

g/l

3.41

814

5776

Sulfonylureas

862

5376

1.29

11.13

1.8

2.4

8.19

7.29

g/l

31.15

614

3925

Malignant neoplasm of bone and articular cartilage

3.86

11.11

6.9

2.1

7.87

7.53

g/l

0.33

Polycystic ovarian syndrome, consortium definition

1186

5768

1.25

11.07

2.0

2.1

7.51

7.43

g/l

0.79

822

4374

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

144

3.27

11.07

1.5

1.3

7.20

7.62

g/l

0.64

108

Social phobias

472

2.13

11.07

1.4

1.8

7.13

7.29

g/l

0.34

379

Colectomy operation

372

2567

1.47

11.06

2.6

2.3

7.69

7.45

g/l

1.52

276

1877

Symptoms and signs involving emotional state

225

2.71

11.05

1.7

1.9

7.59

7.42

g/l

0.29

173

Chronic myeloproliferative disease

166

3.12

11.04

3.3

2.7

6.68

7.50

g/l

2.09

128

Hypoglycaemia, other or unspecified

134

715

1.92

11.04

1.7

2.4

7.58

7.37

g/l

0.63

102

544

Other and unspecified mood [affective] disorders

474

2.12

10.98

1.5

2.1

7.04

7.30

g/l

0.73

370

Ventral hernia

485

3510

1.40

10.96

2.4

2.2

7.59

7.44

g/l

0.94

361

2591

Inflammatory diseases of female pelvic organs

991

5932

1.27

10.94

1.7

2.2

7.44

7.43

g/l

0.07

740

4448

Lung transplant status

4.51

10.93

1.3

2.0

7.91

7.26

g/l

0.92

Mixed hyperlipidaemia

478

2.14

10.93

1.3

2.2

7.92

7.28

g/l

2.38

379

Lung transplantation

4.51

10.93

1.3

2.0

7.91

7.26

g/l

0.92

Other abnormal immunological findings in serum

160

3.07

10.93

2.5

2.4

7.37

7.50

g/l

0.19

122

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

519

3784

1.38

10.93

2.0

2.2

7.28

7.25

g/l

0.15

406

2906

Gingival hyperplasia

311

2.43

10.89

2.4

1.9

7.72

7.30

g/l

0.95

235

Myocarditis

353

2.31

10.88

2.2

2.1

6.92

6.89

g/l

0.06

257

Synovial cyst of popliteal space [Baker]

158

893

1.81

10.85

2.6

2.2

7.54

7.49

g/l

0.12

120

661

Hernia of abdominal wall

905

7159

1.28

10.84

2.2

2.3

7.52

7.37

g/l

1.67

697

5303

Traumatic subarachnoid haemorrhage

330

2.38

10.84

2.6

1.9

6.88

7.53

g/l

2.20

246

Mental and behavioural disorders due to alcohol, excluding acute intoxication

850

6665

1.28

10.81

1.6

2.3

7.43

7.29

g/l

1.35

650

5012

Selective deficiency of immunoglobulin G [IgG] subclasses

4.45

10.74

2.7

1.2

7.15

7.59

g/l

0.58

Artificial opening status

127

675

1.94

10.71

2.5

2.3

7.70

7.49

g/l

0.65

104

518

Fall on same level involving ice and snow

1069

8631

1.25

10.66

2.0

2.3

7.34

7.40

g/l

0.42

760

6441

Panniculitis, unspecified

3.75

10.59

2.8

1.9

7.75

7.44

g/l

0.36

Drug-induced cataract

250

2.60

10.50

2.5

7.25

7.45

g/l

0.34

194

Artificial joint re-operation

170

994

1.76

10.50

2.1

2.6

8.10

7.46

g/l

4.02

135

736

Melanocytic naevi of trunk

201

1224

1.67

10.46

2.1

1.4

7.15

7.38

g/l

0.90

147

917

Lesion of ulnar nerve

271

1773

1.55

10.44

2.1

7.54

7.32

g/l

1.10

207

1359

Benign neoplasm of major salivary glands

196

1189

1.68

10.43

1.8

1.4

7.47

7.49

g/l

0.04

139

883

Polyarteritis nodosa and related conditions

118

3.40

10.34

2.9

2.2

7.34

7.40

g/l

0.08

Excessive, frequent and irregular menstruation

648

2711

1.34

10.34

1.9

2.1

7.54

7.51

g/l

0.12

446

2038

Retinal vascular occlusion

274

1805

1.55

10.33

2.4

2.3

7.54

7.48

g/l

0.18

196

1306

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

452

3267

1.40

10.31

1.5

2.6

8.34

7.14

g/l

31.03

339

2506

Benign neoplasm: Small intestine

490

2.10

10.30

2.3

1.4

7.27

7.51

g/l

0.61

361

Cholangitis (primary sclerosing, PSC), with reimbursement 202

139

3.16

10.26

2.5

1.9

7.44

7.41

g/l

0.03

112

Other diseases of oesophagus

206

1271

1.65

10.25

1.9

2.5

7.37

7.41

g/l

0.11

151

961

Asthma and opportunity respiratory infection

120

637

1.95

10.23

2.4

2.6

7.87

7.43

g/l

1.68

468

Background retinopathy and retinal vascular changes

236

2.63

10.19

1.8

2.8

7.40

7.42

g/l

0.02

183

Benign neoplasm of mouth and pharynx

230

1461

1.61

10.16

3.1

2.4

7.62

7.41

g/l

0.64

164

1114

687

4690

1.31

10.13

2.1

2.2

7.64

7.52

g/l

0.78

462

3341

Other disorders of adrenal gland

438

2.14

10.12

2.7

2.5

7.44

7.41

g/l

0.04

343

Other disorders of nervous system

146

825

1.82

10.11

2.5

2.4

7.25

7.36

g/l

0.31

100

634

Cervicocranial syndrome

195

1192

1.66

10.03

2.0

2.2

7.44

7.47

g/l

0.07

147

898

Retinal vascular disorders

276

1833

1.54

10.02

2.4

7.54

7.48

g/l

0.21

198

1326

Colonic or urogenital fistula

516

3827

1.36

10.02

2.3

2.2

7.49

7.37

g/l

0.71

399

2866

Olecranon bursitis

131

718

1.87

10.01

2.3

2.1

7.27

7.38

g/l

0.25

100

534

Fall involving bed

376

2.25

10.00

2.3

2.2

7.65

7.57

g/l

0.13

270

Other localized connective tissue disorders

209

2.72

9.97

2.8

2.1

7.24

7.54

g/l

0.55

166

Adrenocortical insufficiency

369

2.24

9.96

2.8

2.4

7.48

7.43

g/l

0.06

288

Specific personality disorders

336

2315

1.46

9.96

1.7

2.1

7.19

7.23

g/l

0.16

260

1778

Other psoriatic arthropathies

201

1242

1.65

9.95

1.8

2.4

7.74

7.33

g/l

2.00

141

952

Hyperhidrosis

202

2.70

9.94

2.6

2.5

7.04

7.44

g/l

0.92

152

Crohn disease

214

1341

1.62

9.93

1.6

2.3

7.35

7.32

g/l

0.08

152

1025

Coeliac disease

221

1397

1.61

9.92

2.4

2.3

7.23

7.35

g/l

0.38

156

1060

Causalgia

132

3.17

9.83

1.3

2.1

7.26

7.42

g/l

0.17

104

Supplementary factors related to causes of morbidity and mortality classified elsewhere

537

4017

1.35

9.82

1.9

2.2

7.30

7.37

g/l

0.37

323

3025

Melanocytic naevi of lower limb, including hip

390

2.19

9.82

2.3

1.4

7.00

7.45

g/l

1.52

300

Mastocytosis

5.24

9.80

3.2

1.8

6.37

7.77

g/l

2.27

Postviral fatigue syndrome

5.57

9.77

1.1

2.1

6.45

7.00

g/l

0.82

Other and unspecified nerve root and plexus disorders, also in other diseases

337

2336

1.46

9.77

2.5

2.1

7.29

7.35

g/l

0.23

196

1792

Other nonthrombocytopenic purpura

3.65

9.76

2.2

1.9

7.45

7.47

g/l

0.02

Carcinoma in situ of skin

193

1191

1.67

9.75

1.9

2.4

7.51

7.49

g/l

0.06

154

868

Dermatographic urticaria

115

609

1.93

9.73

1.9

2.2

7.07

7.41

g/l

1.49

479

Late syphilis

145

3.09

9.67

2.7

1.9

7.92

7.37

g/l

0.86

111

Hereditary motor and sensory neuropathy

3.85

9.64

1.9

2.1

6.47

7.45

g/l

3.80

Cholera

103

530

2.01

9.61

3.7

2.3

7.42

7.57

g/l

0.33

397

Adhesive capsulitis of shoulder

321

2213

1.47

9.60

1.8

2.2

7.68

7.43

g/l

1.23

239

1654

Speech and linguistic disorders, excluding more controls

386

2.12

9.58

1.7

2.0

7.33

7.46

g/l

0.23

287

Dislocation, sprain and strain of joint and ligaments of hip

422

2.14

9.57

1.8

2.3

7.55

7.46

g/l

0.15

324

Exfoliative dermatitis

109

3.43

9.56

1.5

2.5

7.31

g/l

0.00

Follicular lymphoma, hilmo

110

581

1.96

9.56

1.4

2.9

7.64

7.44

g/l

0.42

438

Carcinoma in situ of skin of upper limb, including shoulder

307

2.38

9.55

2.5

2.9

7.35

7.51

g/l

0.30

213

Benign neoplasm: Rectosigmoid junction

104

540

2.00

9.51

2.0

2.8

7.34

7.43

g/l

0.20

406

Cardiomyopathy, Hypertrophic obstructive

191

2.75

9.48

1.6

2.7

7.19

7.36

g/l

0.24

141

Eating disorder

446

2.06

9.48

1.7

1.6

7.24

7.32

g/l

0.17

363

Other/unspecified crystal arthropathies

4.30

9.47

1.7

2.1

8.11

7.56

g/l

0.63

Carcinoma in situ of other and unspecified digestive organs

295

2.38

9.43

2.1

1.4

7.33

7.52

g/l

0.30

217

Carbimazole or st.post thyroidectomy, condition for graves disease

358

2527

1.43

9.41

2.5

2.2

7.36

7.41

g/l

0.17

275

1900

Other diseases of jaws

126

695

1.85

9.40

4.5

1.9

7.34

7.32

g/l

0.05

533

Deviated nasal septum

633

4875

1.31

9.40

2.6

2.3

7.18

7.35

g/l

1.74

480

3680

Superficial injury of thorax

273

1832

1.51

9.37

1.5

2.3

7.31

7.42

g/l

0.41

192

1360

Pain associated with micturition

221

1418

1.59

9.36

2.4

2.3

7.12

7.41

g/l

1.83

156

1044

Leukaemia of unspecified cell type

3.85

9.36

2.3

1.2

7.37

7.74

g/l

0.40

MS-disease / Multiple Sclerosis

116

624

1.89

9.35

1.6

2.0

6.79

7.32

g/l

2.82

488

Dissociative [conversion] disorders

275

2.38

9.34

1.2

1.9

7.26

7.36

g/l

0.18

212

Drug-induced osteoporosis

132

3.16

9.32

1.7

2.4

7.39

7.57

g/l

0.21

101

Anogenital herpesviral [herpes simplex] infection

424

2.09

9.30

2.0

1.7

6.98

7.27

g/l

0.88

334

Left bundle-branch block

148

861

1.76

9.27

1.7

2.3

7.33

7.46

g/l

0.33

108

624

Xerosis cutis

183

2.79

9.23

1.6

2.4

6.89

7.39

g/l

1.24

142

Hypothyroidism, strict autoimmune, 3 medication purchases required

1626

9408

1.18

9.23

2.0

2.2

7.44

7.37

g/l

0.76

1219

6974

Alcohol-induced acute pancreatitis

381

2.17

9.22

2.2

2.5

7.45

7.16

g/l

0.57

299

Injuries to the neck

366

2602

1.42

9.21

2.6

2.1

7.20

7.31

g/l

0.56

266

1968

Ulcerative colitis, NAS

238

1557

1.55

9.20

2.1

2.3

7.17

7.33

g/l

0.57

179

1186

Tubulo-interstitial nephritis, not specified as acute or chronic

137

781

1.79

9.19

2.7

2.0

7.55

7.34

g/l

0.60

100

589

Carcinoma in situ of skin of lower limb, including hip

237

2.54

9.17

3.0

1.4

7.56

7.59

g/l

0.05

168

Intestinal malabsorption

470

2.03

9.11

2.0

2.6

7.17

7.25

g/l

0.17

369

Emphysema

162

972

1.71

9.10

2.4

2.5

7.61

7.32

g/l

1.13

125

711

Algoneurodystrophy

279

2.36

9.10

1.3

1.9

7.06

7.44

g/l

1.11

224

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.36

9.08

9.0

2.5

7.68

7.82

g/l

0.10

Other infective otitis externa

121

668

1.86

9.07

2.3

2.4

7.41

7.33

g/l

0.22

504

Hodgkin lymphoma

249

2.45

9.05

1.3

7.52

7.30

g/l

0.28

190

Other prurigo

113

3.30

9.03

1.2

3.0

7.21

7.50

g/l

0.44

Juvenile rheumatoid arthirtis

133

3.02

9.02

1.3

1.9

7.38

7.11

g/l

0.41

Acute generalized exanthematous pustulosis

493

2.00

9.00

4.3

2.6

7.36

7.45

g/l

0.20

378

Other and unspecified erythematous conditions

339

2.23

9.00

2.6

2.2

7.10

7.41

g/l

0.82

258

Vitamin deficiency

102

535

1.96

8.98

2.5

2.3

7.19

7.30

g/l

0.21

405

Vitamin deficiency, wide

102

535

1.96

8.98

2.5

2.3

7.19

7.30

g/l

0.21

405

Acute nephritic syndrome

221

2.55

8.91

2.2

2.6

7.53

7.23

g/l

0.63

173

Calculus of kidney and ureter

611

4727

1.31

8.89

2.0

2.3

7.36

7.37

g/l

0.07

472

3493

Exposure to other and unspecified inanimate mechanical forces

119

657

1.85

8.88

2.5

2.4

7.27

7.35

g/l

0.16

499

Infection due to other mycobacteria

169

2.81

8.87

1.6

2.0

7.91

7.41

g/l

0.78

119

Infections with a predominantly sexual mode of transmission

400

2901

1.39

8.87

2.0

7.27

7.20

g/l

0.31

316

2251

N06DA Anticholinesterases

451

4887

0.74

8.86

1.8

2.2

7.44

7.56

g/l

0.65

293

3439

Use of anticholinesterases

451

4887

0.74

8.86

1.8

2.2

7.44

7.56

g/l

0.65

293

3439

Hallux rigidus

268

1814

1.50

8.86

2.1

2.4

7.38

7.34

g/l

0.12

202

1333

Dipeptidyl peptidase 4 (DPP-4) inhibitors

264

1787

1.51

8.82

1.7

2.3

8.33

7.25

g/l

14.39

195

1337

Other/unspecified enthesopathies of lower limb, excluding foot

125

702

1.81

8.81

1.9

2.1

7.17

7.31

g/l

0.36

104

543

Impacted cerumen

207

1331

1.59

8.78

2.3

7.37

7.44

g/l

0.22

118

1006

Striking against or struck by other objects

513

3876

1.33

8.76

1.9

2.2

7.25

7.26

g/l

0.02

387

2930

Somnolence, stupor and coma

463

2.02

8.75

1.5

2.8

7.33

7.45

g/l

0.20

350

Other demyelinating diseases of the central nervous system

290

2.30

8.75

1.6

1.9

6.95

7.31

g/l

0.75

232

therapeutic use

377

2.16

8.74

1.6

2.3

7.47

7.44

g/l

0.05

277

ILD and respiratory illness in diseases classified elsewhere

4.43

8.65

1.5

2.4

7.76

7.29

g/l

0.46

Eating disorders

124

696

1.80

8.65

2.2

1.8

7.34

7.30

g/l

0.09

550

Carcinoma in situ of colon

149

2.93

8.65

2.5

1.3

7.87

7.56

g/l

0.36

105

Other sleep disorders

203

1302

1.58

8.64

1.7

2.3

7.56

7.42

g/l

0.37

121

994

Superficial injury of abdomen, lower back and pelvis

252

1693

1.51

8.62

1.9

2.2

7.20

7.40

g/l

0.96

197

1272

Sacroiliitis, not elsewhere classified

330

2.19

8.62

2.0

1.7

7.29

7.24

g/l

0.07

255

Mature T/NK-cell lymphomas, hilmo

167

2.81

8.57

1.5

2.5

7.20

7.34

g/l

0.17

128

Multifocal fibrosclerosis

3.85

8.55

1.4

2.4

7.36

7.41

g/l

0.03

Other and unspecified glaucoma

162

990

1.68

8.54

1.7

2.5

7.74

7.51

g/l

0.80

118

715

Other/unspecified soft tissue disorders related to use, overuse and pressure

262

2.36

8.53

2.0

7.05

7.49

g/l

0.95

194

Disease of hard tissues of teeth, NOS

3.64

8.53

6.3

1.6

7.84

7.47

g/l

0.26

Acute pharyngitis

191

1200

1.60

8.52

2.6

2.0

7.12

7.19

g/l

0.18

155

946

Mental and behavioural disorders due to opioids

225

2.45

8.46

1.7

1.6

7.35

7.22

g/l

0.18

181

Alcohol use disorder, ICD-based

768

6145

1.26

8.45

1.6

2.3

7.47

7.28

g/l

2.16

592

4620

Type of accident

495

3746

1.33

8.45

1.8

2.2

7.33

7.40

g/l

0.29

291

2805

Benign neoplasm: Parotid gland

155

938

1.69

8.44

1.9

1.4

7.49

7.44

g/l

0.10

110

697

Ulcerative ileocolitis

354

2.14

8.40

2.9

2.2

6.88

7.31

g/l

1.17

275

Syphilis

252

2.39

8.39

2.4

2.3

8.00

7.27

g/l

1.57

195

Post-traumatic stress disorder

434

2.00

8.36

1.6

1.8

6.92

7.21

g/l

0.85

344

Benign neoplasm: Pancreas

298

2.28

8.35

2.5

1.4

7.41

7.53

g/l

0.18

219

Chronic laryngitis and laryngotracheitis

271

1862

1.48

8.34

1.7

2.2

7.54

7.46

g/l

0.30

200

1382

Pollen allergy

210

1350

1.55

8.33

2.3

2.0

6.91

7.24

g/l

1.99

165

1061

Primary coxarthrosis, bilateral

621

4862

1.29

8.32

2.2

2.3

7.48

g/l

0.01

429

3526

Carcinoma in situ of skin of trunk

385

2.11

8.31

2.7

1.4

7.61

7.58

g/l

0.05

275

Other spirochaetal diseases

479

3622

1.34

8.28

2.6

2.3

7.11

7.42

g/l

3.33

374

2708

Rosacea

206

1340

1.56

8.27

2.0

2.3

7.20

7.36

g/l

0.58

158

1012

Gonarthrosis, primary, with knee surgery

1219

8352

1.20

8.26

2.2

2.4

7.73

7.43

g/l

6.52

899

6128

Benign neoplasm: Other and unspecified parts of mouth

372

2.11

8.21

3.1

1.4

8.04

7.47

g/l

1.07

282

Cholecystitis

291

2034

1.45

8.20

2.1

2.3

7.59

7.46

g/l

0.53

197

1485

Menorrhagia

611

2611

1.30

8.19

1.9

2.1

7.43

7.53

g/l

0.58

420

1954

Squamous cell neoplasms and carcinomas of the skin

284

1980

1.46

8.18

2.4

7.42

7.50

g/l

0.31

204

1415

Oral leukoplakia and related diseases, including avohilmo

182

1156

1.61

8.17

2.1

2.4

7.31

7.41

g/l

0.28

137

865

Benign neoplasm: Descending colon

153

933

1.68

8.17

2.2

2.5

7.90

7.40

g/l

1.70

102

714

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

233

1557

1.51

8.17

1.9

2.2

7.49

7.24

g/l

1.27

174

1215

Psoriasis (vulgaris), strict definition

306

2.22

8.17

1.4

2.4

7.38

7.23

g/l

0.25

244

Cluster headache, strict

286

2.26

8.16

1.7

2.7

7.30

7.32

g/l

0.03

232

Follicular cysts of skin and subcutaneous tissue

332

2376

1.41

8.16

2.5

2.2

7.58

7.38

g/l

0.99

256

1776

Mouth breathing

732

5846

1.26

8.16

2.4

2.3

7.37

7.30

g/l

0.38

547

4450

Listeriosis

4.90

8.15

3.1

1.6

7.78

7.72

g/l

0.04

1079

0.43

8.15

1.2

2.4

6.85

7.32

g/l

1.08

791

Other congenital malformations

122

696

1.78

8.14

1.8

2.3

6.95

7.34

g/l

1.63

538

Other erythematous conditions

381

2.09

8.08

2.6

2.2

7.18

7.50

g/l

0.82

293

Bullous pemphigoid

277

2.31

8.07

1.5

2.6

7.08

7.58

g/l

1.69

200

Coronary revascularization (ANGIO or CABG)

1034

5961

1.22

8.07

1.9

2.3

7.78

7.40

g/l

7.84

761

4384

Other dermatomyositis

4.45

8.06

1.3

2.1

7.22

7.18

g/l

0.03

Other follicular disorders

117

664

1.79

8.01

2.3

2.4

7.61

7.30

g/l

1.08

520

Other disorders of bladder

249

1699

1.49

8.01

2.1

2.4

7.40

7.34

g/l

0.17

174

1242

Other juvenile arthritis

213

2.44

7.95

1.9

1.7

7.47

7.14

g/l

0.61

164

Other disorders of patella

245

1665

1.49

7.92

2.0

2.3

7.28

7.15

g/l

0.50

185

1263

Lyme disease

472

3587

1.33

7.91

2.6

2.3

7.10

7.42

g/l

3.50

369

2686

Disorders of ocular muscles, binocular movement, accommodation and refraction

742

5909

1.25

7.89

2.1

2.2

7.23

7.32

g/l

0.65

554

4454

Certolizumab pegol

111

3.08

7.88

1.3

1.9

7.85

7.47

g/l

0.41

Inguinal hernia

1167

6584

1.20

7.87

2.6

2.2

7.05

7.38

g/l

7.40

870

4869

Erythema multiforme

228

2.41

7.87

1.7

2.4

7.27

7.41

g/l

0.29

180

Postmenopausal bleeding

554

2337

1.32

7.86

2.0

2.2

7.58

7.62

g/l

0.18

418

1732

Trigger finger

245

1671

1.49

7.84

1.6

2.2

7.63

7.40

g/l

1.06

194

1263

Chondrocostal junction syndrome [Tietze]

399

2.04

7.84

2.0

2.1

7.37

7.48

g/l

0.21

302

Malignant melanoma, excluding all cancers (controls excluding all cancers)

330

2379

1.41

7.82

2.3

1.4

7.26

7.47

g/l

1.31

246

1733

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

406

3018

1.35

7.82

1.9

2.1

7.35

7.25

g/l

0.53

296

2336

Carcinoma in situ of other and unspecified digestive organs

320

2.19

7.82

2.1

2.8

7.33

7.40

g/l

0.09

233

Other specified/unspecified hearing loss

174

1106

1.61

7.81

2.7

2.2

7.25

7.47

g/l

0.89

114

843

Alcohol abuse, main dg, excluding more controls

243

1655

1.49

7.81

1.2

2.5

7.47

7.27

g/l

0.88

183

1269

Benign neoplasm: Duodenum

300

2.23

7.81

2.6

1.4

7.47

7.56

g/l

0.13

215

Drug-induced adrenocortical insufficiency

187

2.58

7.78

3.1

2.1

7.72

7.44

g/l

0.29

148

Umbilical hernia

492

3769

1.32

7.77

2.0

2.3

7.45

7.35

g/l

0.62

391

2850

Exposure to other and unspecified forces of nature

4.44

7.75

3.0

1.2

7.62

7.44

g/l

0.11

Melanocytic naevi of lower limb, including hip

428

1.99

7.74

2.3

2.4

7.00

7.37

g/l

1.17

335

Blepharochalasis

596

4687

1.29

7.73

1.9

2.3

7.39

7.54

g/l

1.24

434

3448

4.34

7.72

1.5

2.6

7.82

7.33

g/l

0.44

Idiopathic pulmonary fibrosis

174

1111

1.60

7.72

2.1

2.4

7.97

7.41

g/l

3.14

126

812

Superficial injury of ankle and foot

163

1020

1.62

7.71

1.8

2.2

7.31

7.32

g/l

0.00

120

783

Respiratory disorders in diseases classified elsewhere

153

2.76

7.67

1.6

2.1

7.74

7.57

g/l

0.23

117

Allergic contact dermatitis

216

1443

1.52

7.65

1.4

2.3

7.53

7.40

g/l

0.42

146

1089

Hemiplegia

104

579

1.84

7.65

1.5

2.2

7.04

7.33

g/l

1.03

447

Collapsed vertebra, not elsewhere classified

104

3.24

7.63

14.0

1.7

7.32

7.63

g/l

0.39

Panniculitis affecting regions of neck and back

375

2.05

7.62

1.8

2.0

7.33

7.28

g/l

0.08

296

Secondary thrombocytopenia

131

2.91

7.60

3.1

1.6

7.54

7.53

g/l

0.01

Other and unspecified injuries of lower leg

122

712

1.74

7.60

2.1

2.3

7.37

7.41

g/l

0.08

547

Benign neoplasm: Small intestine

547

1.87

7.58

2.3

2.7

7.27

7.51

g/l

0.61

407

Type 1 diabetes, definitions combined

117

672

1.75

7.56

1.9

2.0

7.27

7.04

g/l

0.63

550

Disorders of oesophagus in diseases classified elsewhere

233

2.38

7.55

3.7

2.5

7.76

7.55

g/l

0.28

176

Portal vein thrombosis

160

2.69

7.54

1.8

2.0

6.51

7.48

g/l

2.54

124

CR(E)ST syndrome

172

2.63

7.54

2.3

1.8

7.03

7.50

g/l

0.97

138

Abrasion of teeth

425

2341

1.35

7.50

2.5

2.0

7.08

7.35

g/l

2.37

321

1696

Superficial injury of shoulder and upper arm

193

1266

1.55

7.49

2.1

2.2

7.24

7.41

g/l

0.60

146

959

Disorders of magnesium metabolism

3.67

7.49

1.2

7.98

7.45

g/l

0.39

Suggestive for eosinophilic asthma

184

1197

1.57

7.47

2.2

2.4

7.33

7.35

g/l

0.04

143

905

Crohn's disease NAS

108

612

1.80

7.47

1.9

2.3

7.25

7.26

g/l

0.01

477

Astigmatism

539

1.85

7.45

2.3

2.5

7.28

7.35

g/l

0.13

414

Melanocytic naevi

482

3703

1.31

7.45

2.2

7.12

7.38

g/l

2.50

369

2784

Pneumonia due to Streptococcus pneumoniae

413

1.98

7.44

4.8

2.0

7.38

7.28

g/l

0.19

305

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

543

1.86

7.41

1.6

1.4

8.16

7.47

g/l

1.74

411

Type 1 diabetes, strict (exclude DM2)

116

669

1.75

7.40

1.9

2.0

7.30

7.02

g/l

0.79

546

Cluster headache, wide

325

2.11

7.38

1.8

2.7

7.29

7.34

g/l

0.09

261

Atypical facial pain

100

557

1.84

7.38

1.9

2.3

7.13

7.35

g/l

0.66

415

Monoplegia

156

2.69

7.37

2.0

2.5

7.45

7.55

g/l

0.11

115

Sacrococcygeal disorders, not elsewhere classified

286

2.19

7.37

2.0

7.07

7.28

g/l

0.39

218

Cardiac arrest

114

564

1.77

7.35

2.2

2.3

7.54

7.02

g/l

1.66

415

IBD patients in KELA-register

358

2639

1.37

7.35

2.3

2.1

7.13

7.28

g/l

0.80

264

2025

Fracture of neck

125

744

1.72

7.35

3.2

2.4

7.19

7.39

g/l

0.60

562

Acute bronchiolitis

231

2.24

7.33

6.1

1.9

7.48

7.44

g/l

0.06

185

Benign neoplasm: Parathyroid gland

117

3.00

7.32

2.6

1.3

7.84

7.60

g/l

0.25

Generalized skin eruption due to drugs and medicaments

430

1.96

7.32

4.5

2.5

7.32

7.43

g/l

0.23

333

Other and unspecified disorders of vitreous body

814

6635

1.23

7.31

2.3

7.16

7.47

g/l

4.87

608

4922

Coxarthrosis, primary, with hip surgery

1001

7928

1.21

7.31

2.1

2.3

7.49

7.46

g/l

0.21

712

5811

D07AA Corticosteroids, weak (group I)

222

1504

1.49

7.30

1.8

2.3

7.42

7.35

g/l

0.25

164

1153

Crushed, pushed or stepped on by crowd or human stampede

550

1.83

7.29

2.7

2.2

6.86

7.31

g/l

1.76

432

Other specified and unspecified personality disorders

134

811

1.68

7.28

1.9

2.1

7.24

7.25

g/l

0.01

106

630

Disorders of optic nerve and visual pathways

160

1013

1.60

7.28

2.2

2.5

7.63

7.29

g/l

1.20

119

777

Other/unspecified disorders of vestibular function

474

1.91

7.28

1.9

2.4

7.45

7.48

g/l

0.06

360

Infarction of spleen

3.83

7.25

1.4

2.3

7.03

7.71

g/l

0.70

Bronchitis, not specified as acute or chronic

163

1038

1.60

7.24

1.8

2.3

6.94

7.30

g/l

1.52

121

765

Carcinoma in situ of skin of ear and external auricular canal

164

2.65

7.24

1.7

1.4

7.07

7.47

g/l

0.79

115

Event of undetermined intent

102

574

1.81

7.24

2.0

2.3

7.28

7.32

g/l

0.06

448

Diseases of peritoneum

204

1367

1.52

7.22

2.0

2.4

7.57

7.41

g/l

0.50

145

1022

Acute peritonitis

130

785

1.69

7.22

2.3

2.5

7.43

7.37

g/l

0.13

596

Other/unspecified enthesopathies, not elsewhere classified

168

1079

1.58

7.21

1.6

2.1

7.29

7.42

g/l

0.36

129

807

ILD-related respiratory insufficiency

427

1.97

7.21

2.1

2.6

7.86

7.49

g/l

1.13

313

Chronic conjunctivitis

289

2.17

7.20

2.2

7.17

7.51

g/l

0.79

217

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

426

1.96

7.20

2.1

2.6

6.99

7.42

g/l

1.62

328

Hodgkin lymphoma, hilmo

276

2.20

7.19

1.3

2.7

7.52

7.27

g/l

0.33

219

Superficial injury of wrist and hand

289

2066

1.41

7.17

1.8

2.2

7.28

7.31

g/l

0.13

223

1585

Abnormal spermatozoa

111

1856

0.59

7.16

1.9

2.5

7.26

7.28

g/l

0.03

1378

Leukaemia of unspecified cell type

3.20

7.14

2.3

2.2

7.37

7.40

g/l

0.02

Hypopituitarism

106

606

1.78

7.11

2.7

2.4

7.12

7.24

g/l

0.20

482

Anosmia

127

2.78

7.11

2.7

1.3

6.66

7.16

g/l

0.79

Right bundle-branch block

407

1.97

7.09

2.9

2.1

7.53

7.46

g/l

0.13

299

Other benign neoplasms of skin

716

5809

1.24

7.08

3.0

2.3

7.35

7.44

g/l

0.72

506

4276

Other and unspecified rosacea

158

1006

1.60

7.07

2.0

2.4

7.25

7.32

g/l

0.20

120

765

Other nutritional anaemias

108

3.04

7.07

2.2

2.0

6.81

7.46

g/l

0.77

6-mercaptopurine

158

2.58

7.07

1.3

2.6

7.24

7.18

g/l

0.07

127

Monoarthritis, not elsewhere classified

414

1.95

7.05

1.6

2.3

7.59

7.15

g/l

1.26

303

Otalgia

134

820

1.66

7.04

2.1

2.3

7.20

7.45

g/l

0.76

631

Emotional disorders starting during childhood or adolecense, excluding more controls

2.99

7.03

1.1

1.5

7.53

7.26

g/l

0.34

Bacterial, viral and other infectious agents

135

827

1.66

7.03

3.0

2.2

7.25

7.22

g/l

0.06

109

650

Parkinson's disease, strict definition, excluding more controls

256

1767

1.44

7.00

1.9

2.3

7.16

7.63

g/l

3.92

178

1310

Endometriosis

567

2642

1.28

7.00

1.9

2.1

7.30

7.52

g/l

1.99

424

1984

Melanocytic naevi of trunk

201

1351

1.51

6.99

2.1

2.3

7.15

7.39

g/l

0.95

147

1033

Benign neoplasm: Oesophagus

120

2.90

6.98

1.2

1.3

6.88

7.63

g/l

1.56

Myasthenia gravis

191

2.47

6.98

1.3

2.4

7.18

7.41

g/l

0.36

140

Erythema nodosum

320

2.09

6.97

3.1

2.1

7.60

7.48

g/l

0.21

249

Urolithiasis

645

5185

1.25

6.96

2.0

2.3

7.37

g/l

0.02

496

3835

Carcinoma in situ of skin of trunk

412

1.97

6.93

2.7

2.4

7.61

7.47

g/l

0.29

298

Other abnormal uterine and vaginal bleeding

422

2281

1.33

6.92

2.1

2.2

7.64

7.62

g/l

0.06

262

1686

Other and unspecified psoriasis

132

810

1.66

6.91

2.0

2.5

7.44

7.34

g/l

0.25

619

Unspecified/other endometriosis

120

717

1.69

6.86

1.9

1.8

7.22

7.40

g/l

0.49

538

Superficial injury of forearm

146

918

1.61

6.85

1.7

2.2

7.22

7.39

g/l

0.53

112

713

Cushing syndrome

116

2.91

6.81

2.5

2.2

8.25

7.51

g/l

0.77

Parodontitis, under 40 years

382

1.95

6.80

1.3

1.4

7.53

6.97

g/l

1.59

296

Arterial embolism and thrombosis

124

752

1.68

6.79

1.4

2.5

7.85

7.42

g/l

1.44

542

Parkinson's disease, excluding more controls

273

1905

1.42

6.78

1.9

2.2

7.19

7.61

g/l

3.38

190

1413

Cerebral cysts

542

1.81

6.78

1.6

2.3

6.87

7.30

g/l

1.09

430

Disorders of orbit

492

1.85

6.77

2.9

2.5

7.68

7.39

g/l

0.62

373

Viral and other specified intestinal infections

247

1693

1.43

6.76

1.8

1.9

7.53

7.25

g/l

1.45

175

1283

Impingement syndrome of shoulder

438

3373

1.31

6.72

2.5

2.4

7.34

7.33

g/l

0.04

303

2552

Duodenal ulcer

227

1577

1.46

6.72

1.7

2.5

7.62

7.41

g/l

0.81

164

1164

Somnolence

111

2.92

6.71

1.5

2.0

7.67

7.37

g/l

0.31

Other or ill-defined heart diseases

514

1.82

6.71

1.5

2.0

7.29

7.34

g/l

0.09

385

Aspergillosis

101

3.09

6.71

2.3

1.4

8.07

7.50

g/l

0.69

Parodontitis, under 40 years, or operation codes

384

1.94

6.71

1.3

1.4

7.53

6.97

g/l

1.62

298

Hyperkinetic disorders, excluding more controls

346

1.98

6.71

1.4

1.7

6.93

7.06

g/l

0.27

272

Benign neoplasm: Skin of eyelid, including canthus

279

2011

1.41

6.70

3.1

1.4

7.31

7.50

g/l

1.06

211

1459

Benign neoplasm: salivary glands, exclude unknown (D119)

175

1156

1.54

6.69

1.9

2.4

7.52

7.40

g/l

0.30

122

882

Dermatopolymyositis, unspecified

3.96

6.68

6.3

2.5

7.09

7.28

g/l

0.20

Injuries to the wrist and hand

1805

11488

1.14

6.65

2.0

2.2

7.32

7.35

g/l

0.25

1370

8597

Carcinoma in situ of skin of lower limb, including hip

274

2.19

6.64

3.0

2.4

7.56

7.52

g/l

0.05

194

Suicide or other Intentional self-harm

364

2736

1.34

6.62

2.0

2.2

7.43

7.28

g/l

0.78

269

2111

Dental caries 2 and operation codes

1211

8219

1.18

6.60

2.6

2.2

7.24

7.31

g/l

0.66

961

6221

Other disorders of optic [2nd] nerve and visual pathways

113

674

1.71

6.60

2.2

2.7

7.65

7.31

g/l

0.86

520

Speech and linguistic disorders

459

1.84

6.59

1.7

1.8

7.33

7.32

g/l

0.01

353

Wet age-related macular degeneration

383

2858

1.33

6.55

2.3

2.2

7.68

7.56

g/l

0.61

269

2006

COPD, hospital admissions 1, only main diagnosis

748

5229

1.23

6.55

1.9

2.3

7.92

7.39

g/l

11.41

555

3815

Nontoxic goitre/thyroid nodule

569

4545

1.26

6.54

2.1

2.3

7.39

7.55

g/l

1.20

413

3343

Combinations of oral blood glucose lowering drugs

560

4467

1.27

6.53

1.7

2.4

8.03

7.21

g/l

17.63

397

3362

Dental caries 2

1239

8341

1.17

6.52

2.6

2.1

7.26

7.31

g/l

0.39

984

6319

Disorders of synovium and tendon in diseases classified elsewhere

203

2.35

6.50

1.6

1.8

7.31

7.38

g/l

0.10

154

Childhood asthma (age<16), excluding more controls

411

1.80

6.50

1.4

1.3

6.81

6.94

g/l

0.33

338

Chondropathies

251

1786

1.42

6.48

1.9

2.1

7.59

7.34

g/l

1.15

176

1364

Enteropathic arthropathies

178

2.43

6.47

1.5

2.2

6.75

7.00

g/l

0.38

132

Open wound of abdomen, lower back and pelvis

248

2.19

6.47

1.8

2.1

7.65

7.25

g/l

0.88

194

Polycythaemia vera

414

1.92

6.46

2.7

1.4

6.76

7.54

g/l

3.28

292

Unspecified lump in breast

276

1999

1.40

6.44

1.9

2.2

7.32

7.58

g/l

1.64

215

1494

Disorders of breast

781

5976

1.22

6.44

2.0

2.2

7.32

7.47

g/l

1.41

574

4459

Carcinoma in situ of colon

174

2.50

6.44

2.5

2.1

7.87

7.39

g/l

0.65

126

Benign paroxysmal vertigo

549

4377

1.27

6.43

2.0

2.3

7.48

7.50

g/l

0.07

388

3219

Additional codes for the location of defect, injury or illness

106

627

1.73

6.41

1.4

2.5

7.31

7.39

g/l

0.18

479

Benign neoplasm: Other and unspecified parts of mouth

408

1.92

6.40

3.1

2.6

8.04

7.40

g/l

1.27

312

Postprocedural disorders of nervous system

551

1.77

6.39

2.2

2.0

6.94

7.38

g/l

1.59

445

Inflammatory bowel disease, strict (require KELA)

358

2700

1.34

6.39

2.3

2.2

7.13

7.29

g/l

0.89

264

2080

Retinal detachment with retinal break

260

1870

1.41

6.38

2.5

2.4

7.35

7.39

g/l

0.12

198

1383

Exophthalmic conditions

109

2.90

6.37

3.5

1.8

7.92

7.57

g/l

0.28

Other bursitis of elbow

3.25

6.37

2.0

1.9

7.38

7.22

g/l

0.13

Other specified and unspecified retinal disorders

409

1.91

6.36

2.3

2.5

7.46

7.41

g/l

0.07

317

Benign neoplasm: Duodenum

326

2.04

6.35

2.6

7.47

7.41

g/l

0.09

241

Benign neoplasm of major salivary glands

196

1341

1.49

6.33

1.8

2.4

7.47

7.42

g/l

0.12

139

1006

Malignant neoplasm of kidney, except renal pelvis

193

1318

1.49

6.32

1.8

2.4

7.80

7.41

g/l

1.53

138

984

Hepatic failure, not elsewhere classified

403

1.91

6.30

1.5

2.7

7.12

7.35

g/l

0.36

301

Thyroiditis

127

791

1.63

6.28

2.2

2.4

7.33

7.46

g/l

0.29

599

Childhood asthma (age<16)

416

1.78

6.27

1.4

1.3

6.81

6.97

g/l

0.42

343

Injury of eye and orbit

218

1524

1.45

6.22

1.9

2.2

7.32

7.28

g/l

0.09

158

1177

Other acute viral hepatitis

2.95

6.22

2.3

1.8

7.46

7.41

g/l

0.04

Melanoma in situ

500

1.81

6.20

2.3

1.4

7.33

7.54

g/l

0.50

367

Visual impairment including blindness (binocular or monocular)

132

834

1.61

6.18

2.1

7.55

7.47

g/l

0.18

608

Thyrotoxicosis with toxic multinodular goitre

128

804

1.63

6.18

1.7

2.3

7.68

7.50

g/l

0.43

592

Personal history of allergy to drugs, medicaments and biological substances

3.01

6.17

2.0

1.5

7.50

7.61

g/l

0.14

Chronic hepatitis, not elsewhere classified

363

1.95

6.17

1.6

2.6

7.69

7.34

g/l

0.61

283

Nail disorders

139

888

1.59

6.17

1.7

2.3

7.34

7.33

g/l

0.01

676

Seborrhoeic dermatitis

172

1152

1.52

6.16

2.2

2.4

7.34

7.41

g/l

0.20

128

869

Abscess of anal and rectal regions

132

833

1.61

6.15

1.2

2.2

7.54

7.28

g/l

0.86

111

654

Mental and behavioural disorders due to use of other stimulants, including caffeine

139

2.57

6.15

1.1

1.5

7.51

6.97

g/l

0.87

113

Disorders of sphingolipid metabolism and other lipid storage disorders

4.95

6.15

2.1

1.5

7.24

8.00

g/l

—

Disorders of refraction and accommodation

375

2852

1.32

6.14

2.0

2.1

7.24

7.37

g/l

0.63

289

2160

Testicular dysfunction

294

2.05

6.13

1.4

2.5

7.40

7.11

g/l

0.39

227

Type1 diabetes, definitions combined, early onset

312

2.00

6.12

1.4

1.5

7.39

7.13

g/l

0.56

252

Other symptoms and signs involving the digestive system and abdomen

279

2043

1.38

6.10

1.9

2.3

7.35

7.48

g/l

0.51

158

1543

Parodontitis, under 40 years and operation codes

355

1.93

6.10

1.3

1.4

7.48

6.97

g/l

1.42

281

Malignant neoplasm of urinary organs

207

1444

1.46

6.08

1.7

2.4

7.82

7.39

g/l

1.91

149

1067

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.09

6.08

1.8

2.2

7.08

7.62

g/l

0.58

Benign neoplasm: Parotid gland

155

1020

1.55

6.08

1.9

2.5

7.49

7.42

g/l

0.15

110

785

Crohn's disease of small intestine

105

628

1.70

6.07

1.7

2.3

7.34

7.30

g/l

0.06

491

Other eating disorders

247

2.13

6.07

1.3

1.7

7.43

7.33

g/l

0.17

210

Bell's palsy

206

1434

1.46

6.06

2.3

2.2

7.19

7.39

g/l

0.85

149

1080

Benign neoplasm: Parathyroid gland

130

2.69

6.06

2.6

1.9

7.84

7.44

g/l

0.45

Parodontitis, operation under 40 years and operation codes

356

1.92

6.05

1.3

1.4

7.48

6.97

g/l

1.41

282

Emergency coronary revascularization (for ACS)

1203

7439

1.17

6.04

1.9

2.4

7.75

7.42

g/l

7.21

876

5418

Scleritis

118

2.75

6.03

2.1

2.0

7.20

7.32

g/l

0.13

Monoamine oxidase A inhibitors

216

1519

1.44

6.01

1.9

2.4

7.21

7.44

g/l

1.34

176

1128

Hyperaldosteronism

311

2.03

6.01

2.4

2.5

7.45

7.54

g/l

0.11

238

Ganglion

313

2337

1.35

6.01

2.0

2.2

7.17

7.36

g/l

1.01

229

1772

Seborrhoeic keratosis

435

3404

1.29

6.00

2.6

2.2

7.35

7.46

g/l

0.60

311

2475

Visual field defects

166

1112

1.52

5.99

2.3

2.2

7.51

7.40

g/l

0.30

117

840

Other specified/unspecified spondylopathies

298

2.05

5.97

2.9

2.0

7.70

7.37

g/l

0.77

220

Disorders of psychological development

106

588

1.68

5.97

1.6

1.8

7.35

7.29

g/l

0.13

457

Varicose veins

1260

8231

1.16

5.96

2.3

2.2

7.47

7.41

g/l

0.44

885

6056

Lichen ruber planus, wide definition including periferal and oral lichen planus

386

2977

1.31

5.95

2.4

2.3

7.40

7.47

g/l

0.35

288

2218

Benign neoplasm: Pancreas

341

1.98

5.95

2.5

2.6

7.41

g/l

0.00

255

Psychotic depression

101

602

1.70

5.92

1.9

2.7

7.05

7.38

g/l

1.24

454

Carcinoma in situ of skin of ear and external auricular canal

181

2.39

5.92

1.7

2.3

7.07

7.37

g/l

0.54

127

Assault

161

1072

1.52

5.89

1.6

2.2

7.26

7.18

g/l

0.20

124

841

Diseases of tongue

117

727

1.64

5.88

2.4

2.0

7.13

7.42

g/l

0.94

541

Fracture at wrist and hand level

548

4412

1.25

5.84

2.3

2.2

7.27

7.31

g/l

0.21

418

3334

Malignant neoplasm of pancreas

866

0.46

5.83

1.4

2.5

7.85

7.43

g/l

0.73

642

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

243

1753

1.40

5.83

2.4

2.2

7.15

7.30

g/l

0.67

182

1339

Carrier of infectious disease

220

2.20

5.80

1.3

1.8

7.18

7.34

g/l

0.25

173

Benign neoplasm: Oesophagus

133

2.61

5.77

1.2

2.2

6.88

7.41

g/l

0.94

Other disorders of penis

168

1137

1.50

5.75

1.6

2.3

6.95

7.30

g/l

1.47

124

861

Benign neoplasm of breast

198

1383

1.45

5.74

2.2

1.5

7.27

7.58

g/l

1.70

144

1005

Plantar fascial fibromatosis

161

1080

1.51

5.74

2.4

2.2

7.22

7.42

g/l

0.72

124

821

Other and unspecified vascular occlusions

197

1378

1.45

5.73

2.5

7.62

7.45

g/l

0.53

140

1011

Other and/or unspecified nontoxic goitre

163

1099

1.51

5.72

2.3

7.40

7.51

g/l

0.41

137

824

Intracranial and intraspinal abscess and granuloma

110

2.77

5.71

3.9

2.9

7.70

7.41

g/l

0.28

Palmar fascial fibromatosis [Dupuytren]

311

2343

1.34

5.71

2.3

2.2

7.33

7.37

g/l

0.14

230

1711

Unspecific neurodegenerative disorder

651

5445

0.82

5.70

1.9

2.3

7.53

g/l

0.01

409

3891

Adenomyosis (Endometriosis of uterus)

240

1738

1.40

5.67

2.2

7.29

7.61

g/l

2.04

193

1302

Bulimia nervosa (incl. atypical)

157

2.39

5.67

1.2

1.6

7.57

7.29

g/l

0.39

139

Ulcerative colitis (strict definition, require KELA)

250

1821

1.39

5.67

2.5

2.2

7.14

7.30

g/l

0.72

187

1390

Cardiac murmurs and other cardiac sounds

131

832

1.57

5.66

2.7

2.2

7.73

7.50

g/l

0.64

102

617

Vitamin D deficiency

152

2.45

5.65

1.3

2.1

6.88

7.24

g/l

0.57

119

Other/unspecified synovitis and tenosynovitis

191

1330

1.45

5.63

1.9

2.1

7.48

7.39

g/l

0.26

147

997

Other chondrocalcinosis

160

2.45

5.62

1.6

2.2

7.76

7.51

g/l

0.34

116

Fentanyl

179

1233

1.47

5.59

6.5

1.7

7.64

7.39

g/l

0.91

120

862

Other Crohn's disease

100

605

1.68

5.57

1.4

2.2

7.17

7.28

g/l

0.22

471

Coronary artery bypass grafting

622

3880

1.23

5.55

1.7

2.3

7.74

7.37

g/l

4.79

460

2829

Entropion and trichiasis of eyelid

185

1288

1.46

5.54

2.2

2.4

7.65

7.54

g/l

0.32

140

931

Other secondary coxarthrosis

399

1.85

5.54

1.5

2.3

7.64

7.34

g/l

0.54

308

Abscess of lung

148

2.46

5.51

1.4

2.3

8.30

7.32

g/l

2.06

112

Benign neoplasm: Pituitary gland, craniopharyngeal duct

502

1.75

5.50

2.8

1.4

7.10

7.31

g/l

0.50

377

Disorders of speech understanding and production

259

2.04

5.50

1.9

2.2

7.69

7.46

g/l

0.33

192

Cachexia

3.99

5.50

2.2

1.5

7.30

7.63

g/l

—

Amenorrhoea

456

1.77

5.50

2.0

1.9

6.99

7.41

g/l

1.23

356

Conductive and sensorineural hearing loss

1624

9945

1.14

5.49

2.3

2.2

7.34

7.44

g/l

1.11

1049

7514

Abnormal findings on diagnostic imaging of central nervous system

437

1.80

5.44

2.4

2.6

7.34

7.38

g/l

0.06

342

Hidradenitis suppurativa

259

2.05

5.43

1.3

1.9

7.79

7.35

g/l

1.14

205

Other and unspecified haemorrhagic conditions

168

2.35

5.43

4.9

2.0

7.63

7.43

g/l

0.26

125

Liver disorders in diseases classified elsewhere

5.09

5.41

2.2

1.2

7.10

8.16

g/l

0.81

Otitis externa, unspecified

169

1160

1.47

5.40

1.9

2.4

7.32

7.31

g/l

0.03

127

879

Bursitis of shoulder

247

2.08

5.39

2.4

1.9

7.55

7.41

g/l

0.18

183

Pustulosis palmaris et plantaris

491

1.75

5.39

1.9

2.4

7.98

7.41

g/l

2.31

380

Unstable angina pectoris

846

5937

1.19

5.38

2.2

2.3

7.80

7.41

g/l

6.95

583

4312

Other and unspecified tonsillitis

399

2647

1.28

5.36

1.8

2.0

7.34

7.17

g/l

0.96

319

2083

Scleritis and episcleritis

102

628

1.65

5.35

1.6

2.2

7.20

7.31

g/l

0.21

490

Testicular hypofunction

261

2.04

5.35

1.4

2.6

7.27

7.07

g/l

0.27

198

Unspecified misadventure during surgical and medical care

103

637

1.65

5.34

1.8

2.5

7.29

7.32

g/l

0.04

486

Iridocyclitis in diseases classified elsewhere

182

2.28

5.33

1.9

2.4

7.34

7.58

g/l

0.34

138

Benign lipomatous neoplasm

485

3900

1.25

5.33

2.5

1.4

7.38

7.42

g/l

0.14

333

2904

Drug-induced neutropenia

137

906

1.54

5.32

2.9

2.5

7.60

7.35

g/l

0.66

109

682

Biological medicines for asthma

114

2.64

5.31

1.7

1.8

6.94

7.24

g/l

0.55

Irregular menses

623

4158

1.22

5.31

2.1

7.34

7.32

g/l

0.08

472

3225

Other epidermal thickening

478

1.75

5.31

2.0

2.5

7.15

7.36

g/l

0.57

366

Pustular psoriasis

546

1.70

5.31

1.9

2.3

7.95

7.41

g/l

2.33

417

Inflammatory disease of uterus

188

1320

1.44

5.30

1.7

2.1

7.24

7.43

g/l

0.83

146

1010

Unspecified visual impairment (binocular)

151

2.41

5.29

1.7

1.8

7.12

7.46

g/l

0.44

110

Oral leukoplakia and related diseases

114

725

1.61

5.28

1.8

2.5

7.39

7.46

g/l

0.14

550

Other obstetric conditions, not elsewhere classified

267

1277

1.36

5.28

1.5

1.7

6.82

7.03

g/l

1.38

217

1023

Use of donepezil

248

3203

0.74

5.28

1.9

2.3

7.51

7.59

g/l

0.24

146

2244

Benign neoplasm of urinary organs

547

1.70

5.28

2.0

1.4

7.25

7.51

g/l

0.69

401

Benign neoplasm: Spinal meninges

115

2.66

5.28

1.3

7.42

7.69

g/l

0.18

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

175

2.26

5.27

1.6

1.7

7.07

7.24

g/l

0.20

143

Other orthopaedic follow-up care

101

623

1.65

5.27

1.8

2.0

7.53

7.35

g/l

0.48

488

Alzheimer disease

440

4149

0.79

5.27

1.9

2.2

7.67

7.56

g/l

0.51

270

2923

Follow-up examination after treatment for malignant neoplasms

181

1266

1.45

5.26

2.3

2.1

7.88

7.49

g/l

1.99

140

950

Ulcer of oesophagus

140

933

1.53

5.24

2.2

2.7

7.51

7.45

g/l

0.12

717

Other misadventures during surgical and medical care

230

2.11

5.24

1.6

2.6

8.57

7.34

g/l

1.93

174

Complications of cardiac and vascular prosthetic devices, implants and grafts

251

2.07

5.22

1.8

2.7

7.77

7.38

g/l

0.61

181

Specific development disorders of speech and language

333

1.87

5.22

1.9

2.0

7.44

7.38

g/l

0.07

249

Procreative management

414

2755

1.27

5.21

1.7

2.0

7.00

7.29

g/l

2.76

336

2148

Benign neoplasm: Other and unspecified parts of small intestine

191

2.24

5.21

1.6

1.4

7.11

7.65

g/l

0.79

139

Tinnitus

423

3361

1.27

5.20

2.3

2.2

7.19

7.45

g/l

2.28

331

2579

Alzheimer’s disease (Early onset)

609

0.40

5.19

1.0

2.0

7.72

7.59

g/l

0.10

432

Urethral stricture

118

760

1.58

5.18

2.1

2.5

7.52

7.26

g/l

0.88

558

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

270

2022

1.35

5.16

2.5

2.2

7.11

7.33

g/l

1.22

203

1539

Alcohol abuse, main dg

243

1792

1.37

5.16

1.2

2.2

7.47

7.30

g/l

0.67

183

1379

Clear cell adenocarcinoma of kidney

606

1.66

5.14

1.6

2.8

8.16

7.36

g/l

2.20

458

Other noninflammatory disorders of vulva and perineum

138

919

1.52

5.14

1.5

2.1

7.50

7.52

g/l

0.04

687

Other disorders of cornea

167

1157

1.46

5.13

1.9

2.3

7.21

7.40

g/l

0.59

118

876

Pneumothorax

132

873

1.54

5.12

2.5

2.3

7.44

7.30

g/l

0.36

106

649

Pediculosis, acariasis and other infestations

521

1.70

5.08

1.9

2.2

7.32

7.29

g/l

0.04

410

Other maltreatment syndromes

232

2.07

5.06

1.5

7.51

7.22

g/l

0.37

175

Papilloedema, unspecified

186

2.21

5.05

1.2

2.3

8.03

7.22

g/l

0.92

145

Attention to artificial openings

456

1.75

5.03

2.3

2.1

7.67

7.28

g/l

1.17

353

Other obstructive and reflux uropathy

381

1.82

5.03

2.0

7.66

7.26

g/l

1.34

292

Other otitis externa (chronic)

116

749

1.58

5.03

2.5

7.63

7.31

g/l

0.78

570

Melanoma in situ of other and unspecified parts of face

143

2.44

5.02

2.3

1.2

7.13

7.51

g/l

0.60

100

Congenital malformations and deformations of the musculoskeletal system

102

634

1.62

5.01

1.4

2.0

7.27

7.33

g/l

0.12

497

Malignant neoplasm of bronchus and lung

236

2963

0.74

5.01

2.0

2.2

8.10

7.42

g/l

5.24

184

2125

Tobacco use

501

1.71

5.01

1.7

2.5

7.73

7.30

g/l

1.09

401

Degenerative macular diseases

250

1865

1.36

5.00

1.9

2.3

7.44

7.51

g/l

0.18

169

1353

Acne

537

1.67

4.99

1.9

1.6

7.19

7.25

g/l

0.11

422

Vascular diseases of the intestine

488

1.72

4.97

2.9

2.3

7.91

7.46

g/l

1.18

362

Lichen planus, including avohilmo

329

2551

1.30

4.97

2.5

2.3

7.41

7.49

g/l

0.34

244

1910

Presence of other devices

457

3684

1.25

4.95

2.5

2.2

7.39

7.53

g/l

0.88

303

2725

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

118

2.53

4.94

4.9

1.6

7.14

7.32

g/l

0.25

Operations for atrial fibrillation

189

2.21

4.94

1.3

3.0

7.15

7.38

g/l

0.20

147

Ulcerative colitis (strict definition, all Crohn cases excluded)

212

1541

1.39

4.94

2.7

2.3

7.04

7.32

g/l

1.45

159

1192

Iron deficiency

124

2.47

4.93

2.2

2.1

7.32

7.28

g/l

0.04

106

Haemangioma, any site

133

889

1.52

4.90

2.6

1.3

7.51

7.40

g/l

0.21

668

Dermatophytosis

237

1759

1.36

4.89

2.4

2.3

7.48

7.38

g/l

0.30

177

1302

Golimumab

256

1.99

4.88

1.3

1.7

7.70

7.37

g/l

0.57

210

Coronary angioplasty

815

5326

1.18

4.87

2.0

2.3

7.76

7.41

g/l

5.68

594

3902

Viral warts

148

1012

1.48

4.86

2.0

2.4

7.16

7.34

g/l

0.59

103

775

Viral conjunctivitis

176

2.22

4.85

2.4

1.7

6.79

7.43

g/l

1.31

142

Other and specified injuries of hip and thigh

244

2.03

4.84

1.4

2.2

7.41

7.63

g/l

0.28

186

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

254

1223

1.35

4.84

1.4

1.7

6.83

7.01

g/l

0.95

207

982

454

3473

1.25

4.83

2.1

2.2

7.64

7.55

g/l

0.40

293

2458

Vulvovaginal ulceration/inflammation in other diseases

430

1.74

4.83

1.7

2.0

7.14

7.49

g/l

1.02

339

Haemangioma and lymphangioma, any site

140

949

1.49

4.82

3.0

1.3

7.48

7.39

g/l

0.17

706

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

322

2467

1.30

4.81

2.1

2.0

7.05

7.24

g/l

1.08

241

1900

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

621

1.61

4.81

2.0

2.3

7.23

7.10

g/l

0.24

471

Oesophagitis

103

655

1.60

4.80

2.1

2.6

7.45

7.42

g/l

0.06

509

Lactose intolerance

272

1.95

4.79

1.4

1.7

7.32

7.38

g/l

0.09

218

Chronic myeloid leukaemia

3.51

4.79

1.6

2.6

7.41

7.45

g/l

—

Pulmonary oedema

211

2.11

4.79

1.6

2.3

8.00

7.47

g/l

0.73

148

Autoimmune hyperthyroidism

553

1.65

4.78

2.2

2.5

7.52

7.30

g/l

0.53

430

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

259

1955

1.34

4.78

2.3

1.4

7.16

7.46

g/l

1.88

186

1431

Lumbosacral root disorders, not elsewhere classified

127

2.46

4.76

2.5

2.0

7.04

7.21

g/l

0.17

Nontoxic multinodular goitre

375

2974

1.27

4.74

1.9

2.4

7.40

7.56

g/l

0.83

251

2190

Congenital malformations of the circulatory system

200

1404

1.39

4.74

1.7

2.3

6.88

7.36

g/l

2.92

158

1080

Atypical mycobacterium lung infection

134

2.42

4.72

1.6

2.0

7.96

7.65

g/l

0.38

Status epilepticus

360

1.81

4.72

1.7

2.6

7.38

7.48

g/l

0.13

280

Benign neoplasm: Kidney

383

1.79

4.71

2.1

1.4

7.14

7.57

g/l

1.24

278

Other and unspecified pemphigoid

110

2.61

4.71

1.5

2.6

7.04

7.55

g/l

0.86

Type 1 diabetes, strict definition

424

1.73

4.70

1.4

1.5

7.24

6.97

g/l

0.62

345

Unspecified urinary incontinence

163

1145

1.44

4.70

1.3

2.2

7.72

7.54

g/l

0.50

104

841

Deficiency of other B group vitamins

247

2.00

4.69

3.7

2.0

7.32

g/l

0.00

191

Other deformities of toe(s)

383

1.79

4.69

2.3

2.2

7.66

7.31

g/l

0.58

278

Other and unspecified nonorganic psychotic disorders

250

1880

1.34

4.68

1.5

2.2

7.41

7.24

g/l

0.81

178

1457

Perineal laceration during delivery

927

0.56

4.68

1.6

6.66

7.18

g/l

2.50

745

Personal history of medical treatment

2.74

4.68

1.4

1.8

8.31

7.55

g/l

0.63

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

489

1.69

4.67

4.0

1.4

7.59

7.48

g/l

0.16

367

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

177

2453

0.71

4.67

1.8

1.4

7.77

7.47

g/l

1.16

110

1795

Other and unspecified follicular disorders

376

1.79

4.67

3.0

2.4

7.58

7.26

g/l

0.72

304

Unspecified protein-energy malnutrition

3.28

4.66

1.7

2.7

7.00

7.56

g/l

—

Recurrent dislocation and subluxation of joint

518

1.66

4.65

2.0

2.2

7.17

7.06

g/l

0.18

396

Obsessive-compulsive disorder

353

1.80

4.64

2.1

2.0

7.00

7.24

g/l

0.46

284

Hyphaema and other vascular disorders of iris and ciliary body

200

2.12

4.64

2.1

2.8

7.93

7.34

g/l

1.32

149

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

231

1719

1.36

4.63

2.5

1.4

7.41

7.40

g/l

0.05

160

1245

Other specific arthropathies, wide

193

2.13

4.63

1.4

2.5

7.77

6.97

g/l

1.43

147

Nail dystrophy

3.04

4.63

1.4

2.3

7.96

7.85

g/l

0.06

Benign neoplasm: Skin of ear and external auricular canal

460

1.71

4.62

2.5

1.4

7.40

7.46

g/l

0.10

341

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.84

4.62

1.6

1.5

8.16

7.45

g/l

0.85

Viral infections of the central nervous system

116

764

1.54

4.61

2.3

7.27

7.40

g/l

0.30

584

Other surgical follow-up care

283

1.91

4.61

2.5

1.9

7.34

7.28

g/l

0.08

233

Melanoma in situ

546

1.65

4.60

2.3

2.7

7.33

7.42

g/l

0.17

408

Alzheimer disease, including avohilmo

543

4727

0.82

4.59

1.9

2.2

7.58

7.55

g/l

0.14

357

3334

Hypotension due to drugs

155

2.29

4.59

3.5

1.8

7.40

7.50

g/l

0.11

109

Triptan medication for migraine, min. 3 purchases

720

4807

1.19

4.59

2.2

2.1

6.95

7.28

g/l

5.83

572

3701

Ulcerative proctitis

591

1.61

4.58

1.4

2.1

7.11

7.29

g/l

0.38

458

Other keratitis

167

1183

1.43

4.57

2.0

2.3

7.49

7.38

g/l

0.29

130

908

Leisure time condition

292

2255

1.31

4.56

1.7

2.2

7.28

7.46

g/l

0.65

150

1698

Disorders of optic nerve, not elsewhere classified

250

1.99

4.56

2.4

2.9

7.74

7.38

g/l

0.48

186

Disorder of external ear, unspecified

350

1.82

4.55

2.5

2.4

7.45

7.38

g/l

0.09

269

Congenital malformations of cardiac septa

550

1.62

4.52

1.7

2.3

6.78

7.32

g/l

1.99

421

Ankylosing spondylitis, strict definition

372

1.78

4.51

1.5

2.3

7.27

7.19

g/l

0.15

294

Other congenital malformations of skin

365

1.79

4.51

1.9

2.4

6.99

7.41

g/l

1.08

285

Shock, not elsewhere classified

2.80

4.51

3.5

2.0

7.64

7.24

g/l

0.46

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

404

3249

1.25

4.50

1.6

2.2

7.28

7.30

g/l

0.08

312

2490

Benign neoplasm of meninges

176

1264

1.41

4.50

1.9

1.4

7.38

7.56

g/l

0.50

127

921

Other condition

211

1559

1.37

4.49

2.1

2.2

7.34

7.36

g/l

0.08

148

1195

Cluster headache, strict, including avohilmo

425

1.72

4.49

1.6

2.3

7.26

7.23

g/l

0.04

339

Alzheimer’s disease (Atypical or mixed)

1351

0.63

4.49

2.1

7.51

7.61

g/l

0.13

929

Maternal care for other conditions predominantly related to pregnancy

210

1527

1.36

4.48

1.9

7.09

7.10

g/l

0.03

168

1217

Other hearing loss

571

4682

1.21

4.47

2.5

2.2

7.32

7.53

g/l

1.98

387

3462

Other other unspecified disorders of the circulatory system

442

1.71

4.47

1.8

2.6

7.74

7.38

g/l

0.79

330

Other bursitis of hip

210

2.06

4.46

2.0

1.7

7.55

7.41

g/l

0.21

146

Third [oculomotor] nerve palsy

218

2.04

4.42

1.7

2.8

7.58

7.43

g/l

0.20

162

severe traumatic brain injury, does not include concussion

418

3386

1.24

4.41

2.3

2.2

7.26

7.41

g/l

0.99

292

2468

Viral agents as the cause of diseases classified to other chapters

204

2.07

4.40

2.8

2.0

6.68

7.45

g/l

2.13

156

Open wound of hip and thigh

295

1.87

4.39

1.3

2.5

6.91

7.15

g/l

0.45

225

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

605

1.59

4.39

1.8

2.2

7.08

7.38

g/l

0.82

472

Postprocedural disorders of digestive system, not elsewhere classified

369

1.78

4.39

1.8

2.6

7.82

7.35

g/l

1.10

280

Other symptoms and signs involving general sensations and perceptions

391

1.75

4.38

2.5

2.6

7.09

7.53

g/l

1.26

299

Lichen planus

235

1774

1.34

4.38

2.8

2.3

7.36

7.50

g/l

0.61

168

1348

Leiomyoma of uterus

701

3335

1.19

4.38

2.1

1.4

7.51

7.37

g/l

0.99

514

2486

Other superficial mycoses

184

2.12

4.38

1.9

2.3

7.09

7.34

g/l

0.40

147

Other and unspecified iridocyclitis

444

1.70

4.38

2.9

2.2

7.57

7.34

g/l

0.51

338

Other retinal artery occlusion

297

1.88

4.36

2.0

2.8

7.34

7.51

g/l

0.23

222

Cluster headache, wide,, including avohilmo

459

1.68

4.36

1.7

2.3

7.25

7.24

g/l

0.02

364

Perioral dermatitis

171

2.16

4.35

1.6

2.1

7.33

7.48

g/l

0.18

136

Early complications of trauma

422

1.71

4.35

2.5

2.3

7.49

7.26

g/l

0.53

331

!Aliquae complicationes praecoces traumatis

422

1.71

4.35

2.5

2.3

7.49

7.26

g/l

0.53

331

Benign neoplasm: Spinal meninges

127

2.40

4.33

1.3

1.8

7.42

7.75

g/l

0.23

Other noninflammatory disorders of uterus, except cervix

412

2266

1.25

4.33

2.4

2.2

7.59

7.63

g/l

0.15

282

1670

Bicipital tendinitis

546

1.62

4.32

2.1

2.4

7.10

7.30

g/l

0.46

414

Familial hypercholesterolemia, with ischemic heart disease

205

1522

1.37

4.32

1.9

2.3

7.82

7.42

g/l

1.90

133

1094

Extreme obesity with alveolar hypoventilation

462

1.68

4.30

1.6

2.7

8.10

7.22

g/l

4.30

356

Use of memantine

359

3892

0.80

4.30

1.8

2.2

7.63

7.57

g/l

0.19

213

2723

Use of other anti-dementia drugs

359

3892

0.80

4.30

1.8

2.2

7.63

7.57

g/l

0.19

213

2723

Other aneurysm

109

722

1.54

4.29

2.0

2.4

7.57

7.36

g/l

0.52

533

Benign neoplasm: Pituitary gland, craniopharyngeal duct

539

1.62

4.29

2.8

2.5

7.10

7.33

g/l

0.54

416

Glucosamine medication

1061

7430

1.15

4.28

2.3

7.44

7.50

g/l

0.51

788

5410

Other specified disorders of muscle

284

1.87

4.26

1.3

2.2

7.43

7.34

g/l

0.12

205

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

103

2.55

4.25

1.5

1.3

7.14

7.49

g/l

0.37

Other noninfective disorders of lymphatic vessels and lymph nodes

380

1.75

4.25

1.6

2.4

7.48

7.42

g/l

0.10

290

Other bullous disorders

292

1.86

4.24

2.8

2.3

7.10

7.32

g/l

0.42

222

Pure hyperglyceridaemia

228

1.98

4.24

1.9

2.4

7.66

7.25

g/l

0.76

182

Other specified/unspecified disorders of bone/cartilage

292

1.86

4.23

2.7

1.9

6.85

7.30

g/l

1.01

223

Other and unspecified corneal deformities and disorders

336

1.80

4.23

2.1

2.3

7.04

7.41

g/l

0.77

256

Localized scleroderma [morphea]

154

2.22

4.21

1.7

1.8

7.35

7.58

g/l

0.26

123

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

807

5420

1.17

4.21

2.0

1.4

7.59

7.48

g/l

0.90

587

3961

Other disorders of iris and ciliary body

293

1.86

4.20

2.2

2.7

7.85

7.34

g/l

1.30

219

Other salmonella infections

404

1.72

4.19

2.4

2.1

7.34

7.30

g/l

0.05

302

Spontaneous abortion

460

3803

0.82

4.17

1.9

2.3

7.24

7.37

g/l

0.84

347

2851

Benign neoplasm of other and unspecified intrathoracic organs

110

2.46

4.17

2.4

1.2

7.74

7.55

g/l

0.16

Benign neoplasm: Skin of other and unspecified parts of face

184

1350

1.38

4.15

3.5

1.4

7.39

7.48

g/l

0.20

106

983

Cholangitis (primary sclerosing, PSC)

107

711

1.53

4.15

1.9

2.4

7.47

7.38

g/l

0.17

537

Benign neoplasm of urinary organs

584

1.59

4.15

2.0

2.7

7.25

7.45

g/l

0.49

444

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

588

3008

1.20

4.14

2.0

1.4

7.42

7.35

g/l

0.31

427

2263

Alcohol dependence

479

3962

1.22

4.13

1.6

2.4

7.46

7.26

g/l

1.59

365

2975

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

469

3873

1.22

4.11

2.6

2.2

7.33

7.34

g/l

0.05

363

2933

Non-small cell lung cancer, squamous, helper endpoint

685

0.50

4.11

2.1

2.4

8.49

7.41

g/l

2.30

484

Non-small cell lung cancer, squamous

685

0.50

4.11

2.1

2.4

8.49

7.41

g/l

2.30

484

Other and unspecified bullous disorders

118

2.40

4.06

3.2

2.0

7.29

7.45

g/l

0.17

Acidosis

218

1.99

4.06

2.0

2.2

7.55

7.36

g/l

0.23

169

Postprocedural musculoskeletal disorders, not elsewhere classified

133

929

1.46

4.04

2.2

2.5

7.60

7.42

g/l

0.45

699

Impetigo

325

1.78

4.04

2.6

2.0

7.09

7.27

g/l

0.34

258

Brachial plexus disorders

123

844

1.47

4.04

2.4

2.2

7.08

7.27

g/l

0.56

660

Post-traumatic wound infection, not elsewhere classified

239

1.93

4.04

1.7

2.3

7.45

7.30

g/l

0.21

184

Colitis, primary sclerosing

2.50

4.03

2.0

6.91

7.39

g/l

0.63

Diffuse brain injury

296

1.82

4.03

2.4

1.9

7.52

7.47

g/l

0.07

226

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

207

1554

1.35

4.03

2.5

1.4

7.38

7.40

g/l

0.05

147

1154

Congenital iodine-deficiency syndrome/hypothyroidism

380

1.72

4.00

3.0

2.1

7.48

7.52

g/l

0.04

283

Premature rupture of membranes

109

1181

0.67

3.99

1.9

1.8

6.69

7.20

g/l

2.84

943

Malignant neoplasm of respiratory system and intrathoracic organs

290

3373

0.78

3.99

2.2

7.99

7.40

g/l

4.82

224

2420

Other ulcerative colitis

549

1.59

3.98

1.3

2.3

7.41

7.28

g/l

0.21

423

Acne vulgaris

393

1.69

3.98

2.0

1.6

6.98

7.25

g/l

0.73

322

Lichen simplex chronicus

365

1.73

3.98

2.8

2.7

7.92

7.35

g/l

1.02

283

Dislocation, sprain and strain of joints and ligaments at neck level

196

1461

1.35

3.97

2.3

7.21

7.26

g/l

0.16

148

1133

Exposure to other and unspecified animate mechanical forces

212

1.97

3.96

3.0

1.7

7.28

7.37

g/l

0.10

174

Drug-induced hypoglycaemia without coma

158

2.15

3.96

1.3

2.8

7.71

7.28

g/l

0.40

123

Hypertensive encephalopathy

3.34

3.96

2.5

2.4

7.43

7.74

g/l

—

Acute suppurative otitis media

266

1929

1.29

3.95

2.8

1.9

7.31

7.18

g/l

0.54

208

1506

Acute laryngitis and tracheitis

119

801

1.47

3.95

1.6

1.9

7.13

7.30

g/l

0.50

618

Retinal breaks without detachment

286

2251

1.28

3.94

2.4

7.19

7.39

g/l

0.85

211

1688

Noninflammatory disorders of female genital tract

641

2725

1.19

3.94

2.1

2.0

7.46

7.51

g/l

0.24

480

2048

Salpingitis and oophoritis

278

2179

1.29

3.94

1.7

2.4

7.63

7.46

g/l

0.83

219

1652

Infective dermatitis

190

1415

1.36

3.92

1.8

2.4

7.63

7.44

g/l

0.65

119

1077

Other specified disorders of kidney and ureter

367

1.73

3.91

2.3

2.8

6.91

7.33

g/l

1.33

283

Exclusion endpoint for clefts

119

2.31

3.91

1.6

1.9

6.70

7.12

g/l

0.57

Subacute thyroiditis

398

1.69

3.88

2.7

2.2

7.29

7.49

g/l

0.32

299

UC patients in KELA-register (code 208), prior to 1994

538

1.59

3.88

2.5

7.00

7.33

g/l

1.22

414

Spinal osteochondrosis

2.55

3.86

1.4

2.0

6.85

7.08

g/l

0.25

Nystagmus and other irregular eye movements

114

2.35

3.84

1.7

2.2

7.16

7.18

g/l

0.01

Benign neoplasm: Other and unspecified parts of small intestine

216

1.97

3.84

1.6

2.1

7.11

7.60

g/l

0.70

164

Encephalopathy

102

2.46

3.84

1.8

2.5

6.89

7.27

g/l

0.49

Asthma mixed form (mode), excluding more controls

491

1.61

3.83

1.9

1.6

7.27

7.36

g/l

0.16

361

Corneal scars and opacities

280

1.83

3.83

1.7

2.6

7.57

7.52

g/l

0.05

211

Lung cancer and mesothelioma

345

2376

1.25

3.83

2.1

1.9

8.08

7.26

g/l

10.45

269

1721

Cysts of oral region, not elsewhere classified

438

1.65

3.81

2.4

2.1

7.49

7.29

g/l

0.46

338

Benign neoplasm of eye and adnexa

166

1217

1.38

3.81

1.7

1.4

7.27

7.47

g/l

0.72

124

882

Ill-defined and unknown causes of mortality

960

0.60

3.80

2.0

2.4

7.77

7.46

g/l

0.45

689

Parapsoriasis

195

2.00

3.80

1.7

2.3

7.01

7.35

g/l

0.48

153

Benign neoplasm of middle ear and respiratory system

131

923

1.44

3.79

2.5

1.4

7.23

7.44

g/l

0.55

102

687

Fasciculation

115

2.35

3.79

1.5

1.9

6.49

7.41

g/l

2.35

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

137

882

1.42

3.76

1.4

1.6

7.07

7.11

g/l

0.08

109

695

Lactose intolerance, other/unspecified

245

1.87

3.75

1.4

1.7

7.41

7.39

g/l

0.03

193

Use of antiglaucoma preparations and miotics

165

1213

1.38

3.75

2.2

2.4

7.79

7.51

g/l

0.97

115

873

Status post-ami

1078

0.65

3.75

1.5

2.3

7.62

7.42

g/l

0.52

740

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

134

951

1.43

3.74

2.0

2.5

7.56

7.41

g/l

0.36

723

Disseminated intravascular coagulation [defibrination syndrome]

3.73

3.74

1.7

1.6

7.17

7.84

g/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

239

1.88

3.70

2.0

7.07

7.37

g/l

0.66

188

Emotional disorders and disorders of social functioning with onset specific to childhood

159

2.06

3.69

1.1

1.4

7.54

7.35

g/l

0.25

133

Thyrotoxicosis with diffuse goitre

207

1575

1.33

3.69

2.1

2.2

7.58

7.42

g/l

0.59

166

1203

Benign neoplasm: Kidney

412

1.66

3.69

2.1

2.6

7.14

7.40

g/l

0.59

308

Dissection of aorta

397

1.67

3.68

1.6

2.7

7.21

7.34

g/l

0.19

296

All dysplastic lesions of the cervix uteri, vagina or vulva

316

2518

1.25

3.68

2.2

2.0

7.27

7.25

g/l

0.09

249

1938

Perichondritis of external ear

212

1.95

3.67

2.6

2.3

7.57

7.43

g/l

0.14

159

Congenital malformations of trachea and bronchus

2.45

3.67

2.7

1.9

8.24

7.52

g/l

0.69

Benign neoplasm: Cerebral meninges

153

1116

1.39

3.65

2.0

1.4

7.30

7.54

g/l

0.76

113

820

Other and unspecified trigeminal disorders

137

2.18

3.61

1.4

2.0

7.05

7.25

g/l

0.25

100

Orchitis and epididymitis

155

1134

1.38

3.61

1.9

2.2

7.39

7.30

g/l

0.25

109

844

Other and unspecified mononeuropathies of upper limb

285

1.79

3.61

1.4

2.1

6.96

7.25

g/l

0.50

218

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

361

1.70

3.61

2.2

1.4

7.54

7.48

g/l

0.08

267

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

212

1.91

3.60

3.6

2.1

7.01

7.34

g/l

0.53

162

Focal brain injury

100

676

1.50

3.59

2.0

2.2

7.47

7.45

g/l

0.03

499

Other disorders of central nervous system

105

2.36

3.59

1.2

1.8

6.64

7.51

g/l

1.88

Other secondary gonarthrosis

654

1.51

3.58

2.4

2.9

7.62

7.35

g/l

0.76

500

Benign neoplasm: Prostate

2.67

3.57

2.5

1.3

7.02

7.63

g/l

0.59

Injury of muscle and tendon at hip and thigh level

151

1103

1.38

3.56

2.1

2.3

7.11

7.35

g/l

0.84

117

851

Viral encephalitis, not elsewhere classified/unspecified

207

1.93

3.56

3.5

2.4

7.14

7.32

g/l

0.25

161

Burns and corrosions

195

1481

1.33

3.54

1.9

2.2

7.57

7.30

g/l

1.19

144

1142

Sixth [abducent] nerve palsy

386

1.67

3.53

2.5

2.6

7.62

7.40

g/l

0.38

285

Contact with sharp object, undetermined intent

172

2.02

3.53

1.9

2.0

7.38

7.23

g/l

0.18

133

Achilles tendinitis

161

1190

1.37

3.52

2.5

2.1

7.31

7.40

g/l

0.24

122

928

Melanoma in situ of other and unspecified parts of face

167

2.07

3.52

2.3

2.5

7.13

7.43

g/l

0.42

124

Other neurotic disorders

575

1.54

3.52

1.5

2.5

7.22

7.37

g/l

0.33

435

Chronic myeloid leukaemia [CML], BCR/ABL-positive

113

2.32

3.52

1.5

2.7

7.14

7.44

g/l

0.30

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

173

2.03

3.51

1.5

1.3

7.75

7.64

g/l

0.13

123

Arthropathy in ulcerative colitis

119

2.26

3.51

1.6

1.8

6.57

7.25

g/l

1.12

Focal epilepsy, strict definition

319

2579

1.25

3.51

2.1

2.2

7.21

7.42

g/l

1.04

216

1904

Sleep disorders, other/unspecified

251

1.82

3.49

1.4

1.8

7.05

7.38

g/l

0.52

205

Injury of nerves at lower leg level

2.43

3.48

1.2

1.9

6.89

7.47

g/l

1.00

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

577

2944

1.18

3.48

2.0

1.4

7.43

7.36

g/l

0.31

417

2212

Otorrhagia

2.64

3.48

2.4

2.5

6.47

7.46

g/l

1.92

Postzoster neuralgia

160

2.07

3.48

3.4

2.1

7.32

7.43

g/l

0.10

114

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

118

831

1.44

3.48

3.2

1.4

7.75

7.44

g/l

0.70

610

Tongue abnormality

112

782

1.46

3.47

2.5

7.11

7.44

g/l

1.02

601

Degenerative diseases of the nervous system

529

4680

0.85

3.47

1.8

2.2

7.59

7.54

g/l

0.18

331

3318

Complications of genitourinary prosthetic devices, implants and grafts

267

1.80

3.46

1.8

1.9

7.37

7.38

g/l

0.01

203

Chronic iridocyclitis

545

1.55

3.46

2.1

2.4

7.61

7.29

g/l

0.94

416

Unspecified event, undetermined intent

223

1.88

3.46

2.4

2.7

6.98

7.31

g/l

0.61

178

Complications of other internal prosthetic devices, implants and grafts

467

1.59

3.44

1.9

2.3

7.16

7.50

g/l

0.66

352

Gluteal tendinitis

381

1.66

3.43

2.0

2.1

7.73

7.35

g/l

0.85

295

Organic, including symptomatic, mental disorders

1041

6685

1.13

3.43

2.0

2.3

7.56

7.49

g/l

0.54

677

4891

Other disorders of binocular movement

174

1.99

3.43

1.7

1.8

6.91

7.34

g/l

0.50

136

Other disorders of pigmentation

507

1.57

3.42

2.9

2.1

7.07

7.46

g/l

1.00

390

Malnutrition

210

1.91

3.42

1.6

2.2

7.01

7.44

g/l

0.43

150

Other blood glucose lowering drugs, excl. Insulins

324

2635

1.24

3.42

1.7

2.3

8.29

7.30

g/l

13.95

227

1951

Alzheimer’s disease, wide definition

349

3551

0.82

3.41

1.8

2.2

7.63

7.58

g/l

0.16

220

2482

Ectropion of eyelid

549

1.54

3.39

1.5

2.4

7.79

7.51

g/l

0.57

373

Type 1 diabetes, strict definition, subgroup 1

380

1.64

3.38

1.4

1.5

7.35

6.94

g/l

1.04

308

Oesophageal obstruction

438

1.61

3.37

2.8

2.9

7.33

7.40

g/l

0.12

335

Benign neoplasm: Skin of eyelid, including canthus

279

2238

1.26

3.35

3.1

2.3

7.31

7.50

g/l

1.07

211

1663

Other ill-defined and unspecified causes of mortality

841

0.60

3.35

1.5

2.4

7.81

7.44

g/l

0.55

600

Secondary parkinsonism, excluding more controls

233

1.84

3.34

2.7

2.2

7.17

7.64

g/l

0.94

175

Atopic conjunctivitis

360

1.66

3.34

1.4

1.9

7.25

7.48

g/l

0.49

276

Benign neoplasm: Anus and anal canal

323

1.71

3.34

2.8

1.5

7.47

7.54

g/l

0.09

235

Left hemicolectomy

301

1.74

3.33

2.5

2.6

8.31

7.40

g/l

2.25

231

Nasal polyp

337

2759

1.23

3.33

2.8

2.3

7.23

7.34

g/l

0.62

258

2060

Other and unspecified mononeuropathies, also in other diseases

331

1.70

3.32

1.8

2.2

7.23

7.40

g/l

0.28

246

Muscle strain

248

1.80

3.31

2.3

2.2

7.30

7.33

g/l

0.04

184

Spontaneous rupture of synovium and tendon

137

999

1.39

3.30

1.8

2.2

7.61

7.44

g/l

0.43

744

2.48

3.30

1.8

1.9

7.06

7.40

g/l

0.23

Other, unspecified and serous retinal detachments

355

1.67

3.29

1.9

2.6

7.67

7.42

g/l

0.41

275

Herpesviral keratitis and keratoconjunctivitis

488

1.56

3.29

2.9

2.4

7.30

7.43

g/l

0.26

377

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

336

2755

1.23

3.28

2.3

1.4

7.69

7.50

g/l

1.00

239

1976

Scabies

370

1.64

3.27

2.0

1.9

7.07

7.21

g/l

0.31

292

Hyperfunction of pituitary gland

401

1.62

3.27

2.9

1.9

7.26

7.34

g/l

0.15

320

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

199

1535

1.30

3.25

1.9

2.1

7.35

7.43

g/l

0.29

158

1162

Focal epilepsy

338

2775

1.23

3.24

2.1

2.2

7.24

7.42

g/l

0.88

226

2054

Personal history of malignant neoplasm

427

1.60

3.23

4.2

1.9

7.69

7.59

g/l

0.14

334

Polyp of the female genital tract

514

2536

1.18

3.22

1.8

2.1

7.51

7.55

g/l

0.19

382

1892

Sensorineural hearing loss

1519

9682

1.10

3.22

2.4

2.3

7.34

7.45

g/l

1.35

975

7297

Atrophic disorders of skin

224

1760

1.28

3.20

2.0

2.1

7.46

7.51

g/l

0.17

177

1311

Hydrocele

211

1646

1.29

3.20

2.5

2.4

6.96

7.34

g/l

2.80

158

1220

Corneal ulcer

270

2169

1.25

3.19

2.2

7.61

7.35

g/l

1.48

207

1640

Redundant prepuce, phimosis and paraphimosis

294

2373

1.24

3.18

2.0

2.3

7.51

7.23

g/l

1.51

220

1795

Allergic contact dermatitis due to drugs in contact with skin

245

1.80

3.17

1.5

2.0

8.06

7.48

g/l

0.85

189

Use of rivastigmine

173

2249

0.76

3.17

1.9

2.3

7.34

7.59

g/l

1.00

123

1553

Corns and callosities

115

821

1.42

3.17

2.0

2.3

7.54

7.43

g/l

0.28

623

Central retinal artery occlusion

283

1.74

3.16

3.7

2.4

7.75

7.48

g/l

0.64

210

Autonomic disorders

223

1.84

3.16

2.1

2.3

6.79

7.36

g/l

1.06

173

Viral meningitis

297

1.71

3.16

1.9

2.0

7.11

7.38

g/l

0.50

235

Paralytic strabismus

124

898

1.40

3.15

2.0

2.4

7.63

7.39

g/l

0.63

687

Congenital malformations of the respiratory system

152

2.02

3.15

2.3

2.1

7.98

7.41

g/l

0.79

117

Disturbance of activity and attention

414

1.58

3.15

1.4

6.88

7.22

g/l

0.91

327

Pre-eclampsia or eclampsia

269

2163

1.25

3.14

2.3

2.1

7.41

7.30

g/l

0.46

196

1662

Malignant neoplasm of other connective and soft tissue

284

1.73

3.12

3.4

2.6

7.82

7.47

g/l

0.47

210

Benign neoplasm: Skin of ear and external auricular canal

511

1.54

3.12

2.5

7.40

7.41

g/l

0.03

386

Single delivery by forceps and vacuum extractor

666

0.65

3.12

1.3

1.6

6.76

7.17

g/l

1.86

549

Arterial embolism and thrombosis of lower extremity artery

455

1.57

3.11

1.5

2.6

7.83

7.40

g/l

1.00

340

Injury of muscle and tendon at lower leg level

245

1954

1.26

3.11

2.5

2.3

7.06

7.30

g/l

1.33

191

1485

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

119

2.17

3.11

2.7

2.3

7.50

7.40

g/l

0.08

Meralgia paraesthetica

345

1.65

3.11

1.5

2.3

7.50

7.34

g/l

0.21

259

Crohn's disease of large intestine

487

1.54

3.08

1.6

2.3

7.12

7.27

g/l

0.25

379

Aortic valve malfunction, age under 60 years

140

1037

1.36

3.08

1.8

2.3

6.98

7.28

g/l

1.14

112

809

Benign neoplasm: Lip

218

1.83

3.07

3.4

1.4

7.74

7.57

g/l

0.14

159

Abnormal blood-pressure reading, without diagnosis

448

1.56

3.07

2.3

2.4

7.40

7.48

g/l

0.11

336

Other diseases of spinal cord

308

1.69

3.06

3.4

2.7

7.75

7.29

g/l

0.77

241

Injury of intra-abdominal organs

218

1.82

3.05

3.0

2.3

8.13

7.30

g/l

1.23

166

Sequelae of injuries of neck and trunk

293

1.70

3.05

2.5

2.7

7.24

7.26

g/l

0.02

229

Complications of labour and delivery

732

4652

0.87

3.04

2.4

2.2

7.32

7.41

g/l

0.76

571

3515

Septal defects

517

1.51

3.04

1.7

2.3

6.82

7.33

g/l

1.70

402

Other mental disorders due to brain damage and dysfunction and to physical disease

211

1660

1.28

3.04

2.6

2.3

7.42

7.48

g/l

0.22

133

1231

Alzheimer’s disease (Early onset), excluding more controls

463

0.50

3.03

1.0

2.1

7.72

7.61

g/l

0.08

337

Assault by bodily force

553

1.50

3.03

1.6

2.1

7.28

7.21

g/l

0.13

437

Emotional disorders starting during childhood or adolescence

152

1.97

3.03

1.1

1.4

7.53

7.42

g/l

0.13

128

Other abnormal findings in urine

176

1.93

3.03

5.5

2.3

7.64

7.36

g/l

0.35

128

Left ventricular outflow tract obstruction (LVOTO), broad definition

146

1092

1.35

3.02

1.7

2.3

7.08

7.29

g/l

0.61

117

852

Hyperkinetic disorders

450

1.54

3.02

1.4

1.5

6.93

7.18

g/l

0.63

359

Other acute disseminated demyelination

2.47

3.01

1.4

2.6

7.33

7.56

g/l

0.15

Other disorders of the genitourinary system

231

1839

1.27

3.01

2.1

2.3

7.51

7.54

g/l

0.10

179

1367

Injury of other and unspecified intrathoracic organs

104

737

1.43

3.01

1.7

2.3

7.25

7.26

g/l

0.01

556

Flat foot [pes planus] (acquired)

136

1007

1.36

3.00

1.8

2.5

7.45

7.26

g/l

0.49

753

Ingrowing nail

507

1.52

2.99

1.7

2.4

7.31

7.26

g/l

0.09

389

Episcleritis

532

1.50

2.98

1.4

2.1

7.29

7.33

g/l

0.07

414

Other inflammation of vagina/vulva

257

1.73

2.96

1.2

2.1

7.30

7.57

g/l

0.43

211

Schizophrenia

139

1850

0.75

2.96

2.4

2.3

7.57

7.28

g/l

1.14

1426

Benign neoplasm: Appendix

122

2.13

2.95

1.4

1.3

7.04

7.55

g/l

1.08

Benign neoplasm: Tongue

289

1.69

2.93

4.0

1.3

7.18

7.41

g/l

0.32

216

Laparoscopic right hemicolectomy

107

768

1.42

2.92

2.1

2.7

7.52

7.43

g/l

0.20

574

Convergent concomitant strabismus

469

1.53

2.92

2.2

2.0

7.24

7.31

g/l

0.11

364

Atrial septal defect

302

1.67

2.91

2.0

7.02

7.42

g/l

0.88

240

Asthma mixed form (mode)

526

1.50

2.91

1.9

1.7

7.27

7.40

g/l

0.26

389

Contusion of toe(s) without damage to nail

178

1.89

2.90

1.2

2.4

6.90

7.24

g/l

0.67

150

Injury of nerves and spinal cord at neck level

245

1.75

2.89

2.7

2.9

6.93

7.32

g/l

0.73

193

Single spontaneous delivery

537

3315

0.86

2.89

2.5

2.0

7.52

7.58

g/l

0.34

409

2461

Haemorrhagic disorder due to circulating anticoagulants

144

2.01

2.88

1.9

2.1

7.89

7.50

g/l

0.40

109

Triptan medication for migraine, single purchase ok

1160

7098

1.11

2.87

2.1

2.2

7.05

7.34

g/l

6.40

908

5391

Migraine, single triptan purchase ok & required. ICD-code if available is included

1160

7098

1.11

2.87

2.1

2.2

7.05

7.34

g/l

6.40

908

5391

Haemangioma, any site

133

990

1.36

2.87

2.6

2.4

7.51

7.31

g/l

0.47

754

Burns and corrosions of external body surface, specified by site

150

1136

1.33

2.87

2.1

2.3

7.52

7.33

g/l

0.61

107

882

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

7.23

8.21

g/l

—

Haemangioma and lymphangioma, any site

140

1052

1.34

2.84

2.9

2.4

7.48

7.35

g/l

0.27

802

Benign neoplasm of breast

198

1560

1.28

2.83

2.2

7.27

7.58

g/l

1.76

144

1160

Benign neoplasm of other and unspecified intrathoracic organs

131

2.06

2.83

2.4

2.1

7.74

7.41

g/l

0.32

Other and unspecified diseases of spleen

3.02

2.82

4.1

2.9

6.05

7.85

g/l

—

Carcinoma in situ of rectum

2.30

2.81

1.5

1.2

7.07

7.61

g/l

0.89

Pre-eclampsia or poor fetal growth

331

2748

1.21

2.79

2.3

2.0

7.24

7.25

g/l

0.01

247

2136

Delivery

543

3319

0.86

2.79

2.5

2.0

7.55

7.58

g/l

0.17

413

2464

Malignant melanoma

270

2208

1.23

2.79

2.1

2.4

7.21

7.48

g/l

1.64

204

1630

Abnormality of red blood cells

2.64

2.78

2.1

1.2

6.58

7.58

g/l

—

Hand

2.72

2.77

1.5

1.4

7.55

7.76

g/l

—

Benign neoplasm: Other parts of oropharynx

2.31

2.76

3.1

1.2

6.71

7.51

g/l

1.15

Epiphora

264

1.71

2.76

2.6

2.3

7.01

7.51

g/l

1.22

194

Strabismus

383

3231

1.19

2.76

2.2

7.23

7.39

g/l

0.84

280

2414

Medical abortion

1009

4927

1.12

2.74

1.8

2.3

7.50

7.44

g/l

0.40

777

3612

Pigmented purpuric dermatosis

119

2.10

2.74

2.5

2.8

7.34

7.56

g/l

0.22

Blindness, monocular

2.25

2.73

4.8

2.0

7.23

7.56

g/l

—

Delivery, wide proxy

451

2804

0.85

2.71

2.3

2.0

7.59

7.64

g/l

0.25

336

2049

Myopia

143

1085

1.33

2.70

1.9

2.2

7.12

7.34

g/l

0.72

108

836

Prolonged pregnancy

884

0.67

2.70

1.5

1.7

7.00

7.11

g/l

0.22

710

Abdominal aortic aneurysm (AAA)

198

1560

1.27

2.67

1.9

2.3

7.61

7.32

g/l

1.39

143

1078

Benign neoplasm: Prostate

2.29

2.66

2.5

2.9

7.02

7.14

g/l

0.10

Trigeminal neuralgia

672

1.42

2.63

2.6

2.3

7.61

7.38

g/l

0.52

511

Focal epilepsy, mode (most common among epilepsy diagnosis)

291

2412

1.21

2.62

2.2

7.13

7.43

g/l

1.78

191

1778

Other arterial embolism and thrombosis

354

1.58

2.61

1.3

2.5

7.73

7.42

g/l

0.44

259

Benign neoplasm: Liver/bile ducts

207

1.77

2.61

2.5

1.3

6.91

7.42

g/l

1.27

159

Behavioural disorders, excluding more controls

2.27

2.61

1.3

2.5

7.84

7.11

g/l

0.66

Other and unspecified mononeuropathies of lower limb

299

1.63

2.61

1.7

2.1

7.36

7.35

g/l

0.00

218

Other meningitis

149

1.92

2.60

2.1

7.49

7.42

g/l

0.07

116

Senility

2.34

2.59

1.6

1.5

6.63

8.08

g/l

1.02

Lateral epicondylitis

184

1454

1.27

2.58

1.8

2.2

7.48

7.33

g/l

0.39

125

1112

Unspecified threat to breathing

2.29

2.58

2.3

2.0

6.50

7.36

g/l

1.29

Moderate visual impairment, binocular

347

1.58

2.58

1.7

1.9

7.88

7.62

g/l

0.43

250

Granulomatous disorders of skin and subcutaneous tissue

246

1.70

2.57

3.0

1.9

7.13

7.55

g/l

0.83

198

Hypertrophy of tongue papillae

129

2.00

2.56

1.7

2.0

7.70

7.49

g/l

0.16

101

Chronic hepatitis NAS

136

1.96

2.56

1.4

2.1

8.59

7.33

g/l

1.44

110

Use of galantamine

1067

0.69

2.53

1.2

2.3

7.51

7.57

g/l

0.12

744

Anorexia (incl.atypical)

428

1.51

2.52

3.1

1.7

7.25

7.41

g/l

0.28

338

Other puerperal infections

428

1.51

2.52

1.2

1.6

7.01

7.29

g/l

0.65

343

Crohn disease (strict definition, require KELA)

552

1.44

2.51

1.7

2.1

7.02

7.31

g/l

0.70

432

Hyperprolactinaemia

255

1.67

2.51

3.3

1.7

7.18

7.48

g/l

0.56

203

Contact with heat and hot substances

495

1.47

2.50

1.8

2.3

7.56

7.36

g/l

0.38

385

319

1.60

2.50

2.1

2.7

8.33

7.43

g/l

2.57

224

Pre-eclampsia

238

1944

1.23

2.49

2.5

2.1

7.43

7.30

g/l

0.55

170

1498

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

124

936

1.34

2.49

2.8

1.4

7.38

7.44

g/l

0.13

688

Peroneal tendinitis

123

1.99

2.49

2.2

1.9

6.67

7.19

g/l

0.99

102

Intentional self-harm by unspecified means

2.43

2.49

1.2

1.7

7.66

7.30

g/l

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

479

4026

1.16

2.47

2.2

1.4

7.54

7.49

g/l

0.24

344

2931

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

582

0.59

2.46

2.1

1.4

8.49

7.42

g/l

2.25

421

Appendectomy

1017

8897

1.10

2.46

2.2

7.33

7.32

g/l

0.07

787

6707

Chronic Coagulation defects

219

1.72

2.45

2.8

1.7

6.91

7.47

g/l

1.42

172

Congenital malformations of heart and great arteries

162

1229

1.28

2.45

2.0

2.3

6.85

7.37

g/l

2.63

121

957

Maternal care for known or suspected fetal abnormality and damage

132

893

1.32

2.44

1.7

6.78

7.10

g/l

1.60

118

715

Scar conditions and fibrosis of skin

376

1.54

2.43

2.0

7.62

7.40

g/l

0.37

290

Melanocytic naevi of upper limb, including shoulder

212

1.73

2.43

2.0

1.3

6.90

7.47

g/l

1.04

163

Contusion of ankle

320

1.58

2.43

1.6

2.1

7.75

7.26

g/l

0.77

251

Varicella [chickenpox]

352

1.55

2.42

5.4

1.9

7.17

g/l

0.00

274

Campylobacter enteritis

266

1.64

2.42

2.0

2.4

7.49

7.35

g/l

0.23

204

Manic episode

258

1.65

2.41

1.9

2.2

7.29

7.35

g/l

0.07

200

Benign neoplasm of bone and articular cartilage

106

785

1.36

2.41

1.5

1.3

7.05

7.35

g/l

1.10

590

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

110

1459

0.75

2.40

2.8

2.3

7.40

g/l

0.01

1079

Myocardial infarction, with ST-elevation

336

2851

1.19

2.39

1.7

2.2

7.79

7.39

g/l

3.57

249

2059

Benign neoplasm of meninges

176

1401

1.27

2.39

1.9

2.4

7.38

7.51

g/l

0.34

127

1032

Optic neuritis

378

1.53

2.38

1.5

2.2

7.61

7.36

g/l

0.39

296

Otitis media, unspecified

114

786

1.34

2.37

2.8

2.1

7.17

7.36

g/l

0.63

609

Crohn disease (strict definition, require KELA, min 2 HDR)

542

1.43

2.37

1.8

2.1

7.02

7.30

g/l

0.63

426

Pedestrian injured in transport accident

104

771

1.36

2.37

1.5

2.3

7.45

7.38

g/l

0.12

589

Alzheimer’s disease (Late onset)

325

3281

0.84

2.37

1.8

2.2

7.63

7.59

g/l

0.15

201

2287

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

436

1.49

2.36

2.8

1.4

7.12

7.45

g/l

0.63

332

Inflammatory disorders of male genital organs, not elsewhere classified

133

1.93

2.35

1.1

3.0

7.28

7.01

g/l

0.33

Other specified/unspecified dorsopathies

363

1.54

2.35

4.1

2.1

7.06

7.27

g/l

0.40

282

Burn and corrosion of wrist and hand

307

1.58

2.35

1.6

2.1

7.53

7.24

g/l

0.49

237

Cerebral amyloid angiopathy

2.72

2.35

5.4

2.1

6.87

7.75

g/l

—

Other factor of the environment

119

1.98

2.35

3.8

1.4

7.39

7.45

g/l

0.05

Later onset COPD

603

4194

1.14

2.33

1.6

2.3

7.95

7.41

g/l

8.78

457

2966

Open wound of wrist and hand

650

5731

1.13

2.31

2.3

2.2

7.40

7.29

g/l

0.80

502

4327

Polypectomy (DHB20)

112

844

1.34

2.31

2.6

2.4

7.32

7.37

g/l

0.09

659

Postpartum haemorrhage

156

1718

0.79

2.30

1.9

2.0

6.91

7.17

g/l

1.45

116

1363

Melanoma in situ of trunk

149

1.87

2.30

2.8

1.3

6.84

7.61

g/l

1.38

107

Suppurative and unspecified otitis media

423

3243

1.16

2.30

2.5

2.0

7.30

7.27

g/l

0.14

326

2481

Medial epicondylitis

357

1.53

2.30

1.4

2.0

7.54

7.39

g/l

0.19

266

Benign neoplasm: Connective and other soft tissue, unspecified

106

2.03

2.29

1.4

1.5

7.01

7.64

g/l

0.90

Amputation of ankle bones

255

1.64

2.29

2.0

2.7

8.21

7.34

g/l

1.93

189

Glaucoma

1105

8882

1.10

2.28

2.2

2.3

7.44

7.46

g/l

0.10

748

6524

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

708

1.37

2.28

3.0

1.4

7.22

7.35

g/l

0.30

529

Conduct disorder

2.04

2.27

1.3

2.0

7.63

7.20

g/l

0.39

Dental caries 2, only avohilmo

1137

8215

1.09

2.26

2.5

2.2

7.26

7.31

g/l

0.36

891

6229

Sudden idiopathic hearing loss

173

1384

1.26

2.26

2.1

2.2

7.28

7.44

g/l

0.56

123

1066

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

319

1.56

2.26

3.1

1.4

7.61

7.49

g/l

0.17

227

Benign neoplasm: other/unspecified salivary gland

319

1.56

2.26

1.6

1.4

7.42

7.55

g/l

0.19

240

Acute lymphadenitis

531

1.43

2.26

2.5

2.3

7.42

7.31

g/l

0.16

407

Impotence

659

1.38

2.25

1.9

2.3

7.33

7.31

g/l

0.03

490

All dysplastic lesions of the cervix uteri

251

2081

1.21

2.25

2.3

2.0

7.22

7.21

g/l

0.03

199

1612

Contracture of joint

114

1.97

2.24

1.3

1.7

7.81

6.99

g/l

0.59

Effects of other external causes

202

1.70

2.23

1.6

2.3

7.19

7.22

g/l

0.03

155

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

600

1.39

2.22

1.7

2.1

7.08

7.29

g/l

0.42

470

Melanocytic naevi of scalp and neck

195

1.72

2.22

2.5

1.4

6.50

7.41

g/l

3.32

151

Adenocarcinoma and papilloma adenocarcinoma of rectum

106

1395

0.75

2.22

2.8

2.3

7.44

7.41

g/l

0.06

1035

Contact with and exposure to communicable diseases

313

2645

1.18

2.21

2.2

2.0

6.98

7.16

g/l

0.88

154

2105

Benign neoplasm: Anus and anal canal

361

1.52

2.21

2.8

2.5

7.47

7.42

g/l

0.06

266

Malignant neoplasm of rectum

107

1406

0.75

2.21

2.5

2.4

7.22

7.42

g/l

0.57

1036

Burns and corrosions of multiple and unspecified body regions

203

1.70

2.21

1.9

2.2

8.00

7.29

g/l

1.10

159

Other specified disorders of external ear

460

1.46

2.20

1.9

2.6

7.24

7.29

g/l

0.06

353

Undefined dementia

138

1613

0.78

2.18

1.7

2.1

7.86

7.57

g/l

0.66

1102

Hordeolum and other deep inflammation of eyelid

552

1.41

2.18

2.7

2.6

7.19

7.31

g/l

0.21

433

Thyroiditis, unspecified

167

1.78

2.15

1.3

1.6

7.26

7.47

g/l

0.19

135

Other proliferative retinopathy

2.82

2.15

1.2

2.6

8.32

7.45

g/l

—

Orthopaedic devices associated with adverse incidents

221

1.67

2.15

1.1

2.4

7.57

7.53

g/l

0.04

160

Dental pulpitis 3

281

1.49

2.15

1.1

1.2

7.23

7.10

g/l

0.21

236

Desensitization to allergens

330

1.53

2.14

1.5

1.7

7.24

7.32

g/l

0.11

266

Ulcer of vagina/vulva

228

1.65

2.14

2.2

7.56

g/l

0.01

181

Sequelae of injuries of head

529

1.41

2.14

2.8

2.4

7.64

7.21

g/l

0.97

408

Benign neoplasm of male genital organs

229

1.65

2.12

2.0

1.4

6.81

7.29

g/l

0.85

173

Melanocytic naevi of upper limb, including shoulder

221

1.66

2.12

2.0

2.5

6.90

7.26

g/l

0.56

173

Pedestrian injured in collision with pedal cycle

340

1.52

2.12

1.7

2.4

7.43

7.37

g/l

0.06

255

Graves ophthalmopathy, strict

229

1.65

2.12

1.2

1.8

7.54

7.58

g/l

0.05

183

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

121

934

1.31

2.10

2.5

2.4

7.33

7.48

g/l

0.37

685

Retinal haemorrhage

301

1.56

2.10

4.6

2.7

7.36

7.48

g/l

0.19

227

Benign lipomatous neoplasm of other sites/unspecified

142

1121

1.28

2.10

3.0

1.4

7.48

7.51

g/l

0.05

808

Benign neoplasm: Ill-defined sites within the digestive system

2.27

2.10

1.1

7.56

7.74

g/l

—

Other lesions of median nerve

325

1.53

2.10

1.2

2.2

7.76

7.45

g/l

0.39

233

Prepatellar bursitis

481

1.43

2.09

1.8

2.1

7.15

7.29

g/l

0.23

356

conjunctival haemorrhage

129

1008

1.29

2.09

2.7

2.4

7.16

7.43

g/l

0.91

759

Use of disulfiram, acamprosate or naltrexone

119

919

1.30

2.08

1.6

2.3

7.48

7.18

g/l

1.08

719

Oral lichen ruber planus, including avohilmo

738

1.34

2.07

2.4

2.5

7.40

7.45

g/l

0.09

552

Disorders of eyelid in diseases classified elsewhere

350

1.51

2.07

1.1

2.4

7.34

7.46

g/l

0.15

271

HSIL lesion of the cervix uteri, vagina or vulva

200

1641

1.22

2.07

2.1

2.0

7.34

7.26

g/l

0.25

156

1261

Hyperosmolality and hypernatraemia

147

1.81

2.07

1.9

2.1

8.62

7.46

g/l

1.33

110

Benign neoplasm: Appendix

140

1.84

2.07

1.4

1.9

7.04

7.39

g/l

0.66

103

Recurrent dislocation of patella

269

1.57

2.06

1.5

1.8

7.46

7.05

g/l

0.96

202

Asymptomatic human immunodeficiency virus [HIV] infection status

2.71

2.04

1.1

2.2

7.28

6.99

g/l

—

Other facial nerve disorders

279

1.56

2.03

2.3

2.2

7.21

7.31

g/l

0.14

209

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

118

1.89

2.03

2.8

1.9

6.60

7.39

g/l

2.03

Complications peculiar to reattachment and amputation

2.22

2.03

1.6

2.6

8.10

7.41

g/l

—

Other disorders of choroid

163

1.76

2.03

1.7

3.2

7.76

7.70

g/l

0.04

121

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

560

1.39

2.03

3.1

1.4

7.99

7.58

g/l

0.94

399

Malignant neoplasm of digestive organs

607

6660

0.89

2.02

2.0

2.3

7.63

7.44

g/l

1.75

438

4825

Diseases of appendix

1228

10351

1.08

2.02

2.4

2.2

7.25

7.33

g/l

0.74

947

7799

Varicose veins of other sites

741

1.33

2.01

2.5

6.84

7.27

g/l

1.27

567

Behavioural disorders

2.02

2.01

1.3

2.1

7.84

7.16

g/l

0.62

Rheumatic valve diseases

280

1.56

2.01

1.5

1.9

7.26

7.58

g/l

0.51

198

Acute alcohol intoxication, ICD10

285

2425

1.18

2.01

1.3

2.3

7.42

7.29

g/l

0.59

220

1842

Vascular dementia (subcortical)

411

1.46

2.01

2.2

7.94

7.62

g/l

0.43

295

Paralytic ileus

452

1.44

2.01

3.5

2.4

7.70

7.33

g/l

0.68

343

Benign neoplasm: Skin of lip

141

1.82

2.01

2.0

1.3

7.83

7.55

g/l

0.28

100

Melanocytic naevi of lip

2.14

2.00

1.3

1.2

6.93

7.50

g/l

—

Pathological resorption of teeth

272

1.56

2.00

1.1

1.9

6.97

7.16

g/l

0.24

213

Mental and behavioural disorders due to tobacco

124

970

1.29

1.99

1.7

2.5

7.74

7.25

g/l

2.28

753

Crohn disease (strict definition, all UC cases excluded)

444

1.43

1.99

1.6

2.2

7.04

7.30

g/l

0.51

347

Conductive hearing loss, unspecified

127

997

1.28

1.98

2.0

2.3

7.48

7.38

g/l

0.21

776

Other acquired deformities of musculoskeletal system and connective tissue

529

1.40

1.98

2.4

2.3

7.70

7.30

g/l

0.84

403

Acute appendicitis

1126

9805

1.09

1.98

2.4

2.2

7.24

7.32

g/l

0.72

874

7404

Disorder of the sleep-wake schedule

134

1.82

1.98

1.1

1.9

7.99

7.33

g/l

0.65

108

Endometriosis of pelvic peritoneum

189

1530

1.22

1.98

1.4

2.1

7.12

7.37

g/l

1.04

135

1167

Benign neoplasm of eye and adnexa

166

1346

1.24

1.97

1.7

2.4

7.27

7.41

g/l

0.44

124

1011

Juvenile osteochondrosis

233

1.60

1.97

1.3

2.1

7.89

7.26

g/l

0.93

188

Malignant neoplasm of ovary

607

0.65

1.97

2.2

7.19

7.62

g/l

0.87

457

Oral lichen ruber planus

290

1.55

1.97

2.5

2.3

7.46

7.57

g/l

0.17

224

Right hemicolectomy

107

824

1.31

1.96

3.0

2.5

7.54

7.46

g/l

0.15

618

Other drug-induced secondary parkinsonism

106

1.95

1.96

1.9

2.1

7.15

7.63

g/l

—

Other and unspecified injuries of wrist and hand

330

1.50

1.95

1.1

1.9

7.05

7.26

g/l

0.35

262

Meningitis

513

1.40

1.95

2.9

2.4

7.14

7.32

g/l

0.38

398

Volvulus

282

1.55

1.95

1.7

2.2

7.33

7.28

g/l

0.06

218

Vascular dementia (mixed)

188

1.69

1.95

2.5

2.1

7.66

7.64

g/l

0.02

133

Schizophrenia or delusion, excluding more controls

395

3426

1.15

1.94

1.9

2.2

7.48

7.33

g/l

0.91

274

2614

Unspecified dementia

138

1556

0.79

1.94

1.7

2.2

7.86

7.53

g/l

0.76

1096

Lung diseases due to external agents

242

2040

1.19

1.93

2.6

2.2

7.54

7.37

g/l

0.70

157

1475

Iliotibial band syndrome

2.00

1.93

2.4

1.7

6.44

7.15

g/l

1.19

Contusion of other and unspecified parts of foot

372

1.46

1.92

2.3

2.2

7.17

7.28

g/l

0.21

290

Other and unspecified acute skin changes due to ultraviolet radiation

316

1.51

1.92

1.9

2.4

7.14

7.49

g/l

0.98

235

Respiratory tuberculosis, confirmed

220

1.62

1.91

1.7

2.5

7.68

7.47

g/l

0.26

161

Parkinson's disease, including avohilmo

295

2532

1.17

1.91

1.9

2.3

7.24

7.47

g/l

1.32

205

1837

Dislocation of lens

166

1.72

1.91

2.8

2.7

7.41

7.59

g/l

0.29

130

Other disorders of conjunctiva

242

2043

1.19

1.91

2.8

2.3

7.23

7.52

g/l

1.47

171

1489

Open wound of shoulder and upper arm

181

1.69

1.91

1.6

2.1

7.67

7.22

g/l

0.60

135

Hereditary ataxia

136

1.81

1.91

1.3

2.4

7.47

7.45

g/l

0.02

108

Lifestyle-related condition

114

1.89

1.91

4.1

1.4

7.37

7.35

g/l

0.01

Other strabismus

279

2375

1.18

1.90

2.2

7.09

7.36

g/l

1.88

214

1811

Malignant neoplasm of breast, HER-negative

261

3059

0.85

1.90

1.9

2.3

7.58

7.60

g/l

0.04

193

2222

Osteomyelitis of vertebra

2.64

1.89

5.8

1.2

8.46

7.28

g/l

—

Other acute skin changes due to ultraviolet radiation

416

1.44

1.89

1.7

2.2

7.21

7.43

g/l

0.52

317

Other and unspecified injuries of ankle and foot

333

1.49

1.88

1.3

2.1

7.36

7.27

g/l

0.12

264

Ménière disease

164

1337

1.24

1.87

1.7

2.5

7.42

7.45

g/l

0.06

118

1000

Carcinoma in situ of rectum

108

1.92

1.87

1.5

1.7

7.07

7.51

g/l

0.71

Surgical ablation of atrial fibrillation

2.22

1.87

1.1

1.4

6.99

7.68

g/l

—

HSIL lesion of the cervix uteri

172

1408

1.23

1.86

1.9

2.0

7.26

7.21

g/l

0.14

136

1092

Injury of blood vessels at shoulder and upper arm level

3.29

1.86

1.4

1.5

8.51

8.21

g/l

—

Acute appendicitis, no complications

831

7579

1.10

1.85

2.5

2.2

7.17

7.29

g/l

1.02

642

5786

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

575

0.65

1.85

1.9

2.1

7.29

7.57

g/l

0.51

444

Flatulence and related conditions

108

1.90

1.85

1.5

2.3

7.09

7.40

g/l

0.24

Burn and corrosion of head and neck

175

1.68

1.85

4.7

2.5

7.50

7.22

g/l

0.30

131

Pedal cyclist injured in noncollision transport accidents

150

1212

1.25

1.85

1.7

2.3

6.82

7.36

g/l

2.91

106

938

Other sexually transmitted chlamydial diseases

301

1.50

1.85

1.4

1.3

7.05

7.12

g/l

0.10

236

Smoking dependency

124

981

1.27

1.84

1.7

2.5

7.74

7.27

g/l

2.11

760

Infectious mononucleosis

484

1.39

1.84

2.1

1.5

6.91

7.26

g/l

0.80

390

Benign neoplasm: Liver

183

1.66

1.84

2.7

1.3

6.73

7.43

g/l

1.79

139

Preparation and fitting of bite rail to mouth

175

1438

1.22

1.84

2.7

2.4

7.32

7.31

g/l

0.01

135

1110

Chronic inflammatory disorders of orbit

3.20

1.84

2.0

1.2

7.14

7.48

g/l

—

Lagophthalmos

138

1.78

1.83

2.2

2.0

7.89

7.40

g/l

0.56

105

Pregnancy, childbirth and the puerperium

406

2419

0.87

1.83

1.8

2.1

7.72

7.62

g/l

0.47

307

1732

Nonspecific lymphadenitis

588

1.35

1.83

1.7

2.1

7.45

7.31

g/l

0.24

455

Other diseases of gallbladder

572

1.36

1.82

2.5

7.11

7.45

g/l

1.04

435

Embedded teeth, including avohilmo

579

1.35

1.82

2.8

1.8

7.25

7.37

g/l

0.20

462

Benign neoplasm: Choroid

711

1.32

1.81

1.6

1.4

6.99

7.48

g/l

1.88

518

Other diseases of appendix

131

1.80

1.81

1.9

2.0

7.78

7.56

g/l

0.21

101

Liposarcoma, excluding all cancers (controls excluding all cancers)

109

1.89

1.81

2.3

1.3

8.02

7.57

g/l

0.27

Use of glatiramer acetate

116

1.84

1.80

1.6

1.8

6.61

7.34

g/l

1.06

Benign neoplasm of middle ear and respiratory system

131

1047

1.26

1.80

2.5

2.4

7.23

7.38

g/l

0.35

102

798

Acquired absence of limb

102

1.92

1.80

1.7

2.0

8.71

7.51

g/l

1.23

Pyoderma

200

1.63

1.80

2.0

2.3

7.56

7.41

g/l

0.14

151

Benign neoplasm: Ill-defined sites within the digestive system

2.11

1.80

1.1

2.2

7.56

7.73

g/l

—

Injuries involving multiple body regions

345

1.47

1.80

2.4

7.48

7.33

g/l

0.22

265

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

109

852

1.29

1.79

2.8

1.4

7.39

g/l

0.01

626

Congenital malformations of genital organs

689

1.32

1.79

1.6

1.9

7.14

7.37

g/l

0.60

545

Benign neoplasm: Liver/bile ducts

232

1.58

1.78

2.5

2.0

6.91

7.48

g/l

1.53

177

Benign neoplasm: Tongue

330

1.48

1.78

4.0

2.4

7.18

7.37

g/l

0.25

250

Embolic stroke with flimmer

322

1.48

1.76

2.4

1.8

7.43

7.70

g/l

0.44

224

Dystonia

636

1.33

1.76

1.2

2.4

6.85

7.39

g/l

3.23

491

Perforation of tympanic membrane

149

1212

1.24

1.75

2.2

2.3

7.06

7.43

g/l

2.10

104

912

Foreign body in ear

155

1.70

1.75

1.8

2.5

7.63

7.25

g/l

0.50

122

Benign neoplasm: Lip

258

1.54

1.74

3.4

2.3

7.74

7.39

g/l

0.34

197

Appendicitis, broad definition

1208

10283

1.08

1.73

2.4

2.2

7.25

7.33

g/l

0.82

932

7751

Benign neoplasm: Larynx

340

1.46

1.73

2.7

1.4

6.89

7.37

g/l

1.29

257

Benign neoplasm: Skin of scalp and neck

242

1.55

1.73

3.3

1.4

7.47

7.54

g/l

0.08

185

Other diseases of peritoneum

543

1.36

1.73

1.6

2.4

7.89

7.46

g/l

0.82

410

Disorders of tooth development and eruption

266

1.51

1.73

2.7

1.7

6.93

7.20

g/l

0.46

212

Other bursitis of knee

118

1.81

1.73

2.0

2.4

7.81

7.34

g/l

0.32

Other predominantly sexually transmitted diseases, not elsewhere classified

172

1421

1.21

1.72

1.9

2.0

7.02

7.25

g/l

1.06

134

1099

Benign neoplasm: Skin of other and unspecified parts of face

184

1533

1.21

1.72

3.5

2.3

7.39

7.42

g/l

0.06

106

1144

Alcohol withdrawal state with delirium

109

858

1.28

1.72

1.3

2.3

7.12

7.23

g/l

0.23

665

Tonsillectomy and adenotomy

544

4215

0.90

1.72

1.8

2.0

7.17

7.16

g/l

0.05

412

3295

Disorders of lacrimal system and orbit in diseases classified elsewhere

259

1.53

1.71

1.2

1.9

7.46

7.48

g/l

0.03

205

Ulcerative rectosigmoiditis

109

858

1.28

1.71

2.0

2.3

7.07

7.30

g/l

0.62

666

Dislocation, sprain and strain of joints and ligaments of thorax

308

1.48

1.70

1.2

2.3

7.10

7.31

g/l

0.32

235

Other degenerative diseases of the basal ganglia

196

1.62

1.70

2.2

2.8

7.05

7.46

g/l

0.55

141

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

207

1745

1.19

1.70

2.5

2.3

7.38

g/l

0.01

147

1333

Malignant neoplasm of small intestine

260

1.53

1.69

2.6

7.47

g/l

0.01

197

Sexual dysfunction

119

1.79

1.68

2.7

2.2

7.69

7.21

g/l

0.49

Nonsuppurative otitis media

245

1807

1.17

1.68

1.9

2.0

7.44

7.32

g/l

0.41

182

1367

Other and unspecified abdominal hernia

503

1.37

1.68

1.3

2.1

7.52

7.49

g/l

0.04

383

Adult respiratory distress syndrome

142

1.73

1.68

4.2

2.1

7.46

7.47

g/l

0.01

106

Vascular dementia

159

1265

1.22

1.68

2.3

2.1

7.89

7.58

g/l

0.84

881

Melanocytic naevi of scalp and neck

212

1.58

1.67

2.5

6.50

7.31

g/l

2.74

164

Graves ophthalmopathy

261

1.52

1.66

1.2

1.9

7.46

7.49

g/l

0.04

210

Benign leiomyoma with endometriosis

234

1998

1.18

1.65

2.1

1.5

7.53

7.60

g/l

0.21

166

1436

Benign neoplasm: other/unspecified salivary gland

344

1.45

1.65

1.6

2.5

7.42

7.56

g/l

0.20

259

Maze procedure for atrial fibrillation

2.16

1.65

1.3

1.7

7.08

7.64

g/l

0.22

Other and unspecified disease of Bartholin gland

344

1.45

1.65

1.3

2.4

7.62

7.51

g/l

0.18

272

Pneumonitis due to solids and liquids

132

1069

1.24

1.64

1.7

2.2

7.46

7.38

g/l

0.16

784

Anankastic personality disorder

302

1.47

1.64

2.1

2.4

6.94

7.20

g/l

0.54

251

Disorders of iron metabolism

143

1.71

1.64

1.3

2.0

7.31

g/l

0.00

115

Benign neoplasm of male genital organs

246

1.53

1.63

2.0

2.7

6.81

7.11

g/l

0.45

181

malignant neoplasm of female genital organs

185

2198

0.84

1.62

1.7

2.2

7.68

7.66

g/l

0.06

136

1602

Diseases of middle ear and mastoid

799

6011

1.09

1.62

2.4

2.1

7.27

7.29

g/l

0.11

597

4539

Congenital deformities of feet

182

1.61

1.62

1.5

1.8

7.84

7.39

g/l

0.47

148

Other vitreous opacities

464

1.37

1.61

3.2

2.8

6.98

7.38

g/l

1.17

342

Other peripheral vertigo

151

1244

1.22

1.61

1.8

2.5

7.28

7.41

g/l

0.39

104

943

Certain zoonotic bacterial diseases

191

1.60

2.5

2.3

7.32

7.41

g/l

0.07

146

Biliary cirrhosis, NAS

2.42

1.59

1.2

1.3

8.60

8.04

g/l

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

1.89

1.59

6.4

1.3

7.62

7.71

g/l

0.06

Other renal tubulo-interstitial diseases

207

1.57

1.58

1.9

6.98

7.30

g/l

0.54

162

Tooth eruption problems

101

787

1.27

1.58

2.4

1.7

7.37

7.28

g/l

0.16

626

Carcinoma in situ of oral cavity, oesophagus and stomach

2.11

1.58

1.0

1.3

8.01

7.59

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

673

1.30

1.58

2.2

2.3

7.29

7.25

g/l

0.09

517

Erythema intertrigo

248

1.52

1.58

2.1

3.0

7.69

7.36

g/l

0.46

185

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

322

1.45

1.57

1.6

2.3

6.60

7.35

g/l

2.26

255

Dacryoadenitis

1.98

1.57

1.7

1.2

6.46

7.62

g/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

232

1.53

1.57

1.7

2.5

7.68

7.41

g/l

0.36

171

Endometriosis of ovary

225

1919

1.17

1.57

1.7

2.1

7.19

7.50

g/l

1.91

162

1451

Dysplasia of cervi uteri

276

1850

1.16

1.56

2.2

2.0

7.27

7.37

g/l

0.43

213

1402

Benign neoplasm of brain and other parts of central nervous system

719

1.29

1.56

2.1

1.4

7.11

7.43

g/l

0.94

534

Abnormal findings in secretions and smears from cervix uteri vagina vulva

588

4195

1.10

1.54

2.2

2.1

7.29

7.33

g/l

0.22

458

3191

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

2.71

1.54

1.9

1.4

7.70

7.86

g/l

—

Acute nasopharyngitis (common cold)

151

1241

1.22

1.54

1.8

2.0

7.01

7.24

g/l

0.79

115

964

Aphakia

161

1.64

1.54

2.1

2.4

8.04

7.29

g/l

0.73

130

Other female pelvic inflammatory diseases

231

1984

1.17

1.54

1.7

2.3

7.56

7.50

g/l

0.14

149

1484

Amblyopia ex anopsia

340

1.42

1.54

1.3

2.1

7.67

7.40

g/l

0.25

258

Leiomyoma of uterus

998

5266

1.08

1.54

2.2

7.61

7.44

g/l

1.81

724

3920

Benign neoplasm: Cerebral meninges

153

1270

1.21

1.53

2.0

2.4

7.30

7.54

g/l

0.76

113

943

Melanoma in situ of trunk

170

1.63

1.53

2.8

2.9

6.84

7.39

g/l

0.88

129

Tuberculosis, IBD comorbidity

128

1044

1.24

1.52

2.3

2.2

7.77

7.43

g/l

1.12

763

Maternal care for other known or suspected fetal problems

129

1015

0.81

1.51

1.5

1.8

7.03

7.07

g/l

0.08

821

Pilonidal cyst

695

1.29

1.51

1.9

2.1

7.43

7.20

g/l

0.59

551

Malignant neoplasm, without specification of site

393

1.39

1.51

3.0

2.4

7.97

7.52

g/l

0.77

280

Any dementia

660

5077

0.91

1.50

2.0

2.2

7.63

7.53

g/l

0.59

404

3635

Graves disease, strict definition

124

1009

1.24

1.50

2.5

2.2

7.37

7.44

g/l

0.16

771

Bitten or struck by other mammals

128

1045

1.23

1.49

2.5

2.4

7.24

7.29

g/l

0.13

108

796

Outcome of delivery

141

715

1.23

1.49

1.7

1.8

6.71

7.23

g/l

3.36

113

595

Cerebral aneurysm, nonruptured

132

1083

1.23

1.48

1.8

2.4

7.30

7.40

g/l

0.24

105

821

Use of levodopa decarboxylase inhibitor

244

2114

1.16

1.48

2.0

2.3

7.05

7.48

g/l

3.47

172

1530

Colorectal adenocarcinoma

282

3214

0.87

1.47

2.3

7.63

7.43

g/l

1.03

198

2326

Nephropathy induced by other drugs, medicaments and biological substances

3.31

1.47

1.8

1.3

7.72

7.83

g/l

—

Benign neoplasm: Other parts of oropharynx

110

1.77

1.46

3.1

1.8

6.71

7.55

g/l

1.24

Benign lipomatous neoplasm

485

4387

1.11

1.46

2.5

2.3

7.38

7.39

g/l

0.05

333

3271

Other disorders of bone density and structure

228

1.51

1.45

1.6

2.2

6.67

7.46

g/l

1.30

178

Dental caries 1 and operation codes, only avohilmo

472

2132

1.12

1.45

2.6

2.8

7.38

7.36

g/l

0.10

369

1462

Other and unspecified injuries of thorax

164

1.61

1.45

1.7

2.2

7.81

7.26

g/l

0.64

121

Hypersomnia

133

1.68

1.45

1.3

2.2

7.89

7.33

g/l

0.70

104

Melanocytic naevi of lip

1.86

1.44

1.3

2.0

6.93

7.58

g/l

—

Hypertrophic disorders of skin

508

1.33

1.43

2.6

2.2

7.16

7.41

g/l

0.44

400

Other disorders of breast

170

1434

1.19

1.43

2.1

2.2

7.06

7.51

g/l

2.35

125

1080

Other noninflammatory disorders of vagina

105

844

1.25

1.43

2.7

2.0

7.52

7.59

g/l

0.12

633

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

483

1.34

1.43

2.8

2.5

7.12

7.38

g/l

0.45

367

Vertigo of central origin

189

1.56

1.43

1.6

2.5

7.36

7.51

g/l

0.22

138

Combined immunodeficiencies

126

1.70

1.43

3.1

1.9

7.57

7.47

g/l

0.07

Benign neoplasm: Connective and other soft tissue, unspecified

126

1.70

1.43

1.4

1.9

7.01

7.53

g/l

0.69

Alzheimer’s disease (Atypical or mixed), excluding more controls

912

0.78

1.42

2.1

2.2

7.44

7.75

g/l

0.55

640

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

157

1316

1.20

1.42

3.0

1.4

7.27

7.40

g/l

0.35

114

963

Procedures for purposes other than remedying health state

246

1.48

1.42

2.3

1.5

6.87

7.39

g/l

1.25

198

Unspecified mental disorder

583

5326

1.10

1.42

1.9

2.2

7.28

7.31

g/l

0.13

412

4035

Malignant neoplasm of mesothelium and soft tissue

554

1.31

1.41

2.8

8.08

7.42

g/l

1.46

416

Contraceptive management

422

3301

0.90

1.41

2.2

2.1

7.09

7.24

g/l

0.94

316

2593

L01XE Protein kinase inhibitors

776

1.26

1.40

3.0

2.6

8.01

7.40

g/l

1.45

595

Hypertrophic scar

458

1.34

1.40

2.7

2.0

7.17

7.42

g/l

0.41

362

Dislocation, sprain and strain of joints and ligaments of knee

870

7508

1.08

1.40

1.9

2.3

7.27

7.28

g/l

0.08

651

5742

Other disorders of prostate

442

1.35

1.39

2.7

2.5

7.32

7.29

g/l

0.04

328

Respiratory conditions due to other external agents

256

1.47

1.39

6.5

1.9

7.38

7.44

g/l

0.06

193

Contact with other hot metals

127

1.68

1.38

1.0

2.0

7.38

7.32

g/l

0.05

Tuberculosis, wide

132

1093

1.22

1.38

2.2

2.4

7.74

7.45

g/l

0.91

798

TMD related pain

289

1.43

1.38

1.8

2.2

7.37

7.52

g/l

0.21

237

Hereditary corneal dystrophies

409

1.36

1.37

1.4

2.7

7.60

7.48

g/l

0.15

312

Brain meningioma, excluding all cancers (controls excluding all cancers)

627

1.29

1.37

2.2

1.4

7.23

7.46

g/l

0.49

450

Degeneration of nervous system due to alcohol

265

1.46

1.37

1.3

2.8

7.13

7.17

g/l

0.05

199

Examination and encounter for administrative purposes

400

1.36

2.9

2.4

7.46

7.41

g/l

0.08

315

Use of rotigotine

136

1.66

1.36

1.9

1.6

7.15

7.64

g/l

0.51

108

Cauda equina syndrome

128

1.67

1.35

2.1

1.7

7.20

7.40

g/l

0.16

100

Maternal care related to the fetus and amniotic cavity and possible delivery problems

412

2697

0.90

1.35

2.4

2.0

7.12

7.29

g/l

1.12

316

2094

Benign neoplasm: Brain, supratentorial

128

1.66

1.35

1.3

1.4

7.37

7.64

g/l

0.36

Glaucoma secondary to other eye disorders

497

1.32

1.34

2.4

2.6

7.87

7.41

g/l

1.33

365

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

113

924

1.23

1.34

2.0

1.4

7.29

7.41

g/l

0.23

685

Obstructed labour due to malposition and malpresentation of fetus

148

1658

0.84

1.34

1.5

1.9

7.02

7.16

g/l

0.57

121

1319

Postpartum hemorraghe, all women as controls

156

1838

0.84

1.34

1.9

6.91

7.15

g/l

1.26

116

1461

Postpartum hemorraghe, parous women as controls

156

1617

0.84

1.34

1.9

2.0

6.91

7.13

g/l

1.12

116

1269

Macular cyst

343

1.39

1.33

1.7

2.9

7.43

7.46

g/l

0.05

268

Neovascular glaucoma

498

1.32

1.33

2.4

7.87

7.36

g/l

1.57

369

Measles

1.84

1.33

1.0

1.4

6.50

7.08

g/l

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

790

1.25

1.33

2.0

1.4

7.58

7.44

g/l

0.33

583

Degeneration of the brain due to alcohol

267

1.44

1.32

1.3

2.8

7.13

7.21

g/l

0.11

200

Nontoxic single thyroid nodule

111

908

1.23

1.32

2.4

2.3

7.18

7.45

g/l

0.91

690

Tularaemia

137

1.64

1.32

3.0

2.1

6.81

7.36

g/l

0.56

107

Antepartum haemorrhage, not elsewhere classified

568

1.29

1.31

2.2

1.8

6.89

7.15

g/l

0.89

454

Anuria and oliguria

1.94

1.31

1.3

2.2

7.11

g/l

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

651

3913

1.09

1.31

2.0

1.4

7.64

7.47

g/l

1.38

496

2871

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

651

3913

1.09

1.31

2.0

1.4

7.64

7.47

g/l

1.33

495

2871

Presbyopia

658

1.27

1.30

1.4

2.2

7.01

7.34

g/l

0.84

511

Peritonsillar abscess

257

2257

1.14

1.30

2.7

2.1

7.35

7.29

g/l

0.20

201

1719

Erectile dysfunction

149

1259

1.19

1.28

2.4

7.11

7.34

g/l

0.90

115

912

Alopecia areata

235

1.46

1.28

1.8

1.9

7.14

7.44

g/l

0.41

190

Other benign neoplasms of connective and other soft tissue

133

1111

1.20

1.28

2.6

1.4

7.23

7.43

g/l

0.65

818

Glaucoma-related operations

795

1.24

1.28

2.7

2.5

7.59

7.51

g/l

0.15

589

Foreign body or object entering through skin

607

1.28

1.27

2.8

2.3

6.98

7.26

g/l

0.83

472

Congenital malformations of ovaries, fallopian tubes and broad ligaments

440

1.33

1.27

1.7

7.35

7.39

g/l

0.07

350

Benign neoplasm: Liver

203

1.50

1.26

2.7

1.9

6.73

7.44

g/l

1.82

155

Injury of muscle and tendon at shoulder and upper arm level

616

5681

1.09

1.26

2.2

2.3

7.43

7.38

g/l

0.29

461

4269

Carcinoma in situ of skin, other sites/unspecified

139

1.62

1.26

3.5

1.2

7.67

7.60

g/l

0.06

Corneal degeneration

171

1.55

1.26

1.2

2.0

7.69

7.55

g/l

0.12

126

Benign neoplasm: Skin of lip

163

1.56

1.25

2.0

1.9

7.82

7.54

g/l

0.30

123

Sequelae of injuries of upper limb

132

1105

1.20

1.25

2.5

7.34

7.29

g/l

0.09

848

Osteomalacia

1.80

1.25

8.1

2.3

6.94

7.39

g/l

—

Infective bursitis

321

1.39

1.25

1.7

2.2

7.41

7.33

g/l

0.09

239

Parkinson's disease, strict definition

256

2259

1.14

1.24

1.9

2.3

7.16

7.46

g/l

1.90

178

1640

Injury of nerves at shoulder and upper arm level

108

1.70

1.24

3.6

2.9

7.71

7.54

g/l

0.14

Benign mammary dysplasia

225

1968

1.15

1.24

2.5

2.2

7.41

7.63

g/l

0.91

163

1461

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

771

1.24

2.2

1.4

7.36

7.51

g/l

0.32

565

Specific development disorders of scholastic skills

161

1.54

1.23

1.3

1.6

6.89

7.30

g/l

0.69

135

Dental pulpitis 3, only avohilmo

264

1.36

1.22

1.1

7.08

7.20

g/l

0.24

220

Postmenopausal atrophic vaginitis

422

2301

1.11

1.21

2.3

2.2

7.21

7.61

g/l

4.89

327

1712

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

401

1.34

1.20

1.9

1.5

7.54

g/l

0.00

286

Peripheral retinal degeneration

358

1.36

1.20

3.2

2.6

7.26

7.43

g/l

0.31

277

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

1072

0.81

1.20

2.1

1.4

7.52

7.48

g/l

0.07

780

Unspecified jaundice

604

1.27

1.20

1.6

2.3

7.00

7.36

g/l

0.97

466

Inflammation of lacrimal passages (acute and unspecified)

173

1.52

1.19

2.9

1.8

7.05

7.52

g/l

0.56

129

Pedal cyclist injured in transport accident

300

2679

1.12

1.19

2.0

2.2

7.08

7.40

g/l

2.43

208

2042

Rheumatic fever incl heart disease

402

1.33

1.19

1.5

2.4

7.19

7.45

g/l

0.48

298

Acute alcohol intoxication

397

3601

1.11

1.19

1.4

2.3

7.47

7.26

g/l

1.36

298

2696

Carcinoma in situ of oral cavity, oesophagus and stomach

1.87

1.18

1.0

2.2

8.01

7.49

g/l

—

Benign neoplasm: Skin of scalp and neck

265

1.41

1.18

3.3

2.7

7.47

7.34

g/l

0.17

207

Fistulae involving female genital tract

182

1.51

1.18

2.0

2.2

8.30

7.60

g/l

0.86

138

Other fall from one level to another

304

2719

1.12

1.17

2.2

7.22

7.36

g/l

0.64

218

2058

Dementia

755

5589

0.93

1.17

1.9

2.3

7.54

7.52

g/l

0.11

473

4047

Lesion of radial nerve

386

1.33

1.16

2.1

2.2

7.82

7.38

g/l

0.68

289

Benign neoplasm of other and unspecified female genital organs

553

0.73

1.16

2.0

2.3

7.76

7.61

g/l

0.20

417

Other maternal disorders predominantly related to pregnancy

628

4265

0.92

1.15

2.1

2.2

7.44

7.31

g/l

0.92

464

3302

Chalazion

156

1337

1.17

1.15

2.9

2.4

7.22

7.39

g/l

0.59

110

1016

Viral haemorrhagic fevers, not elsewhere classified/unspecified

956

0.80

1.15

3.0

2.3

6.99

7.31

g/l

0.93

737

Foreign body in alimentary tract

608

1.26

1.14

1.4

2.5

7.35

7.26

g/l

0.17

462

Secondary parkinsonism+Parkinsonism in other disease

327

1.36

1.14

2.6

2.5

7.14

7.47

g/l

0.64

246

Parkinson's disease

273

2435

1.13

1.14

1.9

2.3

7.19

7.48

g/l

1.88

190

1775

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

135

1.59

1.14

3.0

1.3

7.72

7.71

g/l

0.00

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

478

3555

1.09

1.13

2.0

1.4

7.71

7.52

g/l

1.26

360

2579

1.82

1.13

1.6

3.0

7.58

7.51

g/l

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

735

1.23

1.13

1.2

1.4

7.74

7.54

g/l

0.49

536

Benign neoplasm: Bone and articular cartilage, unspecified

1.82

1.13

2.3

1.2

7.75

7.46

g/l

—

Striae atrophicae

1.73

1.13

1.7

2.3

7.52

7.40

g/l

0.08

Acute otitis externa, noninfective

168

1.51

1.11

1.2

2.2

7.71

7.48

g/l

0.16

131

Ovarian dysfunction

432

1.30

1.11

1.4

1.7

7.23

7.36

g/l

0.19

357

Other acquired deformities of ankle and foot

1.76

1.11

1.4

1.9

8.40

7.37

g/l

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

104

1.66

1.10

1.3

2.2

7.81

7.08

g/l

—

Oligomenorrhoea

294

1.37

1.10

1.6

2.2

7.03

7.54

g/l

0.98

222

Other disorders of Eustachian tube

303

1.37

1.10

1.5

2.2

7.26

7.41

g/l

0.17

235

Other intracranial haemorrhages

399

1.32

1.10

1.7

2.3

7.43

7.48

g/l

0.06

286

Residual foreign body in soft tissue

451

1.29

1.10

2.0

7.20

7.33

g/l

0.18

337

Foreign body entering into or through eye or natural orifice

104

865

1.21

1.09

2.6

2.3

7.23

7.27

g/l

0.09

669

Right side

1.76

1.08

1.3

1.8

—

7.73

—

Benign neoplasm: Spinal cord

137

1.56

1.07

1.1

1.3

6.44

7.41

g/l

2.33

104

Occupational exposure to risk-factors

384

0.70

1.07

4.0

2.6

7.14

7.21

g/l

—

297

Maternal care for cervical incompetence

419

0.71

1.07

7.1

2.4

7.74

7.54

g/l

0.24

327

Other problems related to primary support group, including family circumstances

100

809

1.21

1.06

1.9

2.0

7.22

7.32

g/l

0.22

627

Benign neoplasm: Conjunctiva

331

1.34

1.06

1.3

7.43

7.52

g/l

0.12

246

Persistent delusional disorders

924

0.81

1.06

2.2

2.4

7.51

7.36

g/l

0.32

693

Medicines for HER+ breast cancer

493

5204

0.92

1.06

2.0

2.3

7.68

7.53

g/l

0.93

372

3821

Pregnancy with abortive outcome

1011

4984

1.06

1.8

2.3

7.59

7.45

g/l

1.36

773

3647

Oral leukoplakia

212

1.44

1.06

1.2

2.1

7.59

7.53

g/l

0.04

162

Other diseases of biliary tract

135

1154

1.18

1.06

2.3

2.4

7.30

7.44

g/l

0.40

103

853

Convalescence

570

1.25

1.05

2.1

7.34

7.37

g/l

0.04

450

Tuberculosis of other organs, strict

332

1.34

1.05

2.8

2.5

7.96

7.59

g/l

0.54

243

Other and unspecified nail disorders

212

1.43

1.05

2.2

2.3

6.76

7.40

g/l

1.26

169

Neuralgic amyotrophy

2.37

1.05

7.0

3.0

6.96

7.38

g/l

—

Serous carcinoma of ovary

463

0.73

1.05

2.5

2.4

7.43

7.65

g/l

0.29

356

Alzheimer’s disease, wide definition, excluding more controls

286

1744

1.12

1.05

1.9

2.2

7.64

7.65

g/l

0.03

182

1274

Effects of foreign body entering through natural orifice

340

3085

1.11

1.05

2.2

2.3

7.20

7.29

g/l

0.44

257

2343

Contusion of toe(s) with damage to nail

1.66

1.05

1.6

7.42

7.34

g/l

0.04

Benign neoplasm: Bone and articular cartilage, unspecified

1.77

1.04

2.3

1.7

7.75

7.48

g/l

—

Chondromalacia

315

1.35

1.04

1.4

2.1

8.07

7.36

g/l

0.84

251

Benign neoplasm of other and unspecified sites

341

1.33

1.04

2.7

1.4

7.16

7.49

g/l

0.57

261

Malignant neoplasm of oesophagus

311

0.67

1.04

1.4

2.7

7.16

7.35

g/l

0.20

226

Alzheimer’s disease (Late onset), excluding more controls

274

1637

1.12

1.03

1.9

2.2

7.65

7.64

g/l

0.02

168

1193

Arthropod-borne viral fevers and viral haemorrhagic fevers

102

1215

0.84

1.03

3.2

2.3

7.37

7.34

g/l

0.07

929

Contact with blunt object, undetermined intent

1.93

1.03

1.5

2.9

7.01

7.50

g/l

—

Universal erythroderma, KELA reimbursement

155

1.51

1.03

1.3

2.3

6.83

7.46

g/l

0.57

117

Transient global amnesia

118

1386

0.85

1.02

2.4

7.14

7.54

g/l

1.69

1045

Malignant neoplasm of breast, HER-positive

473

5050

0.92

1.02

2.0

2.3

7.69

7.54

g/l

0.86

356

3702

Acquired absence of organs, not elsewhere classified

131

1.55

1.01

4.2

2.3

8.24

7.36

g/l

0.82

103

Superficial injury of neck

147

1.51

1.01

1.4

1.7

7.43

7.20

g/l

0.15

115

Varus deformity, not elsewhere classified

115

1.59

1.01

1.4

2.1

6.32

7.16

g/l

—

Inguinal hernia, bilateral

177

1551

1.15

1.01

2.5

2.2

7.03

7.33

g/l

1.43

136

1148

Lichen sclerosus et atrophicus

147

1271

1.16

1.01

2.1

2.0

7.36

7.61

g/l

1.23

113

936

Tetraplegia

1.75

1.01

1.8

1.7

7.28

7.50

g/l

—

Other benign neoplasm of uterus: Corpus uteri

1.75

1.01

4.8

1.2

6.23

7.50

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

718

1.22

1.00

2.2

7.29

7.34

g/l

0.10

566

Aneurysms, operations, SAH

262

2353

1.12

1.00

1.9

2.2

7.43

7.45

g/l

0.07

196

1736

Car occupant injured in other and unspecified transport accidents

229

2041

1.13

0.99

2.0

2.2

7.24

7.35

g/l

0.46

169

1547

Dermatitis herpetiformis

198

1.43

0.99

3.4

2.2

6.98

7.45

g/l

0.81

151

Benign neoplasm of bone and articular cartilage

106

894

1.19

0.98

1.5

2.3

7.05

7.31

g/l

0.88

682

Respiratory tuberculosis, clinically confirmed

165

1.48

0.98

1.2

2.6

7.63

7.48

g/l

0.13

123

Reiter disease

1.78

0.98

5.1

1.9

7.01

7.28

g/l

0.28

Separation of retinal layers (serosa)

433

1.28

0.98

1.8

2.4

7.30

7.31

g/l

0.01

338

Vasomotor rhinitis (mode)

104

877

1.19

0.97

2.1

2.6

7.18

7.33

g/l

0.30

663

Myocardial infarction, unclassifiable

364

3543

0.91

0.96

1.8

2.2

7.70

7.46

g/l

1.59

262

2506

Struck by thrown, projected or falling objec

435

1.27

0.95

1.2

2.5

7.01

7.21

g/l

0.22

335

Other specified and unspecified disorders of eyelid

150

1.49

0.94

1.5

2.6

7.08

7.52

g/l

0.46

113

Laparoscopic left hemicolectomy

209

1.41

0.94

2.6

2.4

8.23

7.47

g/l

1.35

157

Dysplastic lesion of unknown severity of the cervix uteri

1.74

0.93

1.5

1.4

7.47

7.32

g/l

0.11

TMD related operations

205

1824

1.13

0.93

2.8

2.3

7.40

7.32

g/l

0.23

160

1404

Dronedarone medication

357

1.30

0.93

2.0

2.5

7.36

7.45

g/l

0.10

266

Acute drug-induced interstitial lung disorder

1.63

0.93

9.7

1.9

6.89

7.55

g/l

0.98

Exposure to unspecified smoke, fire and flames

1.65

0.92

1.0

2.2

7.44

7.35

g/l

—

Benign neoplasm: Choroid

782

1.20

0.92

1.6

2.5

6.99

7.39

g/l

1.38

588

malignant neoplasm of male genital organs

797

4771

1.06

0.92

2.1

2.4

7.44

7.33

g/l

0.84

558

3542

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

786

0.81

0.92

2.9

1.4

7.38

7.63

g/l

0.60

559

Personal history of certain other diseases

1.61

0.91

1.2

1.6

7.35

7.37

g/l

0.02

Inguinal or femoral hernia, bilateral

179

1584

1.14

0.91

2.5

2.2

7.03

7.32

g/l

1.38

138

1173

Benign neoplasm: Lower jaw bone

1.96

0.90

1.7

1.1

7.64

7.61

g/l

—

Achalasia of cardia

194

1.41

0.89

2.2

3.0

7.51

7.38

g/l

0.14

154

Amputation of thigh

368

1.29

0.89

1.3

2.3

8.14

7.54

g/l

1.10

262

Secondary parkinsonism

324

1.31

0.89

2.7

2.5

7.17

7.48

g/l

0.55

242

Use of rasagiline

342

1.30

0.89

1.5

2.8

6.82

7.42

g/l

1.80

257

Hypermetropia

674

1.21

0.89

2.5

2.2

7.93

7.38

g/l

1.36

518

Benign neoplasm: Tonsil

111

1.55

0.89

2.5

1.2

6.98

7.53

g/l

—

Benign neoplasm: Long bones of lower limb

254

1.35

0.89

1.3

7.25

7.38

g/l

0.16

200

Benign neoplasm: Spinal cord

144

1.48

0.88

1.1

2.3

6.44

7.27

g/l

1.88

112

Contact with other hot fluids

237

1.36

0.88

1.4

2.3

7.82

7.28

g/l

0.63

188

Embedded and impacted teeth

193

1458

1.13

0.88

2.0

1.9

7.04

7.15

g/l

0.32

130

1159

Other benign neoplasm of uterus: Other parts/unspecified

594

1.22

0.88

2.7

1.5

7.95

7.87

g/l

0.14

405

Pterygium

378

1.28

0.88

2.1

2.6

6.96

7.41

g/l

0.78

279

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

448

0.75

0.88

2.5

1.4

7.43

7.51

g/l

0.08

323

Benign neoplasm of brain and other parts of central nervous system

777

1.19

0.87

2.1

2.5

7.11

7.36

g/l

0.65

595

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

118

1364

0.86

0.87

2.7

1.4

7.38

7.45

g/l

0.17

993

Spinal enthesopathy

342

1.29

0.87

2.8

1.9

7.52

7.59

g/l

0.09

223

Traumatic amputation of wrist and hand

515

0.77

0.87

1.3

2.6

7.13

7.25

g/l

0.12

388

Disturbances of smell and taste

486

1.24

0.87

2.8

2.9

6.74

7.42

g/l

1.94

371

L02BG Aromatase inhibitors

403

4355

0.92

0.87

2.2

2.3

7.77

7.55

g/l

1.38

308

3211

Benign neoplasm: Skin of trunk

432

1.26

0.87

3.0

1.4

6.80

7.40

g/l

2.06

329

All dysplastic lesions of the vulva

459

1.25

0.87

1.3

2.2

7.65

7.58

g/l

0.10

359

All dysplastic lesions of the vagina

247

1.35

0.86

2.8

1.9

7.57

7.56

g/l

0.00

203

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

179

1.42

0.86

2.1

1.7

7.06

7.55

g/l

0.63

131

Malignant neoplasm of prostate

789

4709

1.06

0.85

2.1

2.4

7.45

7.33

g/l

0.86

550

3495

Tuberculosis of other organs

283

1.32

0.85

2.7

2.4

8.01

7.60

g/l

0.50

205

Bacterial meningitis

371

1.28

0.85

3.7

2.5

6.98

7.24

g/l

0.51

287

Blood alcohol or alcohol intoxication level

196

1.39

0.85

1.4

2.1

6.78

7.20

g/l

0.68

152

Benign neoplasm: Short bones of upper limb

129

1.49

0.84

1.4

6.59

7.41

g/l

1.85

Other and unspecified degenerative diseases of nervous system

301

1.31

0.84

1.6

2.4

7.42

7.55

g/l

0.18

222

Urethritis and urethral syndrome

205

1.38

0.84

1.2

2.2

7.05

7.39

g/l

0.39

160

LeFortI or BSSRO operation

320

0.71

0.84

1.0

1.7

6.53

7.26

g/l

1.06

260

Malignant melanoma of skin

183

1632

1.13

0.84

2.0

2.4

7.07

7.42

g/l

1.96

134

1213

Endometriosis ASRM stages 1,2

195

1744

1.12

0.84

1.4

2.0

7.14

7.39

g/l

1.05

138

1342

Hypertrichosis

121

1.50

0.83

1.2

1.9

7.71

7.39

g/l

—

104

Dementia in other diseases classified elsewhere

617

1.21

0.83

1.7

2.5

7.02

7.50

g/l

1.25

459

Presbycusis

256

2316

1.10

0.82

2.5

2.2

7.37

7.64

g/l

1.53

172

1693

Macular hole

820

1.18

0.82

1.9

2.6

7.73

7.41

g/l

1.01

609

Melanocytic naevi of other and unspecified parts of face

571

1.21

0.82

2.8

1.4

7.37

7.38

g/l

0.01

432

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

122

1.50

0.81

1.3

1.2

6.90

7.64

g/l

0.56

Pregnancy hypertension

465

3906

1.07

0.81

2.3

2.1

7.35

7.29

g/l

0.36

354

3002

Endometriosis diagnosis and infertility diagnosis occurring together

101

866

1.17

0.81

1.6

2.1

7.26

7.30

g/l

0.07

675

LSIL lesion of the vulva

285

1.31

0.81

1.3

2.0

7.59

7.50

g/l

0.11

230

Benign lipomatous neoplasm of other sites/unspecified

142

1250

1.14

0.81

3.0

2.4

7.48

7.41

g/l

0.15

940

Hypertrophy of breast in women and men

240

2177

1.11

0.80

1.9

2.3

7.40

7.37

g/l

0.10

181

1651

Deep bite

107

806

1.16

0.80

2.0

2.3

7.50

7.34

g/l

0.34

637

Mandibular retrognathia AND surgery (BSSRO)

200

0.65

0.80

1.0

1.7

6.40

7.33

g/l

—

164

conjunctival degenerations and deposits

242

1.34

0.80

3.8

1.9

7.67

7.52

g/l

0.12

186

Pleural plaque

179

1601

1.12

0.80

2.3

2.2

7.64

7.35

g/l

1.12

127

1134

Other benign neoplasm of uterus: Corpus uteri

1.62

0.79

4.8

2.1

6.23

7.67

g/l

—

Acute inflammation of orbit

1.69

0.79

10.6

1.2

7.64

7.63

g/l

—

Right ventricular outflow tract obstruction

1.83

0.79

1.0

1.9

6.63

7.59

g/l

—

Benign neoplasm: Larynx

393

1.26

0.79

2.7

2.4

6.89

7.31

g/l

1.07

303

Migraine without aura, drug-induced

1.55

0.79

5.7

2.3

7.49

7.41

g/l

—

Discharge from other and unspecified firearms

0.00

0.79

0.0

2.4

—

6.98

—

Abnormalities of forces of labour

831

1.17

0.79

1.4

2.0

6.95

7.25

g/l

1.48

662

Maternal care for known or suspected abnormality of pelvic organs

184

1419

0.89

0.79

2.6

2.0

7.07

7.21

g/l

0.52

146

1119

Benign neoplasm: Short bones of lower limb

0.50

0.79

1.0

2.5

7.04

7.52

g/l

—

Other obstetric trauma

339

0.73

0.79

1.9

2.1

6.76

7.19

g/l

1.07

277

Schizoaffective disorder

730

1.18

0.79

1.8

2.3

7.63

7.30

g/l

1.00

565

Vascular dementia (undefined)

506

1.22

0.78

2.2

8.29

7.69

g/l

0.95

357

Other benign neoplasms of uterus

750

1.18

0.78

3.0

1.4

7.74

7.76

g/l

0.03

522

Gonococcal infection

331

1.28

0.78

2.2

1.8

8.04

7.41

g/l

1.24

262

FESS (DNB20)

131

1489

0.88

0.78

2.4

2.3

7.24

7.36

g/l

0.29

1137

Uterine polyps

130

1141

1.14

0.78

2.0

2.2

7.56

7.52

g/l

0.09

860

Correction of physiology of bite - demanding therapy visit

639

0.81

0.78

4.3

2.3

7.71

7.38

g/l

0.62

502

Colorectal cancer

359

3872

0.92

0.77

2.3

2.2

7.60

7.44

g/l

0.91

259

2815

LSIL lesion of the cervix uteri, vagina or vulva

137

1208

1.14

0.76

2.6

2.1

7.22

7.34

g/l

0.38

112

927

Carcinoma in situ of skin, other sites/unspecified

158

1.42

0.76

3.5

2.1

7.67

7.44

g/l

0.26

111

Maternal care for known or suspected malpresentation of fetus

101

872

0.86

0.76

1.9

1.7

6.89

7.03

g/l

0.43

697

Crystalline deposits in vitreous body

116

1.49

0.76

3.7

2.7

7.36

7.37

g/l

—

Evidence of alcohol involvement determined by blood alcohol level

124

1.47

0.76

1.6

1.7

6.74

7.09

g/l

0.37

Other contact dermatitis

102

882

1.16

0.75

1.7

2.4

7.21

7.39

g/l

0.48

672

Fall on and from ladder

114

995

1.15

0.75

3.8

2.5

7.11

7.36

g/l

0.73

764

Superficial injuries involving multiple body regions

236

1.32

0.75

3.1

2.4

6.94

7.27

g/l

0.50

186

Occlusion and stenosis of arteries, not leading to stroke

150

1.42

0.74

3.7

2.2

8.22

7.65

g/l

0.37

111

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

115

1312

0.87

0.74

2.7

1.4

7.40

7.48

g/l

0.18

952

Contact with machinery

124

1408

0.88

0.74

2.2

2.3

7.08

7.30

g/l

0.70

1071

Benign neoplasm of ovary

237

2161

1.10

0.74

2.3

1.4

7.71

7.58

g/l

0.42

184

1557

Abscess of Bartholin gland

219

1.33

0.74

3.4

2.2

7.78

7.50

g/l

0.38

183

Placenta praevia

266

0.71

0.74

1.1

1.8

6.76

7.25

g/l

0.66

215

Caught, crushed, jammed or pinched in or between objects

424

1.23

0.73

1.3

2.2

7.11

7.21

g/l

0.13

331

Childhood allergy (age < 16)

400

1.22

0.73

1.1

1.2

6.95

7.18

g/l

0.44

332

Defect, injury or illness of neck

1.82

0.73

1.1

1.3

7.66

7.40

g/l

—

Burn and corrosion of trunk

281

1.29

0.73

1.3

2.5

7.39

7.35

g/l

0.04

220

Mixed conductive and sensorineural hearing loss

200

1811

1.11

0.73

2.6

2.2

7.67

7.54

g/l

0.40

132

1366

Dental caries 3 and operation codes, only avohilmo

522

2460

1.07

0.73

2.4

2.7

7.38

7.34

g/l

0.19

409

1726

Brain glioblastoma and astrocytoma

182

0.65

0.72

1.2

3.1

6.96

7.32

g/l

—

140

Labour and delivery complicated by fetal stress [distress]

138

1039

0.88

0.71

1.6

1.7

7.05

6.98

g/l

0.19

114

839

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

406

3178

1.07

0.71

2.2

1.5

8.00

7.46

g/l

5.63

317

2314

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

359

3339

1.08

0.71

3.2

1.4

8.18

7.44

g/l

7.67

258

2456

Chorioretinal scars

1.75

0.71

1.9

2.2

7.24

7.84

g/l

—

Carcinoma in situ of middle ear and respiratory system

1.58

0.71

1.9

1.3

7.11

7.72

g/l

—

Calcaneal spur

118

1.46

0.70

1.2

1.7

7.20

7.41

g/l

0.24

Chorioretinal inflammation

301

1.27

0.70

1.5

2.3

6.96

7.34

g/l

0.67

234

Malignant neoplasm of bladder

121

1068

1.14

0.69

2.0

2.4

7.38

7.42

g/l

0.07

771

Carcinoma in situ of other and unspecified sites

428

1.22

0.69

3.2

1.4

7.53

7.47

g/l

0.07

325

Abnormal findings on antenatal screening of mother

376

0.77

0.69

1.0

1.5

6.97

7.09

g/l

0.17

298

Use of interferon beta-1a

178

1.36

0.69

1.3

1.8

6.26

7.34

g/l

4.26

150

Inflammatory disorders of breast

538

1.19

0.68

1.5

2.3

7.47

7.42

g/l

0.07

421

Papillary adenocarcinoma of thyroid gland

603

1.18

0.68

2.0

2.5

7.23

7.39

g/l

0.31

459

Radial styloid tenosynovitis [de Quervain]

520

1.20

0.68

2.2

2.1

7.54

7.35

g/l

0.35

397

Carcinoma in situ of breast, intraductal

111

976

1.14

0.68

1.8

1.4

7.54

7.53

g/l

0.02

714

Divergent concomitant strabismus

789

1.16

0.67

1.8

2.2

6.94

7.33

g/l

1.60

594

Frontotemporal dementia

1.58

0.67

2.4

2.1

7.20

7.84

g/l

—

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

1.54

0.67

1.2

1.3

6.93

7.54

g/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

528

0.81

0.67

2.6

2.5

7.63

7.32

g/l

0.42

403

Congenital malformations of the nervous system

136

1.41

0.67

1.2

2.1

6.69

7.34

g/l

1.01

112

Inflammatory diseases of prostate (prostatitis)

196

1783

1.10

0.67

2.1

2.5

7.17

7.31

g/l

0.48

140

1340

Arthropathy in Crohn disease

1.53

0.67

1.1

2.2

6.78

7.28

g/l

—

Melanocytic naevi, other sites/unspecified

772

1.16

0.66

2.0

1.3

7.50

7.38

g/l

0.23

588

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

180

1632

1.11

0.66

2.3

1.4

7.78

7.49

g/l

1.17

127

1160

Alzheimer disease, excluding more controls

309

1912

1.08

0.66

2.1

2.2

7.62

7.65

g/l

0.09

189

1409

Dislocation, sprain and strain of joints and ligaments of head

331

1.24

0.65

1.3

1.9

7.20

7.31

g/l

0.14

259

Adenocarcinoma and papillary adenocarcinoma of stomach

360

0.77

0.65

1.2

2.5

7.39

7.33

g/l

0.08

267

Brain meningioma

662

1.17

0.65

2.2

2.5

7.23

7.51

g/l

0.63

501

Other bursitis, not elsewhere classified

1.49

0.65

4.6

2.0

6.81

7.25

g/l

—

Carcinoma in situ, bladder

387

1.22

0.64

3.4

1.4

7.50

7.44

g/l

0.06

292

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

425

0.79

0.63

3.4

2.3

7.57

7.54

g/l

0.03

309

Communicating hydrocephalus

252

1.28

0.63

1.6

2.7

7.18

7.40

g/l

0.18

190

Carcinoma in situ of larynx

1.73

0.63

2.4

2.9

6.82

7.24

g/l

—

Female genital prolapse

456

2477

1.06

0.62

2.3

2.1

7.62

7.58

g/l

0.19

319

1843

Benign neoplasm: Respiratory system, unspecified

1.71

0.62

1.0

1.3

8.70

7.61

g/l

—

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.62

0.0

1.1

—

7.50

—

Drowning to ice

0.00

0.62

0.0

1.2

—

8.01

—

Convergence insufficiency and excess

1.47

0.62

1.4

1.8

6.85

7.22

g/l

—

Traumatic amputation of hip and thigh

0.00

0.62

0.0

2.0

—

7.53

—

Ankle and foot

1.50

0.61

1.4

2.2

7.53

7.43

g/l

—

Family history of malignant neoplasm

1069

0.88

0.61

2.9

2.0

7.21

7.38

g/l

0.37

823

Benign neoplasm: Conjunctiva

362

1.22

0.61

1.3

2.8

7.43

7.41

g/l

0.02

278

Injury of nerves at wrist and hand level

371

1.22

0.61

2.4

2.6

7.57

7.12

g/l

0.76

281

Benign neoplasm of other and unspecified female genital organs

499

0.82

0.60

2.0

1.3

7.76

7.51

g/l

0.37

363

Other disorders of male genital organs

353

1.22

0.60

1.7

2.5

7.51

7.17

g/l

0.49

263

Phakomatoses, not elsewhere classified

1.51

0.60

2.3

2.1

6.85

7.24

g/l

—

Use of dimethyl fumarate

1.55

0.60

1.0

2.3

6.09

6.88

g/l

—

Other congenital malformations of the digestive system

342

1.23

0.60

1.5

2.5

7.30

7.34

g/l

0.04

263

Benign neoplasm of other and unspecified sites

372

1.22

0.60

2.7

2.2

7.16

7.43

g/l

0.44

285

Dementia, including avohilmo

830

5969

0.96

0.59

1.9

2.3

7.50

7.52

g/l

0.11

527

4322

Vertical strabismus

336

1.23

0.59

1.9

2.5

7.34

7.41

g/l

0.08

256

Beningn neoplasm: Meninges, unspecified

175

1.33

0.59

1.6

1.4

7.93

7.67

g/l

0.30

127

Long labour

183

1748

0.91

0.59

2.3

2.0

7.07

7.18

g/l

0.39

147

1379

Injury of blood vessels at hip and thigh level

1.76

0.59

2.3

1.9

7.30

7.86

g/l

—

Normal-pressure hydrocephalus

744

0.85

0.58

2.5

7.54

g/l

0.00

540

Small plaque parapsoriasis

1.71

0.58

1.7

2.2

7.70

7.88

g/l

—

Benign neoplasm: Brain, supratentorial

158

1.34

0.58

1.3

2.8

7.37

7.50

g/l

0.15

122

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

428

1.19

0.58

2.7

1.9

6.83

7.14

g/l

0.87

327

Vestibular neuronitis

130

1170

1.12

0.57

2.1

2.4

7.41

7.33

g/l

0.16

885

Other and unspecified water transport accidents

1.70

0.57

1.0

1.2

7.67

7.73

g/l

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

247

1.27

0.57

1.7

1.4

7.84

7.44

g/l

0.45

181

Twin gestation

623

1.16

0.57

1.2

1.9

6.81

7.14

g/l

1.03

499

Benign neoplasm: Short bones of lower limb

0.57

1.0

1.3

7.04

7.52

g/l

—

Other specified and unspecified disorders of lens

133

1.38

0.56

1.7

2.6

6.46

7.64

g/l

—

101

Erosion and ectropion of cervix uteri

357

1.21

0.56

3.4

2.0

7.90

7.70

g/l

0.25

273

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

248

1.26

0.56

4.2

1.4

8.11

7.57

g/l

0.82

195

Unequal limb length (acquired)

1.63

0.56

1.2

2.2

7.65

6.99

g/l

—

Acute and transient psychotic disorders

140

1268

1.11

0.55

2.0

2.3

7.36

7.31

g/l

0.12

966

Spermatocele

118

1060

1.12

0.55

2.6

2.3

6.98

7.30

g/l

1.35

791

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

240

1.26

0.54

4.0

1.3

6.91

7.41

g/l

1.08

174

Bilateral sagittal split ramus osteotomy operation

261

0.76

0.54

1.0

1.7

6.53

7.33

g/l

1.18

213

Toxic effect of carbon monoxide

170

0.70

0.54

1.2

2.0

6.94

7.37

g/l

—

128

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

432

1.19

0.54

1.3

2.2

7.53

7.35

g/l

0.19

323

Malignant neoplasm of brain

338

0.79

0.53

1.5

2.4

7.36

7.31

g/l

0.05

262

Disorders of puberty, all

1.54

0.53

1.2

1.9

7.18

7.20

g/l

—

Malignant neoplasm of corpus uteri

107

1192

0.89

0.53

1.5

2.2

7.84

7.72

g/l

0.23

863

Unspecified chronic bronchitis

461

1.18

0.52

1.9

2.8

7.61

7.45

g/l

0.25

330

Anisometropia and aniseikonia

323

1.21

0.52

2.9

2.5

7.23

7.42

g/l

0.34

247

Single delivery by caesarean section

138

880

0.91

0.52

2.0

1.6

7.24

7.22

g/l

0.04

104

732

Other abnormal products of conception

278

1730

1.07

0.52

1.8

2.0

7.09

7.19

g/l

0.45

228

1350

Hirsutism in women

100

1.41

0.52

1.1

1.5

8.14

7.45

g/l

—

Open wound of thorax

135

1.34

0.51

2.2

2.1

6.90

7.39

g/l

0.59

105

Carcinoma in situ of middle ear and respiratory system

1.41

0.51

1.9

3.0

7.11

7.48

g/l

—

Multiple gestation

639

1.15

0.51

1.2

1.9

6.84

7.15

g/l

0.98

513

Crushing injury of wrist and hand

162

1.31

0.50

1.6

2.6

7.22

7.29

g/l

0.05

126

Non-small cell lung cancer

242

2592

0.93

0.50

2.1

2.3

8.08

7.40

g/l

5.18

190

1874

Impacted teeth

116

974

1.11

0.50

1.5

1.7

6.97

7.15

g/l

0.44

780

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

234

1.25

0.50

2.8

1.3

7.54

7.48

g/l

0.08

171

Lesion of sciatic nerve

637

0.86

0.50

1.3

2.4

7.30

7.41

g/l

0.21

458

Congenital malformations of uterus and cervix

127

1.35

0.50

1.2

2.0

6.59

7.47

g/l

1.12

109

Infections of genitourinary tract in pregnancy

924

0.89

0.49

2.2

7.35

7.47

g/l

0.27

715

Embolic stroke

632

1.14

0.49

2.0

2.5

7.51

g/l

0.00

443

Car occupant injured in noncollision transport accident

298

1.21

0.49

3.7

2.4

7.44

7.31

g/l

0.19

231

Venous complications and haemorrhoids in the puerperium

107

0.65

0.49

1.3

1.6

7.29

7.61

g/l

—

Maltreatment syndromes

353

1.19

0.49

2.1

1.8

7.13

7.20

g/l

0.13

282

Oral leukoplakia, including avohilmo

326

1.20

0.49

1.3

2.0

7.51

7.38

g/l

0.09

255

Carcinoma in situ of cervix uteri

614

1.14

0.49

2.3

1.3

7.32

7.28

g/l

0.06

472

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

512

1.16

0.48

2.5

1.4

7.59

7.40

g/l

0.35

383

Other appendicitis

107

968

1.11

0.46

2.9

2.4

7.21

7.34

g/l

0.29

743

Distal bite

175

0.74

0.46

2.4

1.4

6.76

7.41

g/l

—

150

Malignant neoplasm of endocrine gland

864

1.12

0.46

2.4

2.5

7.30

7.37

g/l

0.13

662

Complications predominantly related to the puerperium

264

2481

1.07

0.46

2.0

2.1

7.24

7.29

g/l

0.17

201

1912

Dementia due to Parkinsons disease, excluding more controls

237

1.23

0.46

1.3

2.2

6.84

7.64

g/l

0.84

174

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

537

4498

1.05

0.46

2.2

2.1

7.44

7.30

g/l

0.92

406

3450

Supervision of high-risk pregnancy

171

954

1.08

0.45

1.7

1.8

7.03

7.25

g/l

0.99

128

787

Injury of muscle and tendon at wrist and hand level

182

1690

1.08

0.45

1.9

2.3

7.41

7.36

g/l

0.12

133

1299

Open bite

283

1.20

0.45

1.1

1.5

7.51

7.39

g/l

0.10

235

Other corneal oedema

1.39

0.44

2.7

2.0

6.94

7.63

g/l

—

Other complications of labour and delivery, not elsewhere classified

546

0.86

0.44

1.3

1.5

6.66

7.07

g/l

1.60

443

Carcinoma in situ of larynx

1.67

0.44

2.4

1.1

6.82

7.75

g/l

—

Benign neoplasm: Short bones of upper limb

148

1.29

0.44

1.4

2.1

6.59

7.49

g/l

2.09

118

Female infertility, tubal origin

395

1.17

0.44

1.3

1.8

7.72

7.44

g/l

0.33

311

Ethmoidectomy

143

1551

0.92

0.43

2.8

2.3

7.22

7.35

g/l

0.32

109

1181

Other benign neoplasms of uterus

792

1.12

0.43

3.0

2.2

7.74

7.73

g/l

0.01

582

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

242

2144

1.07

0.43

2.1

1.4

8.08

7.44

g/l

4.65

190

1533

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

113

1031

1.10

0.43

2.0

2.5

7.29

7.38

g/l

0.16

776

Pedal cyclist injured in other and unspecified transport accidents

134

1232

1.09

0.43

2.1

2.3

7.27

7.35

g/l

0.19

948

Other obstructed labour

734

0.88

0.43

1.9

2.2

7.66

7.43

g/l

0.57

575

Keratoconus

230

1.22

0.43

1.8

2.2

7.27

7.44

g/l

0.17

182

Acute appendicitis, with complications

295

2791

1.06

0.43

2.4

2.2

7.43

7.37

g/l

0.23

232

2087

Gastrointestinal stromal tumor and sarcoma

140

1.30

0.43

1.3

2.3

6.90

7.60

g/l

0.53

103

Maternal care for known or suspected disproportion

276

1.20

0.42

1.4

2.1

7.06

7.19

g/l

0.13

220

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.42

0.0

1.3

—

7.44

—

Intentional self-harm by other and unspecified firearm discharge

0.00

0.42

0.0

1.3

—

7.49

—

Disorders of globe

314

1.19

0.41

1.8

2.4

7.56

7.40

g/l

0.18

232

Obstructed labour due to maternal pelvic abnormality

166

1785

0.93

0.41

2.3

2.2

7.36

7.43

g/l

0.19

117

1345

Multiple delivery

837

0.89

0.41

2.1

1.9

7.14

7.31

g/l

0.37

664

conjunctival scars

0.00

0.41

0.0

1.9

—

8.79

—

Benign neoplasm: Tonsil

132

1.30

0.41

2.5

2.0

6.98

7.58

g/l

—

103

Toxic effects of substances chiefly nonmedicinal as to source

110

1202

0.91

0.40

1.7

2.4

6.94

7.36

g/l

1.37

926

Deep endometriosis

1087

0.91

0.40

1.5

2.2

7.20

7.56

g/l

1.23

823

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

297

3006

0.95

0.40

1.9

1.4

7.60

7.58

g/l

0.07

219

2166

Other and unspecified spinal muscular atrophies

106

1.34

0.40

2.0

2.4

7.72

7.41

g/l

—

Hydrocephalus

1064

0.91

0.39

2.2

2.5

7.28

7.50

g/l

0.42

791

Problems related to social environment

270

0.81

0.39

3.2

1.8

7.02

7.45

g/l

0.70

205

Symptoms and signs involving appearance and behaviour

1.42

0.39

1.0

2.2

7.90

7.42

g/l

—

Non-allergic asthma

116

1065

1.09

0.39

2.1

2.5

7.41

g/l

0.00

793

Other and unspecified injuries of shoulder and upper arm

288

1.19

0.39

1.4

2.3

7.91

7.38

g/l

0.70

216

Benign neoplasm: Long bones of lower limb

288

1.19

0.39

1.3

2.0

7.25

7.26

g/l

0.01

227

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

344

1.17

0.39

2.7

1.4

7.63

7.52

g/l

0.13

249

Benign neoplasm: Rectum/anal canal icd-9

115

1.32

0.39

1.1

1.3

7.73

7.84

g/l

—

Female infertility

333

1956

1.05

0.39

1.9

2.1

7.38

7.35

g/l

0.10

259

1506

Heterophoria

770

1.11

0.38

3.0

2.3

6.95

7.42

g/l

1.78

593

Other benign neoplasms of connective and other soft tissue

133

1231

1.08

0.38

2.6

2.4

7.23

7.38

g/l

0.48

929

Malignant neoplasm of head and neck

124

1145

1.09

0.38

2.3

2.4

7.27

7.43

g/l

0.38

861

Hypertrophy of breast

193

1812

1.07

0.38

1.4

2.2

7.40

7.42

g/l

0.06

147

1381

Other benign neoplasm of uterus: Other parts/unspecified

648

1.12

0.37

2.7

2.2

7.95

7.80

g/l

0.31

467

Mumps

268

0.82

0.37

1.4

2.2

7.65

7.31

g/l

0.36

204

Wilms' tumor, excluding all cancers (controls excluding all cancers)

1.41

0.37

1.0

1.2

7.94

7.78

g/l

—

Urticaria due to cold and heat

1.31

0.37

1.7

1.6

7.16

7.37

g/l

—

Sequelae of tuberculosis

253

1.19

0.37

3.8

2.2

7.57

7.55

g/l

0.02

183

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

253

1.19

0.37

1.6

2.2

7.20

7.64

g/l

0.69

195

Generalized epilepsy

346

1.16

0.37

1.7

2.3

7.21

7.19

g/l

0.03

272

Haemorrhage in early pregnancy

295

2739

1.05

0.36

2.1

7.25

g/l

0.01

217

2127

Frontotemporal dementia, wide, incl. Pick's disease

1.35

0.36

2.4

2.0

7.20

7.71

g/l

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

697

1.11

0.36

2.0

2.6

7.42

7.49

g/l

0.12

521

Other deformity of hallux (acquired)

1.33

0.36

1.2

1.9

7.84

7.04

g/l

—

Inflammation of lacrimal passages (chronic)

201

0.79

0.36

1.2

2.1

7.04

7.61

g/l

—

144

Mental retardation, excluding more controls

240

1.19

0.36

1.7

2.4

7.38

7.25

g/l

0.18

184

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

1.41

0.35

3.7

1.1

6.18

7.88

g/l

—

Cyst of Bartholin Gland

357

1.15

0.35

2.5

2.1

7.33

7.47

g/l

0.19

288

Hypersensitivity pneumonitis due to organic dust

181

1.22

0.35

3.3

2.8

8.10

7.35

g/l

0.67

142

Hepatocellular carcinoma

255

1.18

0.35

2.3

2.8

7.37

7.31

g/l

0.05

186

Pedal cyclist injured in collision with motor vehicle

287

0.83

0.35

1.3

2.2

7.61

7.35

g/l

0.30

226

Use of ropinirole

481

1.13

0.34

2.3

2.9

7.38

7.42

g/l

0.04

364

Bruxism

154

1.24

0.34

1.2

2.0

7.22

7.34

g/l

0.11

126

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

145

1.25

0.34

1.4

1.6

7.16

7.52

g/l

0.35

110

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

200

1.21

0.34

1.3

1.4

8.50

7.56

g/l

0.96

141

Malignant neoplasm of breast

751

5577

0.97

0.34

1.9

2.3

7.67

7.50

g/l

1.51

562

4091

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

191

1.21

0.34

2.5

1.3

8.45

7.57

g/l

0.63

137

Sequelae of infectious and parasitic diseases

883

1.09

0.33

2.9

2.1

7.68

7.40

g/l

0.62

665

Failed induction of labour

286

0.84

0.33

1.3

1.6

7.76

7.11

g/l

0.68

233

HSIL lesion of the vulva

182

1.22

0.33

1.4

2.1

7.90

7.72

g/l

0.19

145

Pedestrian injured in collision with car, pick-up truck or van

256

1.18

0.33

1.5

2.3

7.43

7.51

g/l

0.09

196

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

1.32

0.33

5.7

1.3

7.38

7.67

g/l

—

Impacted maxillary molar

228

1.19

0.33

2.1

1.7

7.07

7.33

g/l

0.25

190

Malignant neoplasm of oral cavity

407

1.14

0.33

2.3

2.8

7.59

7.40

g/l

0.29

303

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

105

971

1.08

0.33

1.8

2.2

7.96

7.42

g/l

1.76

740

Mesothelioma

165

0.78

0.32

1.1

2.7

8.64

7.35

g/l

—

124

Renal cell carcinoma of kidney

474

1.12

0.32

1.9

2.6

7.54

7.48

g/l

0.06

340

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

842

0.91

0.32

3.1

2.4

7.73

7.35

g/l

1.00

646

Persons encountering health services in circumstances related to reproduction

690

4814

0.97

0.32

2.1

2.2

7.04

7.31

g/l

3.25

537

3727

Malignant neoplasm of stomach

694

1.10

0.32

1.2

2.4

7.73

7.45

g/l

0.69

506

Other and unspecified disorders of skin and subcutaneous tissue

791

1.09

0.31

1.7

2.4

7.82

7.40

g/l

0.83

601

Other melanin hyperpigmentation

277

1.16

0.31

3.0

2.2

6.85

7.54

g/l

1.15

205

Benign neoplasm: Skin of trunk

485

1.12

0.31

3.0

2.4

6.80

7.38

g/l

1.97

379

Kyphosis

138

1.24

0.31

1.4

1.6

7.18

7.24

g/l

0.04

105

Schizotypal disorder

184

1.20

0.30

1.8

7.09

7.19

g/l

0.12

149

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

325

0.86

0.30

1.2

1.4

7.39

7.45

g/l

0.07

232

Benign neoplasm: Skin, unspecified

410

1.13

0.30

2.3

1.4

7.35

7.38

g/l

0.03

312

Beningn neoplasm: Meninges, unspecified

194

1.19

0.30

1.6

1.8

7.93

7.61

g/l

0.37

144

Postpartum haemorrhage due to retained placenta

797

0.91

0.30

2.0

1.8

6.91

7.13

g/l

0.59

617

Autoimmune thyroiditis

176

1.20

0.29

2.1

1.8

7.68

7.58

g/l

0.07

141

Other congenital malformations of face and neck

232

1.17

0.29

2.9

1.9

6.52

7.25

g/l

1.56

189

Gestational diabetes (for exclusion)

264

1952

0.96

0.28

1.8

7.30

7.04

g/l

1.57

203

1561

Malignant neoplasm of breast, HER2-negative

734

5531

0.97

0.28

1.9

2.3

7.65

7.50

g/l

1.23

549

4051

Intrahepatic Cholestasis of Pregnancy (ICP)

460

1.11

0.28

2.7

1.9

6.83

7.23

g/l

1.27

368

Respiratory tuberculosis, confirmed and not-confirmed

787

1.08

0.27

2.1

2.5

7.64

7.42

g/l

0.46

571

Respiratory tuberculosis

787

1.08

0.27

2.1

2.5

7.64

7.42

g/l

0.46

571

Postpartum care and examination

560

0.92

0.27

1.6

7.00

7.22

g/l

0.44

469

Poor fetal growth

700

1.09

0.27

1.7

1.8

6.72

7.14

g/l

2.02

550

Other specified/unspecified diseases of inner ear

1.22

0.27

1.8

2.0

6.69

7.70

g/l

—

LSIL lesion of the cervix uteri

865

1.08

0.27

3.3

2.1

7.09

7.32

g/l

0.71

677

Malignant neoplasm of liver and intrahepatic bile ducts

424

1.11

0.26

1.9

2.6

7.30

7.34

g/l

0.04

316

ILD medications: acetylcysteine

1.29

0.26

1.6

1.3

7.78

7.67

g/l

—

Mesothelioma, excluding all cancers (controls excluding all cancers)

160

0.81

0.26

1.1

1.3

8.64

7.58

g/l

—

113

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

149

0.80

0.26

1.2

1.4

6.96

7.58

g/l

—

113

Malignant neoplasm of thyroid gland

819

1.08

0.26

2.5

7.27

7.37

g/l

0.20

630

Oral lichen ruber planus, hypothyreosis or thyroxin

188

1.18

0.25

2.7

1.8

7.48

7.57

g/l

0.06

152

Excessive vomiting in pregnancy

655

1.09

0.25

2.3

2.2

7.13

7.38

g/l

0.53

520

Endometriosis of rectovaginal septum and vagina

944

0.93

0.25

1.5

2.1

7.36

7.65

g/l

0.77

708

Female infertility, associated with anovulation

396

1.11

0.25

1.1

1.5

6.80

7.09

g/l

0.74

314

Dependent personality disorder

207

1.16

0.25

1.9

2.0

7.28

7.37

g/l

0.09

168

Benign leiomyoma with endometriosis

234

2245

1.04

0.25

2.1

2.2

7.53

7.60

g/l

0.21

166

1677

Other and unspecified intracranial injuries

311

1.13

0.25

1.9

2.6

7.63

7.27

g/l

0.70

233

Anomalies of dental arch relationship, including avohilmo

184

1576

1.05

0.25

1.9

2.3

7.40

7.33

g/l

0.18

125

1221

Motorcycle rider injured in other and unspecified transport accidents

424

0.89

0.25

1.3

2.0

7.13

7.14

g/l

0.01

335

Malignant neoplasm of oropharynx

191

0.83

0.25

6.4

2.0

6.11

7.26

g/l

2.09

145

Foreign body in respiratory tract

541

1.09

0.24

2.6

2.4

7.17

7.36

g/l

0.34

414

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

541

1.09

0.24

1.6

1.9

7.33

7.18

g/l

0.30

431

Melanocytic naevi of other and unspecified parts of face

638

1.08

0.24

2.8

2.4

7.37

g/l

0.01

490

Ectopic pregnancy

172

1803

0.95

0.24

1.5

2.4

7.51

7.35

g/l

0.50

142

1368

Antenatal screening

188

1010

1.05

0.24

1.9

1.8

6.96

7.26

g/l

1.59

157

830

Other osteochondropathies

706

1.08

0.24

2.3

2.2

7.63

7.34

g/l

0.69

549

Other noninflammatory disorders of cervix uteri

639

1.08

0.23

2.7

2.1

7.37

7.69

g/l

0.61

476

Benign neoplasm: Cranial nerves

313

1.12

0.23

3.1

1.3

7.49

7.38

g/l

0.12

236

Follow-up care involving plastic surgery

399

1.11

0.23

1.5

1.8

7.49

7.33

g/l

0.26

316

Cholesteatoma of middle ear

702

0.92

0.23

2.1

2.5

7.30

7.47

g/l

0.28

533

L02BB Anti-androgens

138

1452

0.95

0.23

1.8

2.4

7.72

7.34

g/l

1.21

1040

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.29

0.23

1.8

1.2

6.56

7.70

g/l

—

Early lumbar disc prolapse, operated

659

1.08

0.23

1.9

7.16

7.07

g/l

0.15

536

Bicuspidal aortic valve syndrome

342

1.11

0.23

2.0

2.3

6.90

7.22

g/l

0.51

264

Toxic effect of ethanol

342

1.11

0.23

1.2

2.2

6.41

7.13

g/l

1.33

270

Malignant neoplasm of other and unspecified urinary organs

1.26

0.23

1.0

1.3

6.76

8.01

g/l

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

285

1.13

0.23

3.2

1.3

7.46

7.40

g/l

0.09

210

Congenital malformations of spine and bony thorax

1.26

0.22

1.0

2.2

6.16

7.65

g/l

—

Gestational [pregnancy-induced] hypertension

240

2306

1.04

0.22

2.5

2.0

7.25

7.23

g/l

0.09

186

1775

Habitual aborter

0.77

0.22

4.7

2.1

6.13

7.30

g/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.23

0.22

1.8

2.8

6.56

7.92

g/l

—

Benign neoplasm of thyroid gland

399

0.90

0.22

2.4

2.2

7.66

7.47

g/l

0.20

310

Female infertility, cervigal, vaginal, other or unspecified origin

295

1909

1.04

0.22

2.0

7.39

7.35

g/l

0.11

230

1470

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

7.51

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

936

0.94

0.21

1.8

2.6

7.74

7.46

g/l

0.65

712

Non-small cell lung cancer, adenocarcinoma

936

0.94

0.21

1.8

2.6

7.74

7.46

g/l

0.65

712

Birth injury to peripheral nervous system

0.00

0.21

0.0

3.5

—

6.80

—

Disorder of amino-acid metabolism, other/unspecified

0.00

0.21

0.0

2.0

—

7.54

—

Hyperalimentation, other specified

0.00

0.21

0.0

1.3

—

7.63

—

Cholesteatoma of external ear

1.25

0.21

4.7

2.0

5.92

7.55

g/l

—

Wilms' tumor

1.26

0.21

1.0

1.3

7.94

7.54

g/l

—

Use of selegiline

634

1.08

0.21

2.2

2.4

6.73

7.46

g/l

3.55

476

Use of levodopa decarbox-comt-inhibitor

441

1.09

0.20

1.1

2.9

6.81

7.46

g/l

2.00

330

Male infertility

303

0.89

0.20

1.6

2.1

6.38

6.94

g/l

0.77

236

Any dementia, excluding more controls

638

4518

0.98

0.20

2.0

2.3

7.63

7.52

g/l

0.67

393

3248

Calculus of lower urinary tract

733

1.07

0.19

1.9

2.5

7.63

7.32

g/l

0.67

549

Intermittent heterotropia

423

1.09

0.19

2.1

2.0

6.75

7.45

g/l

1.66

325

Infections of breast associated with childbirth

241

1.12

0.19

1.1

1.6

7.02

7.48

g/l

0.86

199

Benign neoplasm: Vagina

137

1.17

0.19

2.1

1.3

6.97

7.44

g/l

—

107

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

156

1.16

0.19

1.7

1.4

7.54

7.64

g/l

0.11

120

Left side

1.20

0.18

1.0

2.1

—

7.45

—

Circumscribed brain atrophy

258

0.89

0.18

1.7

2.9

7.23

7.56

g/l

0.49

186

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

834

1.06

0.18

1.8

1.4

7.74

7.39

g/l

0.88

615

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS